Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADIPOQ,Adiponectin,40539,-0.274159742740467,0.00680187868158917,-0.287491424956381,-0.260828060524552,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRP,Agouti-related protein,42754,0.277282572097481,0.00488660715931034,0.267704822065233,0.28686032212973,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN1,CCN family member 1,42569,0.35555779032025,0.00709242728463856,0.341656632842358,0.369458947798141,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES1,Liver carboxylesterase 1,42661,0.335469957428647,0.00800378986694798,0.319782529289429,0.351157385567865,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCG,Pro-glucagon,42346,0.517943717848184,0.0124975818056689,0.493448457509073,0.542438978187295,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF9,Protein turtle homolog A,40511,0.336078562464402,0.00813032648999417,0.320143122544013,0.35201400238479,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLR,Low-density lipoprotein receptor,42644,0.393909840313562,0.00415969781557078,0.385756832595044,0.402062848032081,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPL,Lipoprotein lipase,42636,-0.200929399312306,0.00458079361182392,-0.209907754791481,-0.191951043833131,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFGE8,Lactadherin,42611,0.238548741160615,0.00409396888024001,0.230524562155345,0.246572920165886,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPY,Pro-neuropeptide Y,42721,0.349978281429397,0.00606113871192451,0.338098449554025,0.361858113304769,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHR,Growth hormone receptor,40283,0.110952735708633,0.00279035723882474,0.105483635520536,0.116421835896729,1.1125369292536e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FURIN,Furin,42679,0.12755805223729,0.00324603207347887,0.121195829373272,0.133920275101309,1.11253692925719e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.288897820872724,0.00744294511322559,0.274309648450802,0.303485993294646,1.2012816847563e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,40527,0.15683549387526,0.00411067169408595,0.148778577354851,0.164892410395668,9.23648442081449e-300
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0811826520019939,0.00220238326250591,0.0768659808074823,0.0854993231965055,4.93085545432146e-281
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.11887109875855,0.00328920581310751,0.112424255364859,0.125317942152241,4.1816068306005e-273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBC,Inhibin beta C chain,42611,0.148013433838444,0.00411523575729471,0.139947571754146,0.156079295922741,1.53479491555116e-270
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,42705,0.163562219184137,0.00473475618663012,0.154282097058342,0.172842341309932,1.14556081644186e-250
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH,Parathyroid hormone,40182,0.282300532733176,0.00820774467388851,0.266213353172355,0.298387712293998,2.61023919237078e-246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,42594,0.185205083808807,0.00543591810676932,0.174550684319539,0.195859483298075,4.43501581884243e-244
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.144946343885616,0.00425963692764452,0.136597455507433,0.153295232263799,1.44768028654346e-243
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.292210532483806,0.00872228997567682,0.275114844131479,0.309306220836133,2.25131974001835e-236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9,Complement component C9,40532,-0.178906421075982,0.00532168749193004,-0.189336928560165,-0.168475913591799,2.83373809110353e-236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F7,Coagulation factor VII,42671,0.104727604002663,0.00313096787148625,0.0985909069745496,0.110864301030776,1.00503885059804e-235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLTP,Phospholipid transfer protein,42752,-0.121078089206799,0.00362078125149974,-0.128174820459738,-0.113981357953859,1.17836636101403e-235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.274036354753842,0.00820085635033472,0.257962676307186,0.290110033200498,4.71359623338077e-235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG2,Desmoglein-2,42611,-0.0914777094014956,0.0027507290140931,-0.096869138269118,-0.0860862805338731,4.25232783664882e-233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS15,Enteropeptidase,42587,0.304734103887012,0.00922298338659999,0.286657056449276,0.322811151324748,3.2262010913382e-230
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP1,Neuropilin-1,42705,-0.0922133315948346,0.00280917616046092,-0.097719316869338,-0.0867073463203313,1.91152264933748e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.39869650540876,0.0121580624561858,-0.422526307822884,-0.374866702994636,4.75238671071419e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.262837205075773,0.00802150629399269,0.247115052739547,0.278559357411998,1.37025052636839e-226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR37,Prosaposin receptor GPR37,42357,0.222730057800376,0.00691227529645605,0.209181998219322,0.23627811738143,2.51234382497804e-219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPM,Carboxypeptidase M,42655,0.109684500887218,0.00341445780799341,0.102992163583551,0.116376838190885,3.20206998785838e-218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL27,C-C motif chemokine 27,42636,0.191435635857323,0.00596904622084423,0.179736305264468,0.203134966450177,1.55727006703163e-217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.486101372905657,0.0151979036669409,0.456313481718453,0.515889264092861,2.54020635584827e-216
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.262174249453878,0.0082298111403453,0.246043819618802,0.278304679288955,1.33538162672277e-214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.110402170605691,0.00349368548382365,0.103554547057397,0.117249794153985,1.60890487747757e-211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.198397286374322,0.00629345903875708,-0.210732466090286,-0.186062106658358,1.4217073686385e-210
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.332388146849569,0.0105864061342502,0.311638790826438,0.353137502872699,7.33885096806123e-209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL23,C-C motif chemokine 23,42676,0.133747606442046,0.00426056820104313,0.125396892768001,0.14209832011609,7.76918808563019e-209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,42570,0.0988078326952352,0.00315103028138185,0.0926318133437268,0.104983852046744,2.43864217911872e-208
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN3,Contactin-3,42611,0.0986825352222778,0.00316629372226524,0.0924765995266379,0.104888470917918,6.04640561308991e-206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0971468260121305,0.00314807374463425,-0.103317050551614,-0.0909766014726474,1.10929874011225e-200
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,42676,-0.0887423679795721,0.00289485897849752,-0.0944162915774272,-0.0830684443817169,1.46438827537031e-199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,40387,0.0963625550144208,0.00318874674988291,0.0901126113846503,0.102612498644191,6.44776363387544e-193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUSB,Beta-glucuronidase,42711,0.18406877503887,0.00617266481156573,0.171970352008201,0.196167198069538,2.70744747774272e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTR,Transthyretin,40424,0.0758051175554821,0.00255864379873219,0.070790175709967,0.0808200594009972,8.40446549414938e-186
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF21,Fibroblast growth factor 21,42689,0.351189610532738,0.0119327375337199,0.327801444966647,0.374577776098829,1.41049977775412e-184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,42495,0.0908111389536109,0.00310833263595189,0.0847188069871452,0.0969034709200766,6.45364031279703e-182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCHE,Cholinesterase,40346,0.0825077332348103,0.00282637090749511,0.0769680462561198,0.0880474202135007,1.35912297519972e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.175171118822706,0.00602075659550962,0.163370435895507,0.186971801749904,2.04599873395064e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.0979280523392956,0.00338094787086293,0.0913013945124043,0.104554710166187,5.56368055063473e-179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,42754,0.225199962255853,0.00780296628473218,0.209906148337778,0.240493776173928,8.3115062330245e-178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.205006057156214,0.00710279546177347,0.191084578051138,0.21892753626129,9.14439284207584e-178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIP2,Cysteine-rich protein 2,42495,0.106969067616644,0.00373480112405249,0.0996488574135013,0.114289277819787,4.02686588245222e-175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHBG,Sex hormone-binding globulin,40532,-0.146688961543523,0.00512890385116005,-0.156741613091797,-0.13663630999525,8.94862279903315e-174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFM,Afamin,40539,0.0578965471132484,0.00202494729320667,0.0539276504185633,0.0618654438079334,1.12313134177511e-173
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LG,CMRF35-like molecule 9,42611,-0.111880669842802,0.00392727720860678,-0.119578133171671,-0.104183206513933,2.2553021881855e-173
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA4,Kallistatin,40342,0.0693329772556311,0.00244976008017902,0.0645314474984803,0.074134507012782,3.12137356997387e-170
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY1,Aminoacylase-1,42636,0.174003964682531,0.00617163395403032,0.161907562132631,0.18610036723243,5.78531991624922e-170
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.148398504306051,0.00529036560926969,0.138029387711883,0.15876762090022,2.47269682313513e-168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROC,Vitamin K-dependent protein C,42663,0.0714837871920202,0.00256666202047825,0.0664531296318828,0.0765144447521575,5.07361535035796e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.321327206754949,0.0116111574383063,0.298569338175868,0.344085075334029,5.51412907416342e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA3,Glutathione S-transferase A3,42346,0.215955890494955,0.00780135641932515,0.200665231913078,0.231246549076833,5.52056146100069e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APCS,Serum amyloid P-component,40419,0.0963294142165512,0.00347721588366151,0.0895140710845747,0.103144757348528,1.8698741474779e-163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0714793315739914,0.00260847965944669,0.0663667114414759,0.0765919517065069,6.77472620705966e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,40511,0.156436670443398,0.005696351063182,0.145271822359562,0.167601518527235,8.53890622038563e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR3,Anterior gradient protein 3,42326,0.167689741994377,0.00612272693520892,0.155689197201368,0.179690286787387,1.18659533141709e-160
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAT,Tissue-type plasminogen activator,42760,0.141048607723917,0.00516391186301288,0.130927340472412,0.151169874975422,5.85283267873025e-160
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKB,Creatine kinase B-type,40527,-0.167852140373687,0.00615138586529243,-0.17990885666966,-0.155795424077714,7.70067430177996e-159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.202257322671966,0.00744398053493944,0.187667120823485,0.216847524520448,2.90203189021472e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0548433791731563,0.00202117552489128,0.0508818751443694,0.0588048832019432,8.88985793746622e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPB1,Beta-ureidopropionase,40511,0.248662385916486,0.00915760429320841,0.230713481501798,0.266611290331175,2.36408196703774e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,42658,0.0913974769726363,0.00338126974094386,0.0847701882803863,0.0980247656648862,9.50233060656253e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,40351,0.07337187294686,0.00271889831074606,0.0680428322577977,0.0787009136359223,1.97619555861865e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.15238998609376,0.00567140278792464,0.141274036629428,0.163505935558092,7.14329901582879e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLA,Alpha-galactosidase A,40267,0.102104092029196,0.00379493387040766,0.0946660216431967,0.109542162415195,1.64949265995426e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL16,C-C motif chemokine 16,42794,0.142910008937395,0.005348747553319,0.132426463732889,0.1533935541419,2.52040532999669e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.200746764296627,0.00753646770961085,0.185975287585789,0.215518241007464,2.46708807672363e-152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCA,Alpha-synuclein,40283,0.309806509034528,0.0117382533519734,0.28679953246466,0.332813485604396,6.20085115747656e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.101148270424072,0.00384676228999867,-0.10868792451247,-0.0936086163356748,1.19459520133285e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA1,Glutathione S-transferase A1,42611,0.220694896315545,0.00843951347309112,0.204153449908286,0.237236342722804,4.59796069196678e-147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFH,Complement factor H,39956,0.0609621409577236,0.00233517486166007,0.0563851982288699,0.0655390836865774,1.00857298077962e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUMB,Protein numb homolog,40199,0.218568678087928,0.00838510494996821,0.202133872385991,0.235003483789866,2.1502856064928e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFI,Complement factor I,40539,0.0519935074241831,0.00199865790437797,0.0480761379316023,0.055910876916764,5.79000395314659e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0906135252382604,0.00350212788085085,-0.0974776958847281,-0.0837493545917928,3.91740300820309e-144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO3,Beta-enolase,40223,0.155495462808688,0.00602559690351518,0.143685292877798,0.167305632739578,1.23822584876494e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",42311,0.144580690620294,0.00561713260976032,0.133571110705164,0.155590270535424,1.42804793994368e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F9,Coagulation factor IX,42663,0.0476291362319166,0.00185198309456225,0.0439992493665746,0.0512590230972586,1.96308014442375e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,42346,0.289378730533081,0.0112607054711034,0.267307747809719,0.311449713256444,3.83504561972846e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.150361182125382,0.00584136168293749,0.138912113226824,0.161810251023939,6.03270562645143e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,42611,0.0702785782551285,0.00274535081237186,0.0648976906628797,0.0756594658473773,3.7107921577585e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,42587,0.323123252897671,0.0126366776687219,0.298355364666976,0.347891141128366,7.6115642483992e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOMO1,Nodal modulator 1,42611,0.0603257465526269,0.00237405543020173,0.0556725979094315,0.0649788951958223,3.68186652488191e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.179979131068784,0.00707969554921485,0.166102927792323,0.193855334345246,1.12880533660186e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP5,Retinol-binding protein 5,42587,0.144895680406894,0.00572817742612451,0.13366845265169,0.156122908162098,6.07661165840148e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,40482,0.148787988039022,0.00589045257319992,0.13724270099555,0.160333275082494,5.48390758998391e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,42573,-0.161594786234545,0.00642331358374403,-0.174184480858683,-0.149005091610407,1.69576592763079e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.08112563480348,0.00323321475901398,0.0747885338758126,0.0874627357311474,7.6661736181804e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,40199,0.216816669488361,0.00862661536417049,0.199908503374587,0.233724835602135,1.36639345529591e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXT,Oxytocin-neurophysin 1,42711,0.355804630176129,0.0142084875169967,0.327955994642816,0.383653265709443,2.54993122393937e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFP,Properdin,40539,0.0572394497482797,0.00228400201131579,0.0527628058061008,0.0617160936904587,5.95194224283242e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS1,Protein MTSS 1,40449,0.28584613341112,0.0114256350117633,0.263451888788064,0.308240378034176,1.76672877106274e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0486661738680444,0.00195013857244592,0.0448439022660504,0.0524884454700384,2.15072638883882e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPIND1,Heparin cofactor 2,40516,0.0714778142843664,0.00287628239786839,0.0658403007845443,0.0771153277841884,8.81842854785166e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTYMK,Thymidylate kinase,40511,0.172426620911289,0.00695189033048068,0.158800915863547,0.186052325959031,2.73986312857732e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,42679,0.0567240499230764,0.00230107065262269,0.0522139514439359,0.0612341484022169,2.81720607689686e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.122504298685916,0.00497338807660603,0.112756458055768,0.132252139316064,4.97311788703854e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLUL1,Clusterin-like protein 1,42621,-0.1135621067518,0.00461777588829912,-0.122612947492866,-0.104511266010733,1.15951818733305e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS8,Prostasin,42568,0.106228125086696,0.00432218449210547,0.097756643482169,0.114699606691222,1.6923846327068e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYNU,Kynureninase,42754,0.112284851633293,0.00457066860287138,0.103326341171665,0.121243362094921,2.00830025694142e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4R,Reticulon-4 receptor,42721,0.0868721607053976,0.00354138274757763,0.0799310505201454,0.0938132708906497,4.73973254492841e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,42640,0.100932331664523,0.00412863798772879,0.0928402012085748,0.109024462120472,3.51432060567014e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.170183909397909,0.00694758664380742,0.156566639576047,0.183801179219772,4.82098946529879e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.147936720037222,0.00606121139681566,-0.159816694374981,-0.136056745699463,9.5495844720453e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.136670498525288,0.00560199559501996,0.125690587159049,0.147650409891527,1.16664521742472e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0998529753080701,0.00409393729917064,0.0918288582016956,0.107877092414445,1.35070243760019e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.344252605730109,0.0141687722754628,0.316481812070202,0.372023399390016,3.87468709743544e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.169038399812591,0.00698157312533467,0.155354516486935,0.182722283138247,9.65982010098068e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HJV,Hemojuvelin,40482,0.109805133092701,0.00452713906754702,0.100931940520309,0.118678325665093,9.94630368336468e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH1,Somatotropin,42613,-0.425345833105093,0.0176629547724823,-0.459965224459159,-0.390726441751028,1.77296665453001e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.21134637027032,0.00877667173943315,0.194144093661031,0.228548646879609,5.5766759065679e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,P4HB,Protein disulfide-isomerase,42563,0.0943692485520158,0.00393797249039956,0.0866508224708326,0.102087674633199,2.7147178824679e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRP,Gastrin-releasing peptide,40223,0.138202807753125,0.00575602094192899,0.126921006706945,0.149484608799306,3.24613047787603e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,42679,0.223548410915038,0.0093760475902665,0.205171357638116,0.241925464191961,4.1993384631089e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.136159154929015,0.00574121051485199,0.124906382319905,0.147411927538125,8.6076496771246e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FYB1,FYN-binding protein 1,42590,0.22380875965351,0.00944118285832564,0.205304041251191,0.242313478055828,9.9630775567244e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11R,Junctional adhesion molecule A,42611,0.135055116273206,0.00570932356801809,0.123864842079891,0.146245390466522,3.11158484527044e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,40451,0.13343732344654,0.00565002214800678,0.122363280036447,0.144511366856634,2.11582267850432e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,42587,0.27448982234806,0.0116497329866176,0.251656345694289,0.297323299001831,2.61347181995078e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL16,Pro-interleukin-16,42754,0.0997846520510955,0.00425508393249047,0.0914446875434142,0.108124616558777,3.0252630866129e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.105088140927413,0.00448892404674421,0.0962898497957943,0.113886432059032,7.99205886489219e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0808839945821171,0.00345648615764785,0.0741092817131273,0.0876587074511069,9.98862230975466e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM20A,Pseudokinase FAM20A,40511,0.0680463765606756,0.00290278235112882,0.0623569231524631,0.0737358299688881,1.05176784950358e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH9,Myosin-9,40527,0.275451544086794,0.0117525460505648,0.252416553827687,0.298486534345901,1.1445536608489e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0663766017214264,0.00283819070795923,0.0608137479338263,0.0719394555090265,1.35601979353605e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPY30,Protein dpy-30 homolog,42651,0.144749501977306,0.00620418996812252,0.132589289639786,0.156909714314826,4.67310904980613e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,42587,0.160334187732501,0.00687414044767024,0.146860872455068,0.173807503009935,5.56641305527028e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYY,Peptide YY,40116,0.246406475982279,0.0105437471247827,0.225740731617705,0.267072220346853,6.56700845783928e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EEF1D,Elongation factor 1-delta,40511,0.21865037717542,0.00937815918940505,0.200269185164186,0.237031569186654,1.79261619905029e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2AP,CD2-associated protein,42636,0.152090894492693,0.00654924637397145,0.139254371599709,0.164927417385677,5.32330744198363e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.211958983701214,0.00915155184877854,0.194021942077608,0.22989602532482,2.24567480673877e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,42636,0.0729360455278417,0.00316032532223942,0.0667418078962525,0.079130283159431,1.32162029748501e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.229143269416034,0.0099411468029633,0.209658621682226,0.248627917149842,2.53897881215756e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,42711,0.148684734410631,0.00645839564092263,0.136026278954423,0.16134318986684,4.53260029433315e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSD,Cathepsin D,41747,0.0999026466985711,0.00434488205052663,0.0913866778795389,0.108418615517603,1.251544049635e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORT1,Sortilin,42613,0.0874159480618865,0.00380647853359603,0.0799552501360383,0.0948766459877347,1.65811786661232e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,40456,0.256521893972026,0.0111500277848107,0.234667839513797,0.278375948430255,1.71246010623132e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,40182,0.284906960041196,0.0123947446746328,0.260613260478915,0.309200659603476,3.09577403776759e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES3,Carboxylesterase 3,42587,0.165670551291576,0.00726383300890886,0.151433438594115,0.179907663989038,5.4039256753508e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0452630440294587,0.00199111877489312,0.0413604512306682,0.0491656368282493,2.64817359376922e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BECN1,Beclin-1,40223,0.139731506112033,0.0061567014255706,0.127664371317914,0.151798640906151,1.72063374973382e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJAP1,Tight junction-associated protein 1,42679,0.192007821848229,0.00847922912559964,0.175388532762054,0.208627110934404,1.86996247378518e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPY,Pancreatic prohormone,42600,0.240538681731982,0.0106966779959091,0.21957319286,0.261504170603963,5.90769384241304e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.22419746789182,0.00998630670766915,0.204624306744788,0.243770629038851,1.31686347982047e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR5,Cadherin-related family member 5,42636,0.0897354239169387,0.00399820115910084,0.081898949645101,0.0975718981887763,1.49257656456664e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGF,Hepatocyte growth factor,42754,0.0806179954442261,0.00359415008477271,0.0735734612780716,0.0876625296103806,1.92769100897948e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MVK,Mevalonate kinase,42370,0.184950793367248,0.00824881039389781,0.168783124995208,0.201118461739287,2.65733108915498e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.18218110631704,0.00812938143816879,0.16624751869823,0.198114693935851,7.37335580704774e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXLNA,Alpha-taxilin,42495,0.202007915717832,0.00903190007120879,0.184305391578263,0.219710439857401,8.44469236245459e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEG1,Protein HEG homolog 1,40283,0.0621436957963407,0.00277490101709499,0.0567048898028345,0.0675825017898468,1.10939029251586e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.054268182024099,0.00243484821456404,0.0494958795235535,0.0590404845246445,4.26696423944618e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0950215120838851,0.00426502124147595,-0.103380953717178,-0.0866620704505923,5.27940955724022e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.192749998603577,0.00864794386088469,0.175800028636243,0.209699968570911,1.11509770313136e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYAP1,Synapse-associated protein 1,40283,0.131199427869303,0.00588710482942444,0.119660702403631,0.142738153334975,1.14637904007111e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCLY,Selenocysteine lyase,42674,0.107255698256975,0.00482231001922791,0.0978039706192887,0.116707425894662,1.16388563462343e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREG1,Protein CREG1,42445,0.0881748366128549,0.00397931671554763,0.0803753758503815,0.0959742973753282,7.48411360414545e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPC,C-type natriuretic peptide,42594,0.114888059265068,0.00518835033436307,0.104718892609716,0.12505722592042,9.7934404899449e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLN,Promotilin,42594,0.2027071596787,0.00917903220099963,0.184716256564741,0.220698062792659,3.51291137921893e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,42754,0.0752230154139831,0.00340792250707208,0.0685434873001218,0.0819025435278444,4.20201510768332e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC1,Stanniocalcin-1,42711,0.102860091915988,0.00466612258554596,0.0937144916483184,0.112005692183659,7.90011474185505e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.146635544743471,0.00665452760120031,0.133592670645118,0.159678418841823,1.06470932848322e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,40116,0.144055500786048,0.00653468908066073,0.131247510187953,0.156863491384143,2.09099739153274e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.183738401268247,0.00836126026795284,0.167350331143059,0.200126471393434,3.42636760624202e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A4,Protein S100-A4,42679,0.128996680368295,0.00587533608589582,0.117481021639939,0.140512339096651,5.23478549586395e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRN,"Attractin, Isoform 2",40539,0.0378728653070138,0.0017262629993646,0.0344893898282592,0.0412563407857685,1.60655990235244e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,42476,0.0530291335801469,0.00242081453664887,0.0482843370883151,0.0577739300719787,1.61453012749478e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORD,Sorbitol dehydrogenase,42658,0.150827937746582,0.00689817016282324,0.137307524227449,0.164348351265716,3.60430550504529e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F10,Coagulation factor X,40532,0.0638882283818344,0.00292264603123374,0.0581598421606162,0.0696166146030525,8.59256969715922e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAXX,Protein PAXX,40283,0.102193873556159,0.00467726479698303,0.0930264345540718,0.111361312558245,1.19647855523044e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.238103672582313,0.0109185052150827,0.216703402360751,0.259503942803875,1.24035524253876e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHK,Ketohexokinase,40223,0.140986953295086,0.00646031732446546,0.128324731339134,0.153649175251039,2.09904009736678e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN1,Dynactin subunit 1,42721,0.145050039832124,0.00666742282322039,0.131981891098612,0.158118188565636,3.59859530546721e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAB2,Stabilin-2,40527,0.0628142683064418,0.00289138925329804,0.0571471453699776,0.0684813912429059,1.46224611962792e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,42594,0.0945022614472394,0.00435947650804313,0.0859576874914749,0.103046835403004,1.90983562120765e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.119381223343472,0.00550970403462527,0.108582203435606,0.130180243251337,2.42516544425862e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.249458237696331,0.0115209678028119,0.226877140802819,0.272039334589842,7.22138705920066e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXIN1,Axin-1,42594,0.211185314220316,0.00977497117158736,0.192026370724005,0.230344257716628,8.76822210098921e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.123053898221369,0.00570203637654329,0.111877906923344,0.134229889519394,1.60447246976217e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.179039745125107,0.00829547947098989,0.162780605361966,0.195298884888247,2.87767949162552e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.184464712740233,0.00856987756884842,0.16766775270529,0.201261672775176,1.0331180630185e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,42679,0.0548452592996111,0.00255297822734651,0.0498414219740119,0.0598490966252103,1.08815432452898e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR2,Cadherin-related family member 2,42587,0.156428112997042,0.0072944929954878,0.142130906725886,0.170725319268198,2.47002035961676e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,40483,0.104895531284568,0.00490596972922031,0.0952798306152965,0.11451123195384,1.84836829190606e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0878487631252122,0.00411947381120948,0.0797745944552416,0.0959229317951828,5.84401513128966e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,40013,0.070906235676235,0.00332411783871757,0.0643909647123485,0.0774215066401214,6.29548540520662e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.108623874831164,0.00511960856031409,0.0985894420529487,0.11865830760938,5.77722362987694e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0663311175845015,0.00313221198750328,0.0601919820889951,0.072470253080008,1.2301011532851e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,42618,0.0676415259110723,0.00319936174182469,0.0613707768970959,0.0739122749250487,1.26117533866281e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,42370,0.185245111677846,0.00876622880258076,0.168063303224788,0.202426920130904,1.67338732016596e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS2,Protein MTSS 2,40451,0.214971223049328,0.0101627144607543,0.19505230270625,0.234890143392407,2.01178780809582e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,42754,0.088596092085367,0.00419994666876571,0.0803641966145862,0.0968279875561478,3.22820057781933e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM1,Isthmin-1,42594,0.0838572773428577,0.0039856230782976,0.0760454561093944,0.091669098576321,1.02824201194607e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.046957497326944,0.00223098857088498,0.0425847597280095,0.0513302349258786,1.81714802306859e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,42346,0.138861842660522,0.00661054410617338,0.125905176212423,0.151818509108622,2.18962146623066e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0801138774949178,0.00381840532123335,0.0726298030653004,0.0875979519245352,3.34669748951584e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.142918404368541,0.00681894543045431,0.129553271324851,0.156283537412231,5.70910529071712e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARF6,ADP-ribosylation factor 6,40449,0.231511114635197,0.011045355789329,0.209862217288112,0.253160011982282,1.01112978198933e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.155542170991661,0.00744331754674373,0.140953268600043,0.170131073383279,2.01517210923959e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,40283,0.160328704656575,0.00767077304668511,0.145293989485072,0.175363419828078,3.52145497122185e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLKB1,Plasma kallikrein,40293,0.0531152767162635,0.0025419824141777,0.0481329911844752,0.0580975622480518,3.96153268965539e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.209592145664329,0.0100340816240881,0.189925345681116,0.229258945647541,4.27599358907149e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.159785432616969,0.00765652242408092,0.144778648665771,0.174792216568168,6.18539631170842e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,42689,-0.072491607013216,0.00347981021736574,-0.0793120350392529,-0.0656711789871792,6.85803948620881e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOF,Apolipoprotein F,40532,-0.0512993358635584,0.00246094859328629,-0.0561227951063996,-0.0464758766207173,9.92203087799489e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.155194952326305,0.00746251650660981,0.140568419973349,0.16982148467926,2.95198424973883e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD63,CD63 antigen,42475,0.109404664155685,0.00527630948371316,0.0990630975676076,0.119746230743763,5.12251077290782e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EZR,Ezrin,42711,0.0511461893044469,0.00246877654231251,0.0463073872815144,0.0559849913273794,6.92107645019214e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,42594,0.194352542404872,0.00940747758391751,0.175913886340394,0.212791198469351,2.27772512700106e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.142972584795116,0.00691529793951684,0.129418600833663,0.156526568756569,3.04976437385724e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN2,Ficolin-2,42597,0.0874942032847483,0.00424995725942463,0.0791642870562761,0.0958241195132206,9.68732370542881e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFC,Platelet-derived growth factor C,42346,0.0608297760203174,0.00295535322058158,0.0550372837079775,0.0666222683326573,1.11976640820668e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,42594,0.0846649900387277,0.00411963306639045,0.0765905092286024,0.0927394708488529,1.97061502248379e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3F,Semaphorin-3F,42636,0.0575890628485998,0.00280913042581233,0.0520831672140077,0.063094958483192,5.3870327357476e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,42311,0.165013632152133,0.00806494582953133,0.149206338326252,0.180820925978014,1.29307660123823e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCS1,Neuronal calcium sensor 1,42721,0.0611547035472012,0.00299404882799533,0.0552863678443304,0.0670230392500721,2.36012990809838e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.218273114897571,0.0107185783657465,0.197264701300708,0.239281528494434,8.21519251535168e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0978152112676208,0.0047985477953436,0.0884100575887474,0.107220364946494,1.04862122739054e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHBP1,EH domain-binding protein 1,40511,0.155954853718632,0.00765666108627111,0.140947797989541,0.170961909447723,1.32579981060637e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.104065883579103,0.00512886246269231,0.0940133131522263,0.11411845400598,3.7387513592669e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0430353934016088,0.00212266515737506,0.0388749696931537,0.047195817110064,4.85700248836151e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.154302588198726,0.00760456621345381,0.139397638420356,0.169207537977095,6.95907172027163e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZN,Kazrin,40449,0.218055493589193,0.0107549258306369,0.196975838961145,0.239135148217241,8.5067288375188e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.22781627024549,0.0112369994731992,0.20579175127802,0.249840789212961,8.82067577535292e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,40116,0.141985945871296,0.00702600289581612,0.128214980195496,0.155756911547095,3.47135185042636e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBIN,Erbin,42587,0.212476857228532,0.0105327456641249,0.191832675726847,0.233121038730217,3.55367994663107e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R9B,Neurabin-2,42754,0.194658219469534,0.00968033524450615,0.175684762390302,0.213631676548766,1.20953028920897e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROS1,Vitamin K-dependent protein S,40539,0.0542133124430176,0.00270202103906479,0.0489173512064506,0.0595092736795845,5.07727088340551e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.222206520574454,0.0110766487584057,0.200496289007978,0.243916752140929,5.49307583127171e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNA4,Plexin-A4,42594,0.169988043499708,0.00848610542768446,0.153355276861446,0.186620810137969,5.66659908193895e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCR,Breakpoint cluster region protein,42594,0.188114695409374,0.0094319053753283,0.169628160873731,0.206601229945018,3.06955854990311e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BACH1,Transcription regulator protein BACH1,42594,0.150798006140768,0.0075623079492196,0.135975882560298,0.165620129721238,3.30252211825923e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEP,Leptin,42636,0.136819362481741,0.00687306966523845,0.123348145937874,0.150290579025609,6.34922241481421e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDUA,Alpha-L-iduronidase,42721,0.0953037555023652,0.00480012720006271,0.0858955061902422,0.104712004814488,1.71284317131374e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.117832766444866,0.00594710979407261,0.106176431248484,0.129489101641248,3.96154574114226e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRN,Agrin,42676,0.0747039082594326,0.00377249666363273,0.0673098147987125,0.0820980017201528,4.7361719963704e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP20,Centrosomal protein 20,42346,0.153145503889842,0.00774362859575482,0.137967991842163,0.168323015937521,8.25981269096134e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,42594,0.131828781286504,0.00667033114976279,0.118754932232969,0.144902630340039,1.01721368504296e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.141851091302704,0.00718207310270466,0.127774228021403,0.155927954584005,1.36191318934927e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.106168822356062,0.00536984345595573,0.0956439291823884,0.116693715529735,1.47541936389943e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0721126600218387,0.00365476752558956,-0.0792760043719943,-0.0649493156716832,1.89473785426254e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,40483,0.181072675982763,0.00916646058078756,0.16310641324442,0.199038938721107,2.0430600459948e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,40449,0.172012823201561,0.00872118474789437,0.154919301095688,0.189106345307434,3.68076405900235e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0601530429972229,0.0030533799161436,0.0541684183615815,0.0661376676328644,5.62081207116371e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,40199,0.161981772189784,0.00822044138974792,0.145869707065878,0.17809383731369,5.67169380507393e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTBS,Di-N-acetylchitobiase,40383,0.0545852353588497,0.00277083981061646,0.0491543893300414,0.0600160813876579,5.89611277636537e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,42711,0.193752615778001,0.00985179950350666,0.174443088751128,0.213062142804874,6.37075367044831e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.102487073616355,0.00521134870099956,0.0922728301623962,0.112701317070314,6.60107601587655e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",42587,0.164300553725401,0.00835632355386388,0.147922159559828,0.180678947890974,7.17364669613157e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,42480,0.0755816871902703,0.00384487344301317,0.0680457352419645,0.0831176391385762,7.92112495545983e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL22,C-C motif chemokine 22,42509,0.107995895476465,0.00550280459718318,0.0972103984659861,0.118781392486944,1.45754061491341e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0596555846861191,0.00303686314359067,0.0537033329246814,0.0656078364475568,1.68514854327784e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.140360678583958,0.00714750857208822,0.126351561782665,0.154369795385251,1.87503243737048e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.212528079518167,0.0108763452866333,0.191210442756366,0.233845716279968,7.32227435989851e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,42636,0.174774974233891,0.0089623917242675,0.157208686454326,0.192341262013455,1.53184818166874e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0641407633920964,0.00329002379049703,0.0576923167627222,0.0705892100214705,1.68015113583311e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLA2,Src-like-adapter 2,40482,0.209074252489973,0.0107297496298946,0.18804394321538,0.230104561764566,3.36724259272183e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FETUB,Fetuin-B,42663,0.0648342456469729,0.00333267656494251,0.0583021995796856,0.0713662917142603,3.70838369979539e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBP,Protein AMBP,42706,0.0422495600665933,0.00217185326997439,0.0379927276574435,0.0465063924757431,3.73984271917287e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1A,Meprin A subunit alpha,40449,0.146003243871389,0.00750410295853558,0.131295202072659,0.160711285670118,5.87750847779332e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD6,T-cell differentiation antigen CD6,42746,0.106307945231612,0.0054716170836669,0.0955835757476244,0.117032314715599,5.87846611286439e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.076541251541086,0.00394443976791786,0.068810149595967,0.084272353486205,9.28517667345718e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.228058868029284,0.0117425325110235,0.205043504307678,0.25107423175089,1.13328328077356e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.121906637845487,0.00628669233932976,0.109584720860401,0.134228554830574,1.30669149995793e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK1,Dickkopf-related protein 1,42711,0.117732654376022,0.00607644498283151,0.105822822209672,0.129642486542371,1.63590424184071e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,42676,0.247710418780469,0.0127958836589223,0.222630486808981,0.272790350751957,2.25538838813914e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,42357,0.107553364266332,0.00556760512540093,0.0966408582205459,0.118465870312118,5.18360000843476e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0756786737528346,0.00391254070873436,0.0680100939637153,0.083347253541954,5.24054203941082e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,42587,0.273526563356786,0.0141649024893447,0.24576335447767,0.301289772235902,5.71813186163528e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.195888455398791,0.0101463689381066,0.176001572280102,0.21577533851748,5.96639500355479e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.13621764867622,0.00705495871356993,0.122389929597623,0.150045367754817,6.19917803852036e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MME,Neprilysin,42587,0.161617393630303,0.00842022952248855,0.145113743766226,0.178121043494381,5.07399706884793e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPK2,SRSF protein kinase 2,42594,0.165816896432855,0.00863985604561061,0.148882778583458,0.182751014282252,5.24629526939051e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTD,Biotinidase,40539,0.0408667981625633,0.00213153066942623,0.0366889980504879,0.0450445982746387,1.17685974056418e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSO,Cathepsin O,42754,0.0609263107365164,0.00318925138413779,0.0546753780236063,0.0671772434494264,2.66308026147865e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.147177302871749,0.00769816191339703,0.132088905521491,0.162265700222007,3.48533697662022e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.14374479521949,0.00753174665078075,0.12898257178396,0.15850701865502,3.80999716909808e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO1,Forkhead box protein O1,42594,0.167458164700468,0.00879512219449557,0.150219725199257,0.18469660420168,8.97868722733269e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,42711,0.13113574179242,0.00689094909308007,0.117629481569983,0.144642002014857,1.05430677346138e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELE,E-selectin,42794,0.100064916967615,0.00526464468277879,0.0897462133893683,0.110383620545861,1.59851071616156e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUCB2,Nucleobindin-2,42683,0.072768834378874,0.00382859533230811,0.0652647875275501,0.0802728812301979,1.63849873973951e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAB2,Disabled homolog 2,42721,0.213852855914605,0.0112951662846448,0.191714329996701,0.235991381832509,6.35830529317091e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,42676,0.2039141476203,0.0108358031022911,0.182675973539809,0.225152321700791,5.30045200396675e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0780007804986649,0.00414582583895574,-0.0861265991430182,-0.0698749618543116,5.77110304619169e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,42676,0.132114314257709,0.0070227814143584,0.118349662685566,0.145878965829851,5.95190481097588e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RB,Interleukin-17 receptor B,42416,-0.10424938134881,0.00555400041527073,-0.115135222162741,-0.0933635405348794,1.34756177934188e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOST,Sclerostin,42613,0.0757453666318206,0.00404239442470906,0.0678222735593908,0.0836684597042503,2.35968031976073e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELN,Elastin,40511,0.0712546804793737,0.00380119986129203,0.0638043287512413,0.0787050322075061,3.10743296879292e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN2,Prorelaxin H2,40257,0.0969695783679262,0.00517414736812742,0.0868282495263965,0.107110907209456,3.55976969063289e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD5,Programmed cell death protein 5,42711,0.111528536527221,0.00596471309411687,0.0998376988627524,0.123219374191691,4.79984266308749e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,42754,0.14582749071506,0.00780412391525804,0.130531407841154,0.161123573588966,5.94638827218865e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,42587,0.114510201356017,0.00614383572490126,0.10246828333521,0.126552119376823,1.45938982478435e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC13,Mucin-13,42311,0.10102823919696,0.00542072933386985,0.0904036097025752,0.111652868691345,1.55166420868038e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.205632859325262,0.0110369729647094,0.184000392314432,0.227265326336093,2.47069417298267e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.162691445585377,0.00875570442114977,0.145530264919924,0.179852626250831,4.1188975810848e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELP,P-selectin,42689,0.10767194564688,0.00580242405796938,0.0962991944932602,0.1190446968005,6.35947507731004e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCXR,L-xylulose reductase,42679,0.101128145927749,0.00545210895818222,0.0904420123697117,0.111814279485786,7.35484612699218e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.172827334001737,0.00930935001042833,0.154581007981298,0.191073660022177,8.26214447980193e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THOP1,Thimet oligopeptidase,42571,0.0593423984045396,0.00320189074332793,0.0530666925476168,0.0656181042614623,9.80258836523695e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.1961845131113,0.01059836884506,0.175411710174983,0.216957316047618,2.32650528808784e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0764803701802861,0.00413831088372741,0.0683692808481804,0.0845914595123918,3.77548729043564e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.127409832094893,0.00690182891505792,0.11388224742138,0.140937416768407,3.84518413148413e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.212486278839855,0.0115264769950904,0.189894383929477,0.235078173750232,5.83938603270939e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0991822641942867,0.00538038243830385,0.0886367146152111,0.109727813773362,5.84485564661105e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.136521292996784,0.00739776588627526,0.122021671859684,0.151020914133883,6.09478619367633e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP43,Centrosomal protein 43,42255,0.131910461301284,0.00715748045678976,0.117881799605976,0.145939122996592,6.73371543660148e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,42587,0.0692421314614325,0.0037588945901104,0.0618746980648161,0.0766095648580489,7.48976632406549e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,42600,0.0380861399539652,0.00206865615712626,0.0340315738859977,0.0421407060219327,8.92136761442548e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGLN1,Egl nine homolog 1,42594,0.106058067844922,0.005760561358155,0.0947673675829381,0.117348768106906,8.9279590661736e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,40482,0.118200817218106,0.00641466521625265,0.105628073394251,0.130773561041962,9.96063821450805e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.121287752113653,0.00658770059500442,0.108375858947444,0.134199645279862,1.31289104255937e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,40283,0.148805650164106,0.00808125697157863,0.132966386499812,0.1646449138284,1.3138759021576e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.182140532654286,0.00990547130043317,0.162725808905437,0.201555256403135,1.33772449952611e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXN,Paxillin,42311,0.0975837089798816,0.00530650230451551,0.0871829644630312,0.107984453496732,1.37748832022459e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.130730229638814,0.00710347071745223,0.116807427032608,0.144653032245021,1.5921547053678e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.207115370158469,0.0112595552231925,0.185046641921012,0.229184098395926,1.78120912716481e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK2,Docking protein 2,42636,0.228854998230408,0.0124594806416323,0.204434416172808,0.253275580288007,1.92693706347594e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEXIM1,Protein HEXIM1,42594,0.15368887956724,0.00836777644740553,0.137288037730325,0.170089721404155,1.98126170930715e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.148115418716278,0.00805553063630952,0.132326578669112,0.163904258763445,2.02203767688826e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0463014050116874,0.00252140899862717,0.0413594433743782,0.0512433666489967,2.07646550198904e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPL,N-acetylneuraminate lyase,40511,0.0866957333663982,0.00472110854156188,0.0774423606249369,0.0959491061078595,3.07203733643539e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,42794,0.125328572143274,0.00684818138198382,0.111906136634586,0.138751007651963,6.25407852571955e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.145319899555248,0.00794475249793303,0.129748184659299,0.160891614451196,7.67391494935556e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.104299755724377,0.0057062968183404,0.0931154139604299,0.115484097488324,9.49461523447318e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH2,Neutral ceramidase,42495,0.101459457787325,0.00555932741140211,0.0905631760609767,0.112355739513673,1.61954888099734e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,40457,0.109753496364876,0.00600741007367789,0.0979789726204674,0.121528020109285,1.65482236305226e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.112326736542221,0.00616282973103155,0.100247590269399,0.124405882815043,3.57271726083664e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FN1,Fibronectin,40539,0.0502942933488023,0.00276280476991385,0.0448791959997712,0.0557093906978334,5.21954857307826e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.178556591002269,0.00982043399129518,0.159308540379331,0.197804641625208,5.45877940661765e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP2,Methionine aminopeptidase 2,42689,0.107406231785285,0.0059081834486349,0.0958261922259603,0.118986271344609,5.58675770410707e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.193912090521817,0.0106673003406528,0.173004181854137,0.214819999189496,5.71911152802737e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMIP,C-Maf-inducing protein,40451,0.156103409811735,0.00857930390322001,0.139287974161424,0.172918845462046,6.20540292314505e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.118355591928282,0.00652020522396245,0.105575989689315,0.131135194167248,9.52140238320322e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,42611,0.10083730039643,0.00556366753457923,0.0899325120286549,0.111742088764205,1.50124191345824e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.157262653166613,0.00866756280080034,0.140274230077045,0.174251076256182,1.53543586956829e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINH1,Serpin H1,40302,0.242250064512788,0.0133691598661446,0.216046511175145,0.268453617850432,2.42528552606894e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.177012694883234,0.00978307844103835,0.157837861138798,0.196187528627669,2.67617675618426e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN1,Perilipin-1,42311,0.0654869658115456,0.00362540164849242,0.0583811785805005,0.0725927530425908,4.61396104089146e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,40482,0.134929939115537,0.00746329337768265,0.120301884095279,0.149557994135795,4.80908824586611e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGF,Placenta growth factor,42754,0.0498295487140453,0.00276595423317759,0.0444082784170172,0.0552508190110733,1.01102766435646e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,42594,0.159465429058855,0.00885595881539806,0.142107749780675,0.176823108337036,1.20674461240828e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPD52L2,Tumor protein D54,40283,0.199832361044058,0.0110912959174726,0.178093421045812,0.221571301042305,1.49351071301359e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,42594,0.108006653637158,0.00600282980186736,0.0962411072254984,0.119772200048818,1.54305702094007e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,42711,0.120660421969175,0.00672544152933478,0.107478556571679,0.133842287366671,3.77279908022556e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,40317,0.0252033812053951,0.00140301764815019,0.0224534666150207,0.0279532957957695,3.77946625006937e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINK1,Misshapen-like kinase 1,40483,0.172456767851879,0.00960626578657997,0.153628486910183,0.191285048793576,4.44503736508084e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.206413134397036,0.0115186161765902,0.18383664669092,0.228989622103153,5.63200584450656e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0951768416403954,0.00531281605914719,0.0847637221644669,0.105589961116324,6.33899401481058e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AAMDC,Mth938 domain-containing protein,40223,0.0987529178423223,0.00551048631700062,0.0879523646610011,0.109553471023643,8.14276436140603e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCTN3,Tectonic-3,40511,0.0556982929508266,0.00311117510008661,0.0496003897546568,0.0617961961469964,1.05740520591173e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,42357,0.134273746478834,0.00750995552026422,0.119554233659116,0.148993259298552,1.1657341242692e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOD,Apolipoprotein D,40033,-0.0810032281516921,0.00452674424854107,-0.0898756468788326,-0.0721308094245516,1.34616438513916e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0763639321670326,0.00428216077867069,0.0679708970408381,0.0847569672932272,2.50591308364896e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAMBP,STAM-binding protein,42476,0.116855953578365,0.00655285122548459,0.104012365176415,0.129699541980315,2.58929097269707e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH2,Cadherin-2,42636,0.0657630278935675,0.00369120204181821,0.0585282718916038,0.0729977838955312,3.38971747996215e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0872018510153136,0.0049038185078186,-0.096813335290638,-0.0775903667399891,6.04257161552828e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOT,Angiomotin,40283,0.0715333358614351,0.00401934978380377,0.0636554102851797,0.0794112614376905,6.92967036120781e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT2,Omega-amidase NIT2,40462,0.134780511611357,0.00757606931347234,0.119931415756951,0.149629607465763,7.55009072686489e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0499387993069,0.00281322437922254,0.0444248795236238,0.0554527190901762,1.0547350345622e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLB1,Beta-galactosidase,42495,0.0762749215080022,0.00429719798154688,0.0678524134641703,0.0846974295518341,1.09598354134049e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP5,Fatty acid-binding protein 5,42678,0.124558172469204,0.00701998097503933,0.110799009758126,0.138317335180281,1.19813774438494e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA2,Apolipoprotein A-II,40532,-0.0906539909728381,0.00510683164460056,-0.100663380996255,-0.080644600949421,1.45978553277633e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,40449,0.140279144828327,0.00792495806423871,0.124746227022419,0.155812062634235,3.55720906228875e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNMBP,Dynamin-binding protein,42495,0.109967065350625,0.00622258614926971,0.097770796498056,0.122163334203193,4.22040089504892e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.107038109496239,0.00605740006736671,0.0951656053642003,0.118910613628278,4.25063600341295e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,40511,0.135188757753819,0.00764351767950957,0.12020746310198,0.150170052405658,4.49451194423607e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGFR,Opioid growth factor receptor,42587,0.0596277664931876,0.00337814617797149,0.0530065999843634,0.0662489330020117,6.01905746158289e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR,GMP reductase 1,42754,0.0903083616369314,0.00512857069588774,0.0802563630729914,0.100360360200871,1.22073362289781e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.115328244888983,0.00655147731371467,0.102487349354102,0.128169140423863,1.88842360932897e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2B3,SH2B adapter protein 3,42346,0.177483332948244,0.0101054936359544,0.157676565421773,0.197290100474714,2.83757705792239e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTDH,Protein LYRIC,40199,0.170990249810827,0.00972703300148808,0.151925265127911,0.190055234493744,3.04979054850866e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEFTY2,Left-right determination factor 2,42689,0.0910568319059811,0.00519400651702868,0.0808765791326049,0.101237084679357,4.69936915855146e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX15,Sorting nexin-15,40283,0.0986683210382527,0.00562332409148474,0.0876466058189426,0.109690036257563,5.24932893344932e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USO1,General vesicular transport factor p115,42587,0.16335686601036,0.00932932264557403,0.145071393625035,0.181642338395685,6.84034726548666e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.151956467845777,0.00866829773185906,0.134966604291333,0.16894633140022,7.04929543162136e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.186576384277102,0.0106470091083256,0.165708246424784,0.207444522129421,7.47548828344589e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,42679,0.10081637146176,0.00576713264204744,0.0895127914833474,0.112119951440173,1.10928644926206e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.167542610391132,0.00960493601540295,0.148716935800943,0.186368284981322,2.20882037858247e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL32,Interleukin-32,42594,-0.0804436809353604,0.00461384728913793,-0.0894868216220708,-0.0714005402486501,2.46184943272304e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS6,Growth arrest-specific protein 6,42718,-0.0459488896694588,0.00263759634868408,-0.0511185785128795,-0.040779200826038,3.10778962602406e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,40199,0.175032316086348,0.0100368861185193,0.15536001929405,0.194704612878645,3.33478794071852e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0519625550240447,0.00299288763590101,0.0460964952576787,0.0578286147904106,8.90997982062308e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0793343447780734,0.00457218107112398,0.0703728698786704,0.0882958196774764,1.02863588898887e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUOM,Fucose mutarotase,40283,0.113816420981786,0.00656567009825152,0.100947707589213,0.126685134374359,1.91449536169762e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.127369244447358,0.00735455452995267,0.112954317568651,0.141784171326066,2.53830336651208e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0702122229119058,0.00406367063346845,0.0622474284703076,0.0781770173535039,3.58339239018338e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT1,Deaminated glutathione amidase,40223,0.085019880412975,0.00492752626612453,0.0753619289313709,0.0946778318945791,7.60498304719896e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMN,Protein amnionless,42370,0.08443731712443,0.00490119684380682,0.0748309713105686,0.0940436629382913,8.60705364085839e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.206703408874555,0.0120138173351021,-0.230250490851355,-0.183156326897755,1.21735105125182e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,40482,0.0984349032935981,0.0057152115431025,0.0872330886691172,0.109636717918079,1.22099397849219e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,42587,0.149584722417963,0.00870876316259389,0.132515546619279,0.166653898216647,2.00185904549631e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0416181221282526,0.00242352502449461,0.0368680130802432,0.0463682311762621,2.12783633907705e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,40482,0.134396353507935,0.00782451793533519,0.119060298354678,0.149732408661192,2.69168179688464e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,42611,0.089843184977539,0.00524676699425922,0.0795595216687909,0.100126848286287,4.8575435043889e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,42346,0.107165190908338,0.00625771014297266,0.0949000790281112,0.119430302788564,4.86622106888563e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,40482,0.201609944024708,0.0117627399033811,0.178554973814081,0.224664914235335,4.97426974523067e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0492439720987671,0.00287637641167632,0.0436062743318815,0.0548816698656527,5.12753848624505e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNST,Consortin,42636,0.192734997846829,0.0112594514087881,0.170666473085605,0.214803522608054,5.34968468088399e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSB,Arylsulfatase B,42587,0.0976787640079286,0.00571107748164819,0.0864850521438981,0.108872475871959,6.83378612480166e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0487774446920101,0.00285212781153529,0.043187274181401,0.0543676152026193,6.95501071017106e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.160279878032299,0.00937019252884434,0.141914300675764,0.178645455388834,8.89980750420333e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.184659163174282,0.010820944368768,0.163450112211497,0.205868214137068,1.2884684369939e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,42721,0.064467987432121,0.00378594574952822,0.0570475337630457,0.0718884411011963,2.37149220911386e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0985804999785423,0.00578227244365562,0.0872472459889773,0.109913753968107,2.38132787493153e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QDPR,Dihydropteridine reductase,42581,0.0751322735672031,0.00441359381380587,0.0664816296921436,0.0837829174422626,2.63342961908537e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.135261902561645,0.00794874810760797,0.119682356270733,0.150841448852557,2.9235077829558e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BID,BH3-interacting domain death agonist,42594,0.118737016860654,0.00698790879518391,0.105040715622094,0.132433318099215,4.42402572833146e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST13,Hsc70-interacting protein,40283,0.0994046135570951,0.00585031487740886,0.0879379963973737,0.110871230716816,6.11586798020799e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRAP,BRCA1-associated protein,40342,0.191944666775527,0.0113117176128111,0.169773700254417,0.214115633296637,8.82615037192489e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPHN1,Oligophrenin-1,40483,0.188003456062806,0.011091400957215,0.166264310186664,0.209742601938947,1.16866437839212e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,42605,0.199287837109796,0.0117700229453409,0.176218592136928,0.222357082082664,1.20014766881929e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.139946047271469,0.00825789824921948,0.123760566702999,0.15613152783994,1.23761139105287e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0588259706361606,0.00347044350205354,0.0520239013721357,0.0656280399001855,1.25507376832173e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,40283,0.0708833848600646,0.00418600226692497,0.0626788204168917,0.0790879493032375,1.59808586597274e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOA,Elongin-A,42587,0.0941963650051541,0.0055689636286274,0.0832811962930444,0.105111533717264,1.60309809008251e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,40483,0.11087901577457,0.00656372763742606,0.0980141096052151,0.123743921943925,3.0380379451551e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLK1,Protein delta homolog 1,42794,0.0965852336411325,0.00572693923121268,0.0853604327479557,0.107810034534309,3.56121397659758e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,42357,0.0614033418771963,0.00364219343047678,0.0542646427534618,0.0685420410009308,4.14042167165432e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.135453958747417,0.00803942463469081,0.119696686463423,0.151211231031411,6.28123051997689e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0776510761045242,0.00461391260610138,0.0686078073965655,0.0866943448124829,6.53434978398362e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0382682505030536,0.00227928151398962,0.0338008587356339,0.0427356422704732,1.28802724682968e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.109341413500165,0.00651292155007164,0.0965760872620245,0.122106739738305,1.32945986898848e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAG1,Dystroglycan,42676,0.0799884503374005,0.00476851712310887,0.0706421567761071,0.0893347438986939,1.61795887575347e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM13A,Protein FAM13A,40449,0.117229521419365,0.00698751037524177,0.103534001083891,0.130925041754839,2.05490768299209e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0900073163589624,0.00538454850007071,0.0794536012988238,0.100561031419101,5.60143194428474e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EREG,Proepiregulin,42476,0.139570508033308,0.00836200971567411,0.123180968990587,0.15596004707603,6.50139501850913e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,40482,0.135913817422404,0.00813829422082395,0.119962760749589,0.151864874095219,7.16217270056129e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0914368589207885,0.00548382400511704,0.0806885638707591,0.102185153970818,1.13667143066081e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,42586,0.111835690682732,0.00671467507192766,0.098674927541754,0.12499645382371,1.15191214988163e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MITD1,MIT domain-containing protein 1,42495,0.165561835171529,0.00994040816366348,0.146078635170749,0.185045035172309,1.16262808674499e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.153782709675479,0.00923579022376398,0.135680560836902,0.171884858514056,1.68564730641606e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,40116,0.0749413037751993,0.00450423403913227,0.0661130050585001,0.0837696024918985,2.10240038173997e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRKL,Crk-like protein,42636,0.180519858947438,0.0108706214753,0.15921344085585,0.201826277039026,2.5620518176438e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBPL,FK506-binding protein-like,40449,0.101019667463232,0.00608195091371867,0.089099043672343,0.11294029125412,3.1646590619423e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYDGF,Myeloid-derived growth factor,40511,0.169065426563403,0.010188995952771,0.149094994495971,0.189035858630834,4.12199547646677e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.08803937301563,0.00531724941918219,0.0776175641540329,0.0984611818772271,5.86181101317522e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMA,Granzyme A,42754,0.0612528684574932,0.00370084649334225,0.0539992093305424,0.068506527584444,6.22429504151286e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR2,GMP reductase 2,40283,0.115711687534889,0.00698604670956022,0.102019035984151,0.129404339085627,6.90246346016883e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,40482,0.104809116304892,0.00633824648943013,0.0923861531856085,0.117232079424175,1.04336380107398e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB2,Carboxypeptidase B2,40516,0.0381339840996029,0.00230733979519795,0.033611598101015,0.0426563700981909,1.19603211536305e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GLB2,Endophilin-B2,40483,0.114485283250142,0.00693036582792226,0.100901766227414,0.128068800272869,1.36520366095416e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN2,CCN family member 2,42624,0.0946609758833026,0.00573621056296498,0.0834180031798913,0.105903948586714,1.39166947884449e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0844290981840626,0.00511324076052303,0.0744071462934374,0.0944510500746877,1.61422655982943e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD1,COMM domain-containing protein 1,40223,0.103558252188662,0.00627301853790092,0.0912631358543762,0.115853368522948,1.68999772936693e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,40511,0.140909678245138,0.00854918148479373,0.124153282534943,0.157666073955334,2.47877692893531e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,42594,0.118784826999512,0.0072271615477987,0.104619590365827,0.132950063633197,4.09741525589804e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.105836748875021,0.00643612562992958,0.0932219426403589,0.118451555109683,4.85067264668307e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES2,Cocaine esterase,42587,0.0937714215643328,0.00571065952846667,0.0825785288885381,0.104964314240127,5.26510138301959e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADD1,Alpha-adducin,40283,0.121358688647745,0.00738438304749199,0.10688529787466,0.135832079420829,5.53008030752249e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.134361807552608,0.00819807265319212,0.118293585152352,0.150430029952865,8.67519052091296e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0817173809460903,0.00498467191218489,0.0719474239982079,0.0914873378939727,1.04048148136355e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIAE,Sialate O-acetylesterase,42646,0.077995202238365,0.00476941811302852,0.0686471427368291,0.0873432617399009,1.54769744759683e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,40199,0.0832816862439876,0.00508842136446523,0.0733083803696357,0.0932549921183394,1.65894616630264e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.150909541577378,0.00922903977646739,0.132820623615502,0.168998459539254,2.0468128322956e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,40199,0.0928029403638533,0.00567993756557577,0.0816702627353248,0.103935617992382,2.60560178383398e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMNL1,Formin-like protein 1,42311,0.10508322993069,0.00643866544644846,0.092463445655651,0.117703014205729,2.69919674795442e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.170437460193697,0.0104477524509064,0.14995986538992,0.190915054997474,2.95297132673827e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,40511,0.153317160034321,0.00939275328634121,0.134907363593092,0.17172695647555,3.21299727910655e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUS,RNA-binding protein FUS,42336,0.0675310176427567,0.00414246949917236,0.0594117774243789,0.0756502578611346,3.6252262848198e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCC,Tubulin-specific chaperone C,42495,0.135684315987787,0.00832929881705469,0.11935889030636,0.152009741669215,4.33353658377656e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEC31A,Protein transport protein Sec31A,40223,0.129855045119619,0.00796462732807593,0.11424437555659,0.145465714682648,4.5274856098974e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.07827788163243,0.00481068142660959,0.0688489460362752,0.0877068172285848,5.8838620266382e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.113550145748512,0.00697440710102979,0.0998803078304934,0.12721998366653,6.30721826854091e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBNL,Drebrin-like protein,42676,0.1548696383818,0.00952582294117262,0.136199025417101,0.173540251346498,7.12540599970577e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0792549436518272,0.00488433500435496,0.0696816470432915,0.0888282402603629,1.51326288646094e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0735590596363318,0.00454085894104312,0.0646589761118873,0.0824591431607763,1.87252956056125e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLM2,Protein GOLM2,42711,0.0388967626479056,0.00240159517291569,0.0341896361089908,0.0436038891868203,1.90190260884071e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.137548458419385,0.00849261333045697,0.120902936291689,0.154193980547081,1.96816674613697e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL5,C-C motif chemokine 5,42689,0.167523493743556,0.0103549695359919,0.147227753453012,0.1878192340341,2.54483789944242e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.129993775221025,0.00804177351333222,0.114231899134894,0.145755651307156,3.24675247243465e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0970018442738584,0.00599672006100766,0.0852482729542833,0.108755415593433,3.45429854716087e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.101906478063264,0.00633500343121118,0.0894898713380897,0.114323084788438,1.102273991514e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL13,C-C motif chemokine 13,42734,0.115646134669811,0.00719026372592582,0.101553217766996,0.129739051572626,1.13486746674198e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDHD2,Phospholipase DDHD2,40482,0.109681765088082,0.00681581148688629,0.0963227745737852,0.12304075560238,1.262753129774e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,40532,0.0454280268415402,0.00282363382902628,0.0398937045366486,0.0509623491464317,1.33135110141998e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IST1,IST1 homolog,40375,0.164541562754294,0.0102584719825565,0.144434957668483,0.184648167840105,2.93747000499389e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0753708491113275,0.00470843159970884,0.0661423231758982,0.0845993750467568,3.81908154207419e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.153818588287551,0.00961016339474271,0.134982668033855,0.172654508541247,4.02178044618652e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS9,Galectin-9,42620,0.0537402545716071,0.00336067566124484,0.0471533302755672,0.060327178867647,4.96702141071483e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.132466973856333,0.0082931465340107,0.116212406649672,0.148721541062994,8.53178256216019e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.140720954074045,0.00881054081246315,0.123452294081617,0.157989614066472,8.62547894177459e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,40283,0.136504012570746,0.00854924068088838,0.119747500836205,0.153260524305287,9.32182480490852e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL3,C-C motif chemokine 3,42594,0.0956676834338328,0.00599763359737495,0.0839123215829779,0.107423045284688,9.34207297000501e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.118136021015057,0.00742019401448468,0.103592440746668,0.132679601283447,1.49682673039209e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS8,Galectin-8,42711,0.0989747691640051,0.00622122349129655,0.0867811711210638,0.111168367206946,1.77914469763032e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.174133586073269,0.0109439705596977,0.152683403776261,0.195583768370276,2.21312876574686e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGA,Protein O-GlcNAcase,40449,0.115727126764971,0.00727935244925663,0.101459595964428,0.129994657565514,2.67736348104648e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL17,C-C motif chemokine 17,42604,0.151403766841282,0.00954378873560126,0.132697940919503,0.17010959276306,3.63789235031561e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.108812781262306,0.00685436115541821,0.0953782333976862,0.122247329126926,3.81903110088497e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0960721699885533,0.00606667724810258,0.0841814825822722,0.107962857394834,5.64481489422291e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0989933969290144,0.00625613294511994,0.0867313763565794,0.11125541750145,7.00967575318072e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,40199,0.125033201728737,0.00789938114286137,0.109550414688729,0.140515988768745,8.18789442045223e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBXN1,UBX domain-containing protein 1,40283,0.112307901865968,0.00710270238016161,0.0983866052008517,0.126229198531085,1.04249412733978e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2L,Ataxin-2-like protein,40482,0.0793391571436556,0.00502207388438497,0.0694958923302611,0.0891824219570501,1.26267987999748e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0648867392097324,0.00411590677124423,0.0568195619380937,0.0729539164813711,1.68180794671878e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0626908566168837,0.00397320341869976,0.0549033779162322,0.0704783353175352,1.71943766737808e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0329097586193607,0.00208928718419743,0.0288147557383337,0.0370047615003877,2.10058404243552e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,40482,0.123295309273639,0.00782370155852425,0.107960854218931,0.138629764328346,2.30688793435265e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.17626140026013,0.0111881274298785,0.154332670497568,0.198190130022692,2.48784554539262e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE4,Ribonuclease 4,40169,0.0480065908699724,0.00304739153470843,0.0420337034619438,0.0539794782780009,2.62417546528445e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN3,Ataxin-3,40483,0.101944852662792,0.00647681276762907,0.0892502996382389,0.114639405687345,3.10603838563725e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.139047006703535,0.00884872037966489,0.121703514759392,0.156390498647678,3.75832470869753e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.188368553493504,0.0120005546640772,0.164847466351913,0.211889640635096,4.92831312225726e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD36,Platelet glycoprotein 4,40199,0.073166535107402,0.00466015205547345,0.0640326370786741,0.08230043313613,5.91570238243986e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASHC3,WASH complex subunit 3,40483,0.122137106167595,0.00778392993218469,0.106880603500513,0.137393608834677,6.62323235843421e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.114062852947263,0.00728424792512026,0.0997857270140275,0.128339978880499,8.79090026779231e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,42676,0.13926975051508,0.00889527409697643,0.121835013285007,0.156704487745154,9.08650886825896e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.07105249978042,0.00453847373507754,0.062157091259668,0.079947908301172,9.36754697716084e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASC3,Protein CASC3,40182,0.0682547051799062,0.00436808658091111,0.0596932554813205,0.076816154878492,1.87034426572238e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COCH,Cochlin,40511,0.0762465234684611,0.00488085084288873,0.0666800558163992,0.085812991120523,1.91946721714574e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,42676,0.211589407459888,0.0135593363427107,0.185013108228176,0.238165706691601,2.02222727809558e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0835916042964601,0.00535657577635523,0.0730927157748039,0.0940904928181164,2.06122413184384e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,40287,0.10540581932063,0.00675257832758616,0.0921707657985606,0.118640872842698,2.36284403591478e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,40223,0.143476884159781,0.00920290777814238,0.125439184914622,0.16151458340494,3.20171911804683e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TALDO1,Transaldolase,40499,0.0713769112787963,0.00458261957315295,0.0623949769154165,0.0803588456421761,3.89075946311773e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,42311,0.136836632238925,0.00879778636078019,0.119592970971795,0.154080293506054,4.57335944445016e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPACT,Protein IMPACT,40483,0.090764301686627,0.00583168243660747,0.0793342041108764,0.102194399262378,4.65292839758867e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.235506525842151,0.0151441788607784,0.205823935275025,0.265189116409276,5.7015645726167e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,42706,0.058352560522648,0.00376077479051781,0.0509814419332331,0.0657236791120629,7.85971210610079e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.141376512014164,0.00913327166619561,0.123475299548421,0.159277724479908,1.39288191886797e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,42716,0.0943231004521742,0.00609746389030379,0.0823720712271788,0.10627412967717,1.60760702514785e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RWDD1,RWD domain-containing protein 1,42711,0.101128856927129,0.00653962836434389,0.0883111853330153,0.113946528521243,1.74179503690209e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TWF2,Twinfilin-2,40527,0.133436049632858,0.00862388601116793,0.116533233050969,0.150338866214747,1.86043763005082e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIP,Gastric inhibitory polypeptide,40223,0.0945412791374135,0.00611264665647276,0.0825604916907269,0.1065220665841,2.11989563658867e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,40482,0.187739092783902,0.0121441496325209,0.163936559504161,0.211541626063643,2.30007931622814e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSZ,Cathepsin Z,42648,0.0517294214358501,0.00335998578098823,0.0451438493051131,0.058314993566587,4.94978778471941e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS2,Trypsin-2,42689,0.0895167579771031,0.00582471132118305,0.0781003237875843,0.100933192166622,7.46596047314837e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFASC,Neurofascin,42754,0.0465300195588276,0.0030286238044914,0.0405939169020244,0.0524661222156307,8.01800291378335e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,40527,0.054684300555965,0.0035609879485951,0.0477047641767187,0.0616638369352114,1.0856621844519e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPART,Spartin,40283,0.122232617039307,0.00795952534583125,0.106631947361478,0.137833286717136,1.11016922509018e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCG,Gamma-synuclein,42495,0.110111433714049,0.00717810229088908,0.096042353223906,0.124180514204191,1.1676086062809e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D23,TBC1 domain family member 23,42587,0.142466336838879,0.00930634312701331,0.124225904309933,0.160706769367825,1.86382911819962e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB3,Plexin-B3,42597,0.074556756143973,0.00487457339753201,0.0650025922848103,0.0841109200031358,2.2832042831527e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB1,Carboxypeptidase B,42794,0.0965502245865541,0.00632749386421461,0.0841483366126935,0.108952112560415,3.88401407144637e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA5,Integrin alpha-5,42611,0.0397777473818084,0.00260929241913743,0.034663534240299,0.0448919605233177,4.87413436597711e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.130230491067524,0.00854059999640626,0.113490915074568,0.14697006706048,5.57117412522916e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBKS,Ribokinase,42317,0.0787411288071738,0.00517421575798468,0.0685996659215238,0.0888825916928238,7.44072727057476e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL11,Eotaxin,42754,0.0581868487400934,0.00382700212269898,0.0506859245796034,0.0656877729005834,8.84797336862927e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.138632808889748,0.00911863229830182,0.120760289585076,0.15650532819442,1.09586939867298e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53,Cellular tumor antigen p53,42346,0.068108019343867,0.00448779773264354,0.0593119357878857,0.0769041028998484,1.3879884099914e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP2B1,AP-2 complex subunit beta,40182,0.0765042205737187,0.00503675222794932,0.066632186206938,0.0863762549404993,1.39103860015525e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,40058,0.0840028233804549,0.00553022869679289,0.0731635751347408,0.094842071626169,1.39830335491217e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,40199,0.139025047505495,0.00915437058490335,0.121082481159084,0.156967613851906,1.44039396802817e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0778896150194899,0.0051342247778199,0.0678265344549629,0.0879526955840169,1.47915966701364e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,40199,0.0707666518301821,0.00466341777078332,0.0616263529994468,0.0799069506609174,1.72033618046706e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,42721,0.197391421612652,0.013024778265048,0.171862856213158,0.222919987012146,1.85477667034436e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTPBP2,GTP-binding protein 2,40182,0.127454938295913,0.00840862619220215,0.110974030959197,0.143935845632629,2.22787870506129e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,42754,0.105269401367006,0.00695290488695508,0.0916417077885736,0.118897094945438,2.30632671670281e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,42594,0.0886615232544241,0.00585600456323715,0.0771837543104793,0.100139292198369,2.33532434076419e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.163533818790291,0.0108166370824538,0.142333210108681,0.1847344274719,3.22210321944502e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,42594,0.0574759240966902,0.00380184188004517,0.0500243140118016,0.0649275341815787,3.26153974310034e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,42794,0.064806208502359,0.00429058187573216,0.0563966680259239,0.073215748978794,3.94079612592988e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXJ3,Forkhead box protein J3,40199,0.0686538075016171,0.00455116156929358,0.0597335308258017,0.0775740841774325,6.56322516927805e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,42357,0.11819292440643,0.00784505073772932,0.102816624960481,0.13356922385238,7.20077881688485e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,40283,0.107840514384949,0.00716579048995249,0.0937955650246424,0.121885463745256,1.10213323157634e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0803709557108173,0.00534555541460043,0.0698936670982004,0.0908482443234341,1.10394269311774e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,40449,0.148531955056048,0.00988143045667356,0.129164351360968,0.167899558751128,1.41344610806438e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0516128559655478,0.00343742696445234,0.0448754991152213,0.0583502128158744,1.51022241981306e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK1,Docking protein 1,40483,0.212234136348067,0.0141358945329994,0.184527783063388,0.239940489632746,1.8270239939453e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MENT,Protein MENT,40283,-0.036245385042636,0.00241572715575562,-0.040980210267917,-0.031510559817355,2.15809114131507e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0515387412536883,0.00344168235042671,0.044793043846852,0.0582844386605246,2.71725503140599e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.119057171116233,0.00795061763428903,0.103473960553026,0.134640381679439,2.74158181655861e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0839212122669757,0.00560043668504131,0.0729443563642948,0.0948980681696567,2.86355481102625e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0544359928718779,0.00363894806162393,0.047303654671095,0.0615683310726608,3.44046882309883e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.170644640689905,0.0114152285209787,0.148270792788787,0.193018488591024,3.99211145884409e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLG4,Disks large homolog 4,40483,0.109077840087614,0.00729233236229296,0.0947848686575195,0.123370811517708,4.172995664944e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0601249752895196,0.00403027044641115,0.0522256452145538,0.0680243053644855,6.39550271684105e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.100961931799961,0.00677683676880155,0.0876793317331097,0.114244531866812,8.42009690699398e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,42357,0.0762720270763377,0.00513651238317069,0.0662044628053231,0.0863395913473523,1.77475047961409e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEPR,Leptin receptor,42636,-0.0482227418240372,0.00325280412509873,-0.0545982379092307,-0.0418472457388437,2.476621442659e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.110855548025527,0.00747834029322835,0.0961980010507995,0.125513095000255,2.52177031050327e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YWHAQ,14-3-3 protein theta,40283,0.113305086300016,0.00764119090829362,0.0983283521197603,0.128281820480271,2.85099339546721e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICA1,Islet cell autoantigen 1,42370,0.121245783150709,0.00819656259712784,0.105180520460339,0.13731104584108,4.06869229012446e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPP,Lipoma-preferred partner,40116,0.101459973436327,0.00685701340886432,0.088020227154953,0.114899719717701,4.59983328959428e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.10715328795964,0.00724239722226317,0.0929581894040045,0.121348386515276,4.65390097755548e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,42636,0.121036884094863,0.00818973083589177,0.104985011656516,0.137088756533211,4.84535187361884e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,42594,0.0789213807083351,0.00534463413326732,0.0684458978071312,0.0893968636095391,5.84301272693399e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.05079191862034,0.00344003618231906,-0.0575343895376853,-0.0440494477029946,5.898738848368e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.134153965223122,0.00908640254411025,-0.151963314209578,-0.116344616236666,6.01148948371186e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6AP2,Renin receptor,42346,0.0621693327177908,0.00421441838274429,0.053909072687612,0.0704295927479696,7.38109516486316e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH9,Protocadherin-9,40449,0.0530779414633911,0.00359718660797554,0.046027455711759,0.0601284272150232,8.10804490417142e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.185411755969876,0.01257508755934,0.160764584353569,0.210058927586182,8.28663064250801e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,40539,0.0261157915356751,0.00177183363327443,0.0226429976144573,0.029588585456893,1.0145706688035e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDC,Nuclear migration protein nudC,42754,0.0950391527873715,0.00645625456998188,0.082384893830207,0.107693411744536,1.13060449759477e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0891886649312391,0.00606001884556263,0.0773110279939364,0.101066301868542,1.21141526932569e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YJU2,Splicing factor YJU2,40451,0.0497409366081287,0.00338180898813294,0.0431125909913881,0.0563692822248692,1.60450899324485e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,42346,0.138897952274557,0.00945084099121664,0.120374303931773,0.157421600617342,1.63591837843038e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0742731667773265,0.00505204718774576,0.0643711542893448,0.0841751792653082,1.76532238776101e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.10054020176866,0.00685676720712189,0.0871009380427014,0.113979465494619,3.14091937216745e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN1,Pantetheinase,40532,0.111101228019487,0.00758454399683456,0.0962355217856914,0.125966934253283,3.79577636708826e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG4A,Cysteine protease ATG4A,42346,0.0897536930858332,0.00613913351040354,0.0777209914054422,0.101786394766224,4.98928650614376e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0684303757188044,0.00468006222589347,-0.0776032976815555,-0.0592574537560532,5.60384914581398e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD207,C-type lectin domain family 4 member K,42365,0.0606286771501629,0.00415457904931861,0.0524857022134984,0.0687716520868274,7.32849516018249e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F13B,Coagulation factor XIII B chain,40479,0.0393715439322591,0.00270050492503774,0.0340785542791852,0.0446645335853331,1.03135912468441e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,42346,0.0863566261071864,0.00592798675818544,0.0747377720611429,0.0979754801532298,1.0612999616012e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP10,Stromelysin-2,42608,-0.0894337390295743,0.00614009522862666,-0.101468325677683,-0.077399152381466,1.07573694868458e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0890912032118035,0.00611872620760544,0.0770984998448969,0.10108390657871,1.16612194549402e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM3,Dynamin-3,40482,0.0833118707589175,0.00572408709714149,0.0720926600485201,0.0945310814693148,1.47054425914023e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TADA3,Transcriptional adapter 3,40451,0.0599072797592658,0.00412199503814966,0.0518281694844925,0.0679863900340392,1.99415182198389e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0868690842331225,0.00599120744073253,0.0751263176492868,0.0986118508169583,2.83663866756452e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA1,Carboxypeptidase A1,42794,0.0944922386678453,0.0065189090333836,0.0817151769624135,0.107269300373277,2.92738998628963e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.117757973802768,0.00812672292528258,0.101829596869214,0.133686350736322,3.23458108024137e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,42495,0.119018703820913,0.00821631708699536,0.102914722330402,0.135122685311424,3.41294408298657e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18,Interleukin-18,42566,0.0701947190853389,0.00484668579160368,0.0606952149337957,0.0796942232368822,3.5279555970318e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST3,Cystatin-C,42659,0.0456744994409958,0.00315382400852591,0.039493004384285,0.0518559944977066,3.5473508365971e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0418948794295357,0.00289696640694217,0.036216825271929,0.0475729335871423,4.78640279990019e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY4,Protein canopy homolog 4,42587,0.111285004378127,0.00770366613199835,0.0961858187594098,0.126384189996843,6.00980421870132e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0850805842499718,0.00590162898203744,0.0735133914451784,0.0966477770547651,9.10871972093864e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP10,Caspase-10,42311,0.107196268432813,0.00745261501278189,0.0925891430077603,0.121803393857865,1.47964589267799e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK3,NT-3 growth factor receptor,42711,-0.0326980703299982,0.00227479962554841,-0.0371566775960731,-0.0282394630639234,1.65781116770756e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESYT2,Extended synaptotagmin-2,40483,0.123282392970813,0.008572161989719,0.106480955470963,0.140083830470662,1.7342044224683e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RFC4,Replication factor C subunit 4,40451,0.031694378295898,0.00220465245779479,0.0273732594786202,0.0360154971131758,1.88210553060504e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0989350536791513,0.00688501820840625,0.0854404179906751,0.112429689367628,2.09380957207362e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0797902119003197,0.00555741464801432,0.0688976791902117,0.0906827446104278,2.11458854051666e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,42594,0.124371466018896,0.00866287091253076,0.107392239030336,0.141350693007456,2.13157382929748e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.107615014089356,0.00748982362073514,0.0929349597927155,0.122295068385997,2.15596122696408e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN3,Centrin-3,40449,0.113324608277177,0.0078886316358808,0.0978628902708505,0.128786326283503,2.18691436720961e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM17,Splicing factor 45,40482,0.1142193001038,0.00795823391392392,0.0986211616325094,0.129817438575091,2.63014488555181e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0850381575986086,0.00592707532929229,0.0734210899531957,0.0966552252440215,2.88845544533044e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0997615931800325,0.00696433897180854,0.0861114887952878,0.113411697564777,3.34427627743659e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0848359524096432,0.00593082819567278,0.0732115291461246,0.0964603756731619,5.20608577400449e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.125828428212731,0.00880247107082331,0.108575584913918,0.143081271511545,5.22175700705976e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,42618,-0.0513066811193274,0.00359181445629995,-0.0583466374536753,-0.0442667247849794,5.94832979047764e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0885153660556144,0.00619806316671614,0.0763671622488507,0.100663569862378,6.32321469953602e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.125431562086296,0.00877770193576799,0.108227266292191,0.142635857880401,6.47136220474511e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1S,Complement C1s subcomponent,40539,0.0310007487273091,0.00216986522649213,0.0267478128833845,0.0352536845712337,6.59722786899801e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRAS,Ras-related protein R-Ras,40182,0.193022511590362,0.0135145096021197,0.166534072770208,0.219510950410517,7.2219358076183e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.08413107448838,0.00591233221836559,0.0725429033403834,0.0957192456363766,1.28545505285855e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD226,CD226 antigen,40199,0.0629381369170503,0.00442042782215156,0.0542740983856332,0.0716021754484673,1.35056081871356e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0832824884915153,0.00585470302025439,0.0718072705718167,0.0947577064112139,1.37866383558026e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.1455135137287,0.0102333843792199,0.125456080345429,0.165570947111971,1.50821993911098e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FEN1,Flap endonuclease 1,42346,0.0945616764180651,0.00665183590787913,0.081524078038622,0.107599274797508,1.58690915440726e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO3,Forkhead box protein O3,42346,0.140656732183249,0.00990522511439446,0.121242490959036,0.160070973407462,1.97672188432092e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0718564881178307,0.00506417076790086,0.061930713412745,0.0817822628229164,2.6125738581367e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.115240188092383,0.00812971253563751,0.0993059515225334,0.131174424662232,2.78702784293925e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,42346,0.067746197094924,0.00479462499068741,0.0583487321131766,0.0771436620766713,5.32235510522872e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,40449,0.0861461269006625,0.00609856896366384,0.0741929317318813,0.0980993220694436,6.38334770402926e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL7,C-C motif chemokine 7,42594,0.0872494834599688,0.00618172598762164,0.0751333005242304,0.0993656663957073,6.52083581507646e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C19orf12,Protein C19orf12,42311,0.0936909887923418,0.00663812950663528,0.0806802549593366,0.106701722625347,6.62783845840736e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEXN,Nexilin,40532,0.101302335386516,0.00718007090691614,0.0872293964089602,0.115375274364071,8.01773485223051e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARK7,Parkinson disease protein 7,42611,0.0760618644013296,0.00539940074173289,0.0654790389475331,0.086644689855126,9.49866247329519e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANG,Angiogenin,42618,0.0493155668456055,0.00350211099919715,0.0424514292871791,0.0561797044040319,1.02414525250371e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0469072436509007,0.00332991969262163,0.0403806010533623,0.0534338862484391,1.11905787290277e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.118198606955275,0.00839940715058461,0.101735768940129,0.134661444970421,1.33874316215471e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POSTN,Periostin,40527,-0.0566726025591546,0.00402913247456887,-0.0645697022093095,-0.0487755029089996,1.461284171072e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.125662133762893,0.00895664866284591,0.108107102383715,0.143217165142071,2.1512174466454e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAX,Protein max,42311,0.153119181668323,0.0109180889497523,0.131719727326809,0.174518636009838,2.31233724791968e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.047589964591858,0.00339442245755248,-0.0542430326086609,-0.0409368965750552,2.40730380620491e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,42636,0.185408801963054,0.0132280932568034,0.159481739179719,0.211335864746389,2.54117981695288e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.139509745782347,0.00996279074660961,0.119982675918992,0.159036815645702,3.05933999053942e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRADD,Death domain-containing protein CRADD,42476,0.109123657621227,0.00779539762023774,0.0938446782855608,0.124402636956893,3.28180482743471e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",42357,0.134675498843922,0.00962637968288838,0.115807794665461,0.153543203022384,3.70158077891665e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.141739017388068,0.0101254205475,0.121893193114968,0.161584841661168,3.73035509701228e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACYBP,Calcyclin-binding protein,40267,0.148496106751301,0.0106113421902656,0.12769787605838,0.169294337444222,4.0208736263387e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.150872246924436,0.0107850028744886,0.129733641290438,0.172010852558434,4.3040707274446e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.13583270162334,0.00971112758637568,0.116798891554044,0.154866511692637,4.34382989001165e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRY2,Protein sprouty homolog 2,42370,0.134058387646824,0.00959578595876031,0.115250647167654,0.152866128125994,4.85931945460126e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0552598920441894,0.00395641806589705,0.0475053126350312,0.0630144714533477,5.03437789132036e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.110060304482261,0.00788101983103792,0.0946135056134262,0.125507103351095,5.23665636514226e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,40532,0.0682655098338843,0.00488942494141229,0.0586822369487162,0.0778487827190524,6.15065691627462e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE2,Glia-derived nexin,40511,0.0934461777809516,0.0066937342642043,0.0803264586231112,0.106565896938792,6.29955513227728e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.152114090451954,0.0109009721354669,0.130748185066439,0.173479995837469,6.88082309106917e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.122783979159311,0.00881217957735328,0.105512107187699,0.140055851130924,8.12521325494024e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5E,5'-nucleotidase,42679,0.082213013120955,0.00591117767381175,0.070627104880284,0.093798921361626,1.13308477149336e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,40283,0.160685392567015,0.01155053062191,0.138046352548071,0.183324432585959,1.25324346279915e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF19,Fibroblast growth factor 19,42676,0.112515892077018,0.00810281547252224,0.0966343737508741,0.128397410403161,1.53502959026801e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0462038283537468,0.00332779257474186,0.0396813549072527,0.0527263018002408,1.5764990470597e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED8,Protein TMED8,40449,0.147634834168801,0.0106352156666499,0.126789811462167,0.168479856875434,1.86437930974374e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,42620,0.134742699493622,0.00971869253039533,0.115694062134047,0.153791336853196,2.07577358308783e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIFBP,KIF-binding protein,42587,0.117918679985396,0.00850555482547948,0.101247792527456,0.134589567443336,2.09523027476875e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0939552408117108,0.00678563333269362,0.0806553994796313,0.10725508214379,2.69861767658352e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0573237564611617,0.00413974044149544,0.0492098651958306,0.0654376477264928,2.98468051777919e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD244,Natural killer cell receptor 2B4,42754,0.0395694580829639,0.00286197395405005,0.0339599891330258,0.045178927032902,3.48984935159455e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0664411486342523,0.00481057385973347,0.0570124238691747,0.0758698733993299,4.26278664065769e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA11,Annexin A11,42570,0.0960933396189159,0.0069592654694726,0.0824531792987496,0.109733499939082,4.50409679225482e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,40283,0.178887641795741,0.0129514642650207,0.1535027718363,0.204272511755181,4.88693164242424e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIF,Macrophage migration inhibitory factor,42586,0.0973620866014642,0.00705466901090815,0.0835349353400842,0.111189237862844,4.94511960578478e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG2,Secretogranin-2,42636,0.0493519632039717,0.0035761016870757,0.0423428038973033,0.05636112251064,4.97294598024507e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILP,Rab-interacting lysosomal protein,42674,0.0856754419754232,0.00620864073813686,0.073506506128675,0.0978443778221715,5.03911421598669e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTBDN,Retbindin,42587,0.0430783471939902,0.00312204764083585,0.0369591338179519,0.0491975605700284,5.15043645216904e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.119275449594259,0.00864747863115873,0.102326391477188,0.13622450771133,5.50269468316463e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCB,Tubulin-folding cofactor B,42495,0.142791807540695,0.0103690109058637,0.122468546165202,0.163115068916188,7.4919306403644e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGLL,Monoglyceride lipase,42654,0.12320119168674,0.00894722612092922,0.105664628489718,0.140737754883761,7.56088154548434e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0870017678011044,0.0063198150338592,0.0746149303347404,0.0993886052674684,7.89502694955621e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.109447223846733,0.00795026307964919,0.0938647082106203,0.125029739482845,9.14503794528203e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,40482,0.0933176260621188,0.00680145118925932,0.0799867817311705,0.106648470393067,1.68279816494102e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATOX1,Copper transport protein ATOX1,42679,0.0994251731665459,0.00725779730864041,0.0851998904416107,0.113650455891481,1.97695269727304e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN2,Centrin-2,42311,0.0960121366322209,0.00701207650879408,0.0822684666749845,0.109755806589457,2.20447547316418e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA1,Apolipoprotein A-I,40539,-0.0395003029777359,0.00288425775302108,-0.0451534481736572,-0.0338471577818145,2.35611957461411e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.073722333018838,0.0053910007572078,0.0631559715347107,0.0842886945029653,3.10961488792009e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,40283,0.168305066414973,0.0123226454729899,0.144152681287913,0.192457451542033,3.9519886550007e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRL,Appetite-regulating hormone,42636,0.121034274054533,0.0088731260231818,0.103642947049097,0.138425601059969,4.38001082387452e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0505928190891056,0.00371153452750548,0.0433182114151948,0.0578674267630163,4.94969722170716e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0949495494975095,0.00696774154911119,0.0812927760612515,0.108606322933767,5.25882482597619e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0631434678235887,0.00463084280141273,0.0540670159328198,0.0722199197143577,5.37120645842017e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PENK,Proenkephalin-A,40283,0.0466366017510533,0.0034216926127046,0.0399300842301523,0.0533431192719543,5.80518147687378e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0896366562142383,0.00658781564717272,0.0767245375457797,0.102548774882697,6.94430254954457e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0379838758089836,0.00279135249283733,-0.0434549266949448,-0.0325128249230225,7.67251453914172e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,42346,0.0808689881316029,0.0059516229909186,0.0692038070694025,0.0925341691938034,9.06201574476524e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM3,Junctional adhesion molecule C,40283,0.0719209157449554,0.00529026803067829,0.0615519904048259,0.0822898410850848,9.26605633460672e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0427629100633444,0.00314875488132847,0.0365913504959405,0.0489344696307482,9.77964691695847e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,40500,0.0674708720969779,0.00496856719987316,0.0577324803852265,0.0772092638087293,1.12321841607386e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0896706651496845,0.00660528031638331,0.0767243157295733,0.102617014569796,1.18824957374545e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WDR46,WD repeat-containing protein 46,40451,0.0509488126410398,0.00375485360157602,0.0435892995819508,0.0583083257001288,1.30192771911717e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0881320335524862,0.00649625114840329,0.0753993813016157,0.100864685803357,1.33800955111174e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.127431412251833,0.00939907321198642,0.109009228756339,0.145853595747326,1.5331566872079e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0536579949624492,0.00397627230929295,0.045864501236235,0.0614514886886633,3.16456278478755e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.119652308481126,0.00886521357891683,0.102276489866449,0.137028127095803,3.40478678722215e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,42794,0.0325282450456196,0.00241459953187871,0.0277956299631373,0.0372608601281018,4.22246026968158e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,42611,0.034122522322242,0.00253349591721516,0.0291568703245002,0.0390881743199837,4.42747042784973e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACYP1,Acylphosphatase-1,40250,0.091967943823187,0.00682933361699236,0.078582449933882,0.105353437712492,5.17349405102611e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX4,Syntaxin-4,42587,0.0833427532871799,0.00620081243334763,0.0711891609178185,0.0954963456565412,6.43514037901548e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILPL2,RILP-like protein 2,40511,0.135667132507192,0.0100934406926541,0.11588398874959,0.155450276264794,7.14151452170388e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGL1,Fibrinogen-like protein 1,40532,-0.0920783381596065,0.00686504874762057,-0.105533833704943,-0.0786228426142702,1.04148529743368e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THTPA,Thiamine-triphosphatase,40436,0.123003869455511,0.00917189651178765,0.105026952292407,0.140980786618614,1.07133480705883e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF23,Fibroblast growth factor 23,42711,0.0761749700163478,0.00569142458537246,0.0650197778290178,0.0873301622036778,1.35657859212544e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GET3,ATPase GET3,40511,0.0755122857482555,0.0056412935541044,0.0644553503822108,0.0865692211143001,1.49177468122569e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0930689819439815,0.00695404351579509,0.0794390566530231,0.10669890723494,1.575344817836e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0698613765306707,0.00522068481883173,0.0596288342857605,0.0800939187755809,1.60418457923724e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.102004950102922,0.00762791631540356,0.0870542341247308,0.116955666081113,1.61067001903393e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREH,Trehalase,40527,0.103789754780884,0.00775810135701524,0.0885838761211344,0.118995633440634,1.6435950909609e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCA,Calcitonin,42476,0.0883304680083706,0.00660803739542543,0.0753787147133367,0.101282221303404,1.71863481017622e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,40182,0.112502037376073,0.00841631209999325,0.0960060656600862,0.12899800909206,1.94588203000722e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD69,Early activation antigen CD69,42585,0.121755733299879,0.00912211092807882,0.103876395880845,0.139635070718913,2.22374419232475e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,42569,0.123355675363781,0.00924448742663293,0.105236480007581,0.141474870719982,2.33456263712086e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGF,Pro-epidermal growth factor,42597,0.142988074654654,0.0107165765630939,0.12198358459099,0.163992564718318,2.36277686632868e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIAPIN1,Anamorsin,42679,0.0862158273969075,0.00646758268945799,0.0735393653255698,0.0988922894682452,2.76858839786004e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0844776844909474,0.00633638476392066,-0.0968969986282319,-0.0720583703536629,3.08078599874088e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARC,SPARC,42679,0.0973147532119755,0.00730511137022836,0.0829967349263279,0.111632771497623,3.11837729390843e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PF4,Platelet factor 4,40463,0.136201178696907,0.0102332742265712,0.116143961212827,0.156258396180986,4.08394734477167e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0682153982591031,0.00513015878110548,0.0581602870481363,0.0782705094700698,4.87590249101246e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MET,Hepatocyte growth factor receptor,42654,-0.0275852121098361,0.00207626050869678,-0.0316546827068818,-0.0235157415127904,4.98549209753121e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0546899935674056,0.00411895308004102,0.0466168455305252,0.0627631416042859,5.56139688437089e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0415088183719477,0.00312914550563848,0.0353756931808963,0.0476419435629992,7.40682594220312e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMT,Catechol O-methyltransferase,42214,0.114953184645063,0.0086715856461429,0.0979568767786227,0.131949492511503,7.51626772933763e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.126588700973192,0.00955195008960506,0.107866878797566,0.145310523148818,8.76818275685827e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTF1,Cardiotrophin-1,42357,0.116082881680775,0.00876600949218291,0.0989015030760966,0.133264260285454,8.96820338356781e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.128781095066979,0.0097317589919411,0.109706847442774,0.147855342691183,1.00744846974548e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XCL1,Lymphotactin,42721,0.0775401348320891,0.0058686209367266,0.066037637796105,0.0890426318680732,1.30442208818707e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2,Microtubule-associated protein 2,40483,0.064143007446883,0.00485299886909696,0.054631129663453,0.0736548852303131,1.37356660444337e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDT,D-dopachrome decarboxylase,40527,0.0573702578488511,0.00434079384086337,0.0488623019207588,0.0658782137769433,1.38177657879406e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4D,Semaphorin-4D,42711,0.0411874779436389,0.00311988176223359,0.035072509689661,0.0473024461976167,1.50847335623232e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP2,Caspase-2,42594,0.0926961270398289,0.0070310916487068,0.0789151874083636,0.106477066671294,1.91556685636064e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LARP1,La-related protein 1,40451,0.0843074737202606,0.00639498959821534,0.0717732941077585,0.0968416533327626,2.14152416150753e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THPO,Thrombopoietin,42357,0.0535736725850575,0.00407286594302446,0.0455908553367296,0.0615564898333855,2.86199537272645e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.082189733888334,0.0062546110121874,0.0699306963044467,0.0944487714722213,3.77398720857348e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0997991864212093,0.00759635213785591,0.0849103362310117,0.114688036611407,3.86614800408763e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0743391688814932,0.00565817962055541,0.0632491368252046,0.0854292009377818,3.90317532299225e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,40116,0.0899365708952567,0.00685545464764811,0.0764998797858664,0.103373262004647,5.05406549232955e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0594286593015922,0.00454030595307982,0.0505296596335557,0.0683276589696286,7.31286626269264e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0873329976310185,0.00667790307601242,0.0742443076020342,0.100421687660003,8.44244703483746e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPSE,Heparanase,40408,0.127929463053502,0.00978927275477471,0.108742488454143,0.14711643765286,9.57969327432973e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHD3,EH domain-containing protein 3,40223,0.159829726652637,0.0122402754860833,0.135838786699914,0.18382066660536,1.11132843935802e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP7,Caspase-7,40483,0.113672343323233,0.0087216967556129,0.0965778176822318,0.130766868964234,1.50080952052563e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0781975466557988,0.00601384062662005,0.0664104190276235,0.0899846742839741,2.01867259662821e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0722648562227544,0.00555806151372059,0.0613710556558621,0.0831586567896468,2.05849969669043e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,40539,0.04161995891183,0.00320044435376126,0.0353470879784579,0.047892829845202,2.1708580512308e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB9,Serpin B9,42495,0.0445645210270016,0.00343072286956888,0.0378403042026466,0.0512887378513566,2.39045543066924e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN1,Ficolin-1,40515,0.0756176910626318,0.00581906780366325,0.0642123181674518,0.0870230639578117,2.46053727486643e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0543814600266201,0.0041904485223857,0.0461681809227441,0.0625947391304961,2.77507801119621e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12A_IL12B,Interleukin-12,42587,0.110933541330379,0.00857114645193798,0.094134094284581,0.127732988376178,4.37236860702341e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0711841959758199,0.00549945939176009,0.0604052555679701,0.0819631363836697,4.74537744001711e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,42311,0.0829016890736092,0.00641496204516785,0.0703283634650803,0.0954750146821382,5.67859791348468e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.103553562499009,0.00801152737054332,0.0878509688527442,0.119256156145274,6.01002782812697e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,40449,0.117218608373867,0.00907032488541617,0.0994407715984509,0.134996445149282,6.18672588459571e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC5,Glypican-5,42495,0.075990580065308,0.00588380835787931,0.0644583156838646,0.0875228444467515,6.24465574622181e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0819973482851123,0.00636031451007078,0.0695311318453736,0.094463564724851,9.34762095583195e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,40451,0.0743214835255908,0.00576715672712768,0.0630178563404205,0.0856251107107611,9.8401980047275e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0504392567426259,0.00391785535322017,0.0427602602503144,0.0581182532349374,1.0502584652573e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0462819862732189,0.00359376115874298,0.0392382144020826,0.0533257581443551,1.09822149486693e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.045776405403864,0.00355720524776578,0.0388042831182431,0.0527485276894849,1.12973005239683e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL2,C-C motif chemokine 2,42475,0.071524941476141,0.00556001778344688,0.0606273066205851,0.0824225763316968,1.20156992410206e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,42636,0.0872208978433929,0.0067897969239568,0.0739128958724376,0.100528899814348,1.50832817394405e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0815779295572962,0.00634968150122834,0.0691325538148886,0.0940233052997037,1.62269458121424e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0836969309512167,0.00651541830507935,0.0709267110732612,0.0964671508291722,1.67619518302054e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.101458712412101,0.00791103869725569,0.0859530765654801,0.116964348258722,1.96840151450606e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.13265238159247,0.0103387211919324,0.112388488056282,0.152916275128658,2.05427026602617e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F12,Coagulation factor XII,40539,0.055613057163346,0.00433520155172258,0.0471160621219698,0.0641100522047223,2.07183872481789e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIN2,Bridging integrator 2,42611,0.120575164187001,0.00942199787484632,0.102108048352302,0.1390422800217,2.80736560719184e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0511731161685373,0.0040019492153483,0.0433292957064546,0.05901693663062,3.54407793092143e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0268098871056865,0.00209927865540314,0.0226953009410963,0.0309244732702766,4.29759009788494e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBN,Nibrin,42370,0.0714651442434813,0.00560204059732518,0.060485144672724,0.0824451438142387,4.72059326567493e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB1,Heat shock protein beta-1,42448,0.0898465141029036,0.0070632421623877,0.0760025594646237,0.103690468741183,7.48976380875196e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0339535709515846,0.00266993908549417,0.028720490344016,0.0391866515591532,7.72370259296754e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,40482,0.0823317666009257,0.00647156558470602,0.0696474980549019,0.0950160351469495,7.97705738219241e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,40449,0.109469188198403,0.00862117747613149,0.0925716803451857,0.126366696051621,1.08645078777013e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICALL2,MICAL-like protein 2,40182,0.0913784401182387,0.00719661295125372,0.0772730787337814,0.105483801502696,1.10564472293081e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPBP,Platelet basic protein,40471,0.111337762546177,0.00877838487912858,0.0941321281830852,0.128543396909269,1.30314264331332e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DXO,Decapping and exoribonuclease protein,40483,0.0603661743560215,0.00477160262475428,0.0510138332115031,0.0697185155005399,1.94799541596104e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0702776903534886,0.00556173378106101,0.0593766921426091,0.0811786885643682,2.3915530169434e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.120067498145955,0.00950648438409734,0.101434788753124,0.138700207538786,2.57404256333339e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.145848388054653,0.01155959050204,0.123191590670655,0.168505185438651,2.7612826514703e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRB1,Chymotrypsinogen B,42611,0.0764638109184403,0.00606836228631984,0.0645698208372534,0.0883578009996272,3.36744825418971e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OCLN,Occludin,40482,0.0593294349578762,0.00471092459394187,0.0500960227537501,0.0685628471620022,3.9838108449924e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRD2,Protein ZNRD2,40449,0.0917310707262165,0.00728485668111582,0.0774527516312295,0.106009389821203,4.09072014516292e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.062469626098944,0.00496124942316709,0.0527455772295365,0.0721936749683515,4.11021881949318e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.064510124538876,0.0051231920895949,0.05446866804327,0.074551581034482,4.14982328687046e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0384827577658955,0.0030589830276547,0.0324871510316923,0.0444783645000988,4.3071770869589e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD72,B-cell differentiation antigen CD72,40283,0.0582923587630144,0.00463402852391493,0.0492096628561412,0.0673750546698877,4.84112427984522e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCA,Tubulin-specific chaperone A,40283,0.111110491734071,0.00883715818178689,0.0937896616977689,0.128431321770373,5.2236412802842e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.118359181087374,0.00941531450796323,0.0999051646517664,0.136813197522982,5.30747646355987e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA3,Annexin A3,42681,0.0910852424409815,0.00725059057163871,0.0768740849205696,0.105296399961393,5.40070469391336e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL4,C-C motif chemokine 4,42642,0.0898178019446366,0.00715563118774573,0.075792764816655,0.103842839072618,6.15907611928025e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBI,Acyl-CoA-binding protein,42562,0.100005485618541,0.00796955427048742,0.084385159248386,0.115625811988697,6.46015791500399e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,42794,0.0938712684704533,0.00748669563788672,0.0791973450201954,0.108545191920711,7.26393997640431e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,40199,0.045169732126048,0.00360113762947735,0.0381115023722724,0.0522279618798236,7.61556051495706e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,42311,0.0749833551033035,0.00598525346482738,0.0632522583122418,0.0867144518943651,8.40769358519439e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD22,B-cell receptor CD22,42754,0.0571129004389542,0.00456087615849626,0.0481735831683016,0.0660522177096069,8.88553310626953e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMVK,Phosphomevalonate kinase,42303,0.141198332239581,0.011275035898801,0.119099261877931,0.163297402601231,8.94190362602125e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.112548159763761,0.0089833460579779,0.0949408014901243,0.130155518037398,9.09912898375041e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB6,Serpin B6,42679,0.0755891990707076,0.00603827474531279,0.0637541805698946,0.0874242175715207,9.36397119389321e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0544393197774475,0.00435259072876097,0.045908241949076,0.062970397605819,1.08197654837972e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.111986266055182,0.0089512787680685,0.0944417596697679,0.129530772440596,1.12536765727016e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.116444806582699,0.00932532928973307,0.0981671611748221,0.134722451990576,1.50816356305582e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSNAX,Translin-associated protein X,40116,0.0515642424574454,0.00413165183335857,0.0434662048640626,0.0596622800508282,1.66938391231735e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLO1,Lactoylglutathione lyase,42357,0.0755804285797974,0.00605974905794613,0.063703320426223,0.0874575367333718,1.67307784992541e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,40483,0.128818381155222,0.010348044868722,0.108536213212527,0.149100549097917,2.42796421396487e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0437653535549585,0.00352155642842434,0.0368631029552468,0.0506676041546702,2.88734175004437e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MESD,LRP chaperone MESD,42611,0.15592583509711,0.0125502999324326,0.131327247229542,0.180524422964678,3.02275616793766e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK10,Kallikrein-10,42636,0.0527476087480412,0.00425099423417378,0.0444156600490606,0.0610795574470218,3.67005503834307e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,40532,0.093301957352694,0.00752197741349449,0.0785588816222448,0.108045033083143,4.20278681100074e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0473538817951547,0.00382243047923011,0.0398619180558636,0.0548458455344457,5.14504816970522e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CERT,Ceramide transfer protein,42311,0.0790036266151069,0.00638240809396043,0.0664941067509444,0.0915131464792693,5.36793027603409e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0544627825931451,0.00440007496471779,0.0458386356622983,0.063086929523992,5.8243758098469e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0621352105175288,0.00502639975606338,0.0522834669956445,0.071986954039413,6.56061842865694e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,42624,0.0971127817284053,0.00786586139429786,0.0816956933955815,0.112529870061229,7.89765013351096e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0791671930304206,0.00641264603726218,0.0665984067973867,0.0917359792634544,7.96661372228301e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0619093040536389,0.00502072101150427,0.0520686908710905,0.0717499172361872,9.61657363714725e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMFG,Glia maturation factor gamma,40511,0.0920146219993082,0.00745893734889383,0.0773951047954763,0.10663413920314,9.66987967190221e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,40283,0.0299269504739114,0.00242626360113015,0.0251714738156963,0.0346824271321265,9.96178724805466e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT1,Angiopoietin-1,42554,0.107966383265044,0.00876239491363501,0.0907920892343196,0.125140677295769,1.06987950350047e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTF2,Transcription termination factor 2,40182,0.0631477201985514,0.00512400565243987,0.0531046691197693,0.0731907712773336,1.1408090807651e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0942882442608301,0.00765214009472914,0.079290049675161,0.109286438846499,1.16799789351143e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0951410598765892,0.00772193456390666,0.0800060681313321,0.110276051621846,1.1769984392213e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C3,Complement C3,39989,0.0605146311492716,0.0049182316363314,0.050874897142062,0.0701543651564811,1.46595187175838e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0406500487116802,0.00330646795793506,0.0341693715141275,0.0471307259092329,1.49027302020244e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX8,Syntaxin-8,42594,0.0614705486395903,0.00500286082751657,0.0516649414176578,0.0712761558615227,1.62991466210896e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.138184685023181,0.011244454895803,0.116145553427408,0.160223816618955,1.72300427427029e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.127102714720552,0.0103498744447346,0.106816960808872,0.147388468632231,1.764194318298e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG6,Large proline-rich protein BAG6,42357,0.0455062872024399,0.00371971307495555,0.0382156495755271,0.0527969248293528,3.14578499691922e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGT1,Protein SGT1 homolog,42346,0.102373645269047,0.00837005382736694,0.0859683397674081,0.118778950770686,3.25896927426193e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.141516864322964,0.0115904249126799,0.118799631494112,0.164234097151817,4.17208659981068e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTD,Deoxycytidylate deaminase,40283,0.1195616894572,0.00980892309809031,0.100336200184943,0.138787178729457,5.85952239746192e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D5,TBC1 domain family member 5,42594,0.0998811781929107,0.00819926725892879,0.0838106143654103,0.115951742020411,5.88085961217488e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSA,Arylsulfatase A,42611,0.0566456138669147,0.00465610927330646,0.047519639691234,0.0657715880425954,7.12291496910226e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,40527,0.0760825145867817,0.00625225312133736,0.0638280984689605,0.0883369307046029,7.40798330248837e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,40473,0.0875846272994821,0.00720238050143162,0.0734679615166761,0.101701293082288,8.20909727816782e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLF4,Krueppel-like factor 4,40136,0.051081623684618,0.00420159192867708,0.0428465035044109,0.0593167438648251,8.62150840667055e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.101279186306831,0.0083375000933457,0.0849376861238735,0.117620686489789,9.72993623014873e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0542214360935155,0.00447250282934456,0.0454553305480001,0.0629875416390308,1.18927191961601e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRGN,Neurogranin,40532,0.114768107279654,0.009476660573008,0.0961938525565583,0.13334236200275,1.49481727170234e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK13,Kallikrein-13,42381,0.0585012356014097,0.00483304789594239,0.0490284617253627,0.0679740094774568,1.50719605596039e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,42611,-0.0344620920450532,0.00284735857796941,-0.0400429148578733,-0.0288812692322332,1.51925345144162e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0607286626635636,0.00501701481445911,0.0508953136272238,0.0705620116999035,1.61136188005147e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO9B,Unconventional myosin-IXb,42370,0.0834591525768197,0.0069046255011207,0.0699260865946231,0.0969922185590162,1.85010438651724e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7,Interleukin-7,42594,0.0802606202575872,0.00664058838143319,0.0672450670299781,0.0932761734851962,1.86110867421181e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0665617331925506,0.00550539598632802,0.0557711570593477,0.0773523093257535,1.9155910278203e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0507378486811564,0.00419977849056518,0.0425062828396486,0.0589694145226641,2.13374880683054e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SWAP70,Switch-associated protein 70,40449,0.0450629993695138,0.00373259207645084,0.0377471188996701,0.0523788798393574,2.36149995252179e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP3,Caspase-3,42794,0.109205182116473,0.00905546810930212,0.0914564646222406,0.126953899610705,2.55349292442851e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0261821860020607,0.00217312288871549,-0.0304415068639431,-0.0219228651401784,2.93800762592266e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,42679,0.104938179890488,0.00871463398716477,0.0878574972756451,0.122018862505331,3.17906448320071e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.11804325412955,0.00983322167379058,0.0987701396489202,0.137316368610179,5.34749987117007e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,42587,0.105719058376724,0.00881655590132414,0.0884386088101288,0.122999507943319,5.8434914027179e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS1,Galectin-1,42636,0.0439898864378784,0.00366936278435116,0.0367979353805501,0.0511818374952067,6.01527820914743e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,40482,0.0962552844103257,0.00802660498653581,0.0805231386367155,0.111987430183936,6.19991916688536e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12B,Interleukin-12 subunit beta,42754,0.0712033120358344,0.00594093983321516,0.0595590699627327,0.0828475541089361,6.23123774891033e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0865091983126885,0.00721923354479933,0.0723595005648818,0.100658896060495,6.99749025319857e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,40482,0.107639489096546,0.00899904301665585,0.0900013647839004,0.125277613409191,8.94831177900738e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM106A,Transmembrane protein 106A,40451,0.0875764245772129,0.00732617143782209,0.0732171285590816,0.101935720595344,9.77189596446504e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.121337215371069,0.0101546462719187,0.101434108678108,0.141240322064029,1.03426601275611e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,42689,0.0371415688236539,0.00311032542341319,0.0310453309937641,0.0432378066535438,1.05240765676066e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0947449773560259,0.0079310304554402,0.0792001576633631,0.110289797048689,1.07219790458574e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0555949945619519,0.00465652617400121,0.0464682032609096,0.0647217858629943,1.17647938653019e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.115934467023359,0.00973453965054318,0.0968547693082941,0.135014164738423,1.53665535987811e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL2,Chordin-like protein 2,42636,0.058895171097556,0.00494523794064454,0.0492025047338927,0.0685878374612193,1.53984128490341e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,42495,0.0436398479612093,0.00366538439506211,0.0364556945468876,0.0508240013755311,1.61210531846616e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UMOD,Uromodulin,42764,-0.0687820722043639,0.00578282733726322,-0.0801164137853998,-0.0574477306233279,1.83923982563036e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0750602646437566,0.00631400787346746,0.0626848092117604,0.0874357200757528,2.00509845981938e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD2,Polycystin-2,40116,0.0725636809733121,0.00610269041863469,0.0606024077527881,0.0845249541938361,2.1022101266227e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2R,Proteinase-activated receptor 1,42654,0.0692896107793977,0.00585027578679912,0.0578230702372714,0.080756151321524,3.34750073728972e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLB,Beta-klotho,42311,-0.0924693737763762,0.00781447592911799,-0.107785746597448,-0.077153000955305,3.83577023293701e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.115011419536685,0.00972427561597186,0.0959518393293805,0.13407099974399,4.07761423245372e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0447858822498478,0.00378556885716138,0.0373661672898115,0.0522055972098841,4.25286591431598e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0851567065857573,0.00720037391048092,0.0710439737212147,0.0992694394502999,4.44480844765713e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP6,Bone morphogenetic protein 6,42342,0.0501855000801598,0.00424598268713932,0.0418633740133668,0.0585076261469529,4.49652228288713e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,42754,0.0581500072109831,0.00492860084035533,0.0484899495638866,0.0678100648580795,5.69585585388878e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,40449,0.0590792540929005,0.0050052173206981,0.0492690281443322,0.0688894800414688,5.77500011970994e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0538920648097008,0.00456672183020002,0.0449412900225087,0.0628428395968928,5.99925393998165e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0884859603629456,0.00750950749162164,0.0737673256793672,0.103204595046524,6.86469593116843e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APP,Amyloid-beta precursor protein,42592,0.0817886435257519,0.00694432350415116,0.0681777694576156,0.0953995175938882,7.29671992020234e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0828448691589039,0.00703029900920035,0.0690654831008712,0.0966242552169365,7.35986107674264e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0497230817034742,0.00422720928977528,0.0414377514955146,0.0580084119114337,8.69610273843179e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNMT,Histamine N-methyltransferase,42439,0.0590446463540971,0.00502200543229875,0.0492015157067915,0.0688877770014026,9.32787647201359e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0850176939770113,0.00722850479787645,0.0708498245731734,0.0991855633808491,9.58088183014491e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL8,C-C motif chemokine 8,42706,0.074272933394821,0.00632395910809914,0.0618779735429467,0.0866678932466953,1.07216587188649e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMSB10,Thymosin beta-10,42611,0.0907278864330514,0.00774054589542809,0.0755564164780124,0.10589935638809,1.41599415518859e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0628452426338761,0.00536453664709356,0.0523307508055727,0.0733597344621795,1.52012787197532e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0370247820965674,0.00316149858415549,0.0308282448716226,0.0432213193215121,1.70347067017132e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,42441,0.0442831497512094,0.00378662878946287,0.0368613573238621,0.0517049421785566,1.93822914776389e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB1,Beta-crystallin B1,40511,0.0778250136432827,0.006667114580471,0.0647574690655595,0.0908925582210058,2.64749972235744e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN4,CCN family member 4,42721,0.0488988975227995,0.00419293114374572,0.0406807524810579,0.0571170425645411,2.80563794601188e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,40483,0.0826310230247366,0.0070893393172013,0.068735917963022,0.0965261280864511,3.23944320187848e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,40223,0.0679836655852114,0.0058365900134401,0.0565439491588689,0.079423382011554,3.58171142185981e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0835650477280935,0.00718173359960558,0.0694888498728666,0.0976412455833205,4.13565770745953e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1,Allograft inflammatory factor 1,42346,0.063356505455931,0.00545245893088708,0.0526696859513923,0.0740433249604696,4.63531301302091e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.132820266047841,0.0114411292421933,0.110395652733142,0.155244879362539,5.25055782624189e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.128949178761142,0.0111125249013356,0.107168629954524,0.15072972756776,6.01590986863594e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",42603,0.131682566939378,0.0113643389347877,0.109408462627194,0.153956671251562,6.70350505205753e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0286070806592445,0.00247139512592227,0.0237631462124369,0.0334510151060522,7.67049726800671e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0770340386694272,0.00665933587931928,0.0639817403459614,0.090086336992893,8.46141426572767e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB2,Lysosome membrane protein 2,42302,0.0424363438292151,0.00366916466492212,0.0352447810859678,0.0496279065724625,8.67660883530474e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0804557664287979,0.00695748278641351,0.0668191001674275,0.0940924326901684,8.8433947601493e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADM,Pro-adrenomedullin,42721,0.032479805083132,0.00281046981746767,0.0269712842408954,0.0379883259253687,9.51889960153409e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,42501,0.035409409071455,0.00306724916438948,0.0293976007092516,0.0414212174336584,1.10361006339875e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0461858279682829,0.00400120416800675,0.0383434677989897,0.0540281881375761,1.12661446808627e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0739761869975355,0.00641323907730593,0.0614062384060159,0.0865461355890551,1.22356720160098e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLNK,B-cell linker protein,40199,0.0492488780891397,0.00427293343122659,0.0408739285639355,0.0576238276143438,1.46476094222751e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTNB,Dystrobrevin beta,40430,0.0515577239414248,0.00447807054629904,0.0427807056706787,0.060334742212171,1.67473904464016e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA4,Ephrin-A4,42475,0.0409421867946529,0.00355891400527198,0.0339667153443198,0.047917658244986,1.75360976634787e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.11663179359321,0.0101453435753467,0.0967469201855306,0.13651666700089,2.05646454091399e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0520320635945062,0.00452639737008821,0.0431603247491333,0.060903802439879,2.05755536649109e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,42545,0.054231445165634,0.00472005590513813,0.0449801355915632,0.0634827547397047,2.06841314996347e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0652103243997287,0.00567425528994406,0.0540887840314384,0.0763318647680191,2.14914125312708e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.150713564390355,0.0131434732424121,0.124952356835227,0.176474771945482,2.84860380270474e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ING1,Inhibitor of growth protein 1,42292,0.0564084018474822,0.00493182989429234,0.0467420152546692,0.0660747884402952,3.77047187446086e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0800836721710681,0.00700167442778827,0.0663603902926031,0.0938069540495331,3.96582505166865e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSTB,Cystatin-B,42437,0.0509251785072195,0.00445698744945149,0.0421894831062946,0.0596608739081444,4.29341152575205e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,42679,0.0317279754824789,0.00278538548506165,0.0262686199317581,0.0371873310331998,6.36158700939117e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,40302,0.0891543865609912,0.00783583056422159,0.0737961586551169,0.104512614466866,7.88979500255373e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0308695827425809,0.00271467750290248,0.025548814836892,0.0361903506482697,7.94741307976891e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",40223,0.103200643395298,0.00907261501350638,0.0854183179688257,0.120982968821771,8.1682324760173e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.140079450803826,0.0123246263599184,0.115923183138386,0.164235718469266,8.45611727651452e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB10,Ras-related protein Rab-10,40511,0.0635678885445328,0.00559118982677294,0.0526091564840579,0.0745266206050078,8.62603233828571e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0878325502593273,0.00773288971904343,0.0726760864100022,0.102989014108652,9.2794213582054e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINC1,Antithrombin-III,40516,0.0174866963283733,0.00154004761243862,0.0144682030079936,0.020505189648753,1.01801521380055e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF6,SLAM family member 6,42346,0.0461877189853783,0.00406940133632466,0.038211692366182,0.0541637456045747,1.01950210907412e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,42676,0.102774287332472,0.009057042787814,0.0850224834683566,0.120526091196588,1.04139636685103e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.071504281893516,0.00629955702057918,0.0591571501331808,0.0838514136538512,1.06485070235052e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,42495,0.0563770966865532,0.0049733677151508,0.0466292959648577,0.0661248974082488,1.19311686629099e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0509864739095539,0.00450163118608474,0.0421632767848278,0.05980967103428,1.41916785142904e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPA,Apolipoprotein(a),40324,-0.215573166483762,0.0190440746041876,-0.25289955270797,-0.178246780259554,1.52026898845313e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0438405665615036,0.00387457375883871,0.0362464019941797,0.0514347311288274,1.59575867137079e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0830485813900385,0.00734069118183447,0.0686608266736429,0.0974363361064341,1.62122208962026e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0623773089972234,0.00552034589377345,0.0515574310454274,0.0731971869490193,1.91455401573772e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,42711,0.0943133727781854,0.00835152000553638,0.0779443935673341,0.110682351989037,1.92601023835783e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLG,Plasminogen,40285,0.0253336491113546,0.00224230093853018,0.0209387392718355,0.0297285589508738,1.94247379919629e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.106813560927081,0.00947662891499607,0.0882393682536884,0.125387753600473,2.46564343822148e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCOF1,Treacle protein,40511,0.0380194882083649,0.0033735972254763,0.0314072376464313,0.0446317387702984,2.65200821625037e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0538324380384231,0.00478359715560222,0.0444565876134428,0.0632082884634035,3.20931197064468e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0373403492336154,0.00332226768693654,-0.043851993900011,-0.0308287045672198,3.67351652102145e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.119541277415137,0.0106505226422038,0.0986662530364176,0.140416301793857,4.46885448380263e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.140372425597485,0.0125430998052898,-0.164956901215853,-0.115787949979117,6.06367181451002e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0449143231782766,0.0040121892010905,0.0370504323441392,0.052778214012414,6.16319863608086e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2,Prothrombin,40539,0.0174296024670252,0.0015571651580079,0.0143775587573297,0.0204816461767207,6.24290013175707e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,42594,0.0388066940191864,0.00347306297918368,0.0319994905799864,0.0456138974583865,7.36312375519087e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPLAH,5-oxoprolinase,40223,0.0791255248583782,0.00707981770406766,0.0652490821584056,0.0930019675583508,7.61658543465827e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA14,Carbonic anhydrase 14,42721,-0.0421163353310565,0.00377199377994005,-0.049509443139739,-0.034723227522374,8.03604374716331e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0610447507197912,0.00546894744791822,0.0503256137218715,0.0717638877177109,8.42198736479233e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN6,Dynactin subunit 6,42311,0.0837771215881835,0.00750651588470942,0.069064350454153,0.098489892722214,8.56870776913599e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0712279911488136,0.00638211474482574,0.0587190462489552,0.0837369360486721,9.07751123576148e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPL14,60S ribosomal protein L14,40223,0.0468283359740923,0.00419719443643102,0.0386018348786875,0.0550548370694971,9.42606067345812e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",40483,0.123073314377607,0.0110335562333428,0.101447544160255,0.144699084594959,9.62443599065135e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,42578,0.0968490002387684,0.00869292653275227,0.0798108642345739,0.113887136242963,1.0579231433479e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,40223,0.0899873864446515,0.00807575682329324,0.0741589030709967,0.105815869818306,1.10314637431685e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSNL1,Visinin-like protein 1,40483,0.0447792209955961,0.00402284537367174,0.0368944440631995,0.0526639979279928,1.24573270031512e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0859103448830295,0.00772376396021347,0.0707717675210111,0.101048922245048,1.36581392239751e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX,Glutaredoxin-1,42546,0.065208276353632,0.00586710510999153,0.0537087503380486,0.0767078023692154,1.42769388641721e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0946876492679649,0.00852392072840353,0.077980764640294,0.111394533895636,1.52028061251023e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0285385783511407,0.00257266827877424,0.0234961485247432,0.0335810081775382,1.80539486937233e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3B,Protein FAM3B,42587,0.0410154841898136,0.0036983684596587,0.0337666820088826,0.0482642863707447,1.8626144627514e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,40429,0.100344893298888,0.00904933635125208,0.0826081940504336,0.118081592547342,1.99982506338514e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX2,Heme oxygenase 2,42311,0.0529818749731613,0.00478120819679057,0.0436107069074518,0.0623530430388709,2.06738803933062e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.114981029880169,0.0103846763789291,0.0946270641774683,0.13533499558287,2.39502415967245e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0348101015598158,0.00314694521988927,0.0286420889288328,0.0409781141907988,2.55468068908719e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100P,Protein S100-P,42357,0.0631352294271111,0.0057087109385103,0.051946155987631,0.0743243028665913,2.62876243881517e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA11,Integrin alpha-11,42594,-0.0394086153989399,0.00356384207083088,-0.0463937458577685,-0.0324234849401114,2.66078746738606e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMTN,Smoothelin,40460,0.106711594111637,0.00965316492953564,0.0877913908497468,0.125631797373527,2.91055517777422e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0386221871084815,0.00349576419536883,0.0317704892855586,0.0454738849314044,2.94888440427491e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA9,Serpin A9,42538,0.082981078291364,0.00751625665711973,0.0682492152434094,0.0977129413393187,3.23822403477602e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.037335588819007,0.00338267350971797,0.0307055487399598,0.0439656288980542,3.51802448807798e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RP2,Protein XRP2,42587,0.0483361857148979,0.00439236921491032,0.0397271420536737,0.0569452293761222,4.78924415164293e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0483040310183934,0.00438746339218063,0.0397046027697194,0.0569034592670674,4.80093164794994e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBN1,Drebrin,40199,0.0575229951174182,0.00523102855879093,0.047270179142188,0.0677758110926485,5.55461785324312e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0945308934606403,0.00860349225254673,0.0776680486456487,0.111393738275632,6.07926266268191e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVR,Poliovirus receptor,42711,0.0421899795758275,0.00384819652925402,0.0346475143784896,0.0497324447731654,7.49292957357341e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0346047827809734,0.00315646099008471,-0.0407914463215394,-0.0284181192404074,7.53413461982732e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAP3,Cytosol aminopeptidase,42370,0.0556636696191941,0.0050771616386936,0.0457124328073546,0.0656149064310336,7.54772715810866e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.037399137563107,0.00341404666643986,0.0307076060968849,0.0440906690293291,8.72489973618252e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.111312167190743,0.0101727345462053,0.0913736074801805,0.131250726901305,9.48581090211975e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMB1,Laminin subunit beta-1,40223,0.0348033871786946,0.00318681818786208,0.0285572235304849,0.0410495508269043,1.26614718731067e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN9,Septin-9,42587,0.0325354084402098,0.00298140257179497,0.0266918593994917,0.0383789574809279,1.30862150053481e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.022514891454477,0.00206328742831055,-0.0265589348139657,-0.0184708480949884,1.31780340532412e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0404371951799778,0.00370638240499772,-0.0477017046937734,-0.0331726856661823,1.42559777826717e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NADK,NAD kinase,42636,0.062402129112378,0.00572858275638729,0.0511741069098589,0.0736301513148971,1.61983048652551e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA2,Carboxypeptidase A2,42670,0.0753002736410112,0.00691669990509864,0.0617435418270179,0.0888570054550046,1.7352363767699e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0293081936994727,0.00269193668298528,0.0240319978008216,0.0345843895981239,1.82565674006042e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.134867188486881,0.0124158328374567,0.110532156125466,0.159202220848296,2.25804422868728e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,42495,0.0592511547572051,0.0054575185974804,0.0485544183061435,0.0699478912082667,2.41068575251255e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.064378763088209,0.00593414539840159,0.0527478381073419,0.0760096880690762,2.63751107854362e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2,Complement C2,42663,0.026034231226307,0.00239998532455463,0.0213302599901799,0.0307382024624341,2.65300585960494e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSS,Cathepsin S,39872,0.0276830289617425,0.0025558756647197,0.0226735126588919,0.0326925452645931,3.39338356887863e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0978897902702714,0.00905571951040589,0.0801405800298759,0.115639000510667,4.23513224483166e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0534173133001221,0.00494492293647954,0.0437252643446222,0.063109362255622,4.54455289542646e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,42794,0.0472192322589077,0.00437864465675287,0.0386370887316721,0.0558013757861433,5.26885419753731e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA4,Carbonic anhydrase 4,42794,-0.0272411129177626,0.00252856345310312,-0.0321970972858447,-0.0222851285496804,5.90831848961334e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0526426612736026,0.00489201611364367,0.043054309690861,0.0622310128563442,6.81104561467244e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA2,Annexin A2,40054,0.0818115890317735,0.0076064567468376,0.0669029338079718,0.0967202442555752,7.6172319180598e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,42495,0.0450542554603445,0.00419143861707875,0.0368390357708702,0.0532694751498189,7.71187640556126e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP2,Neuropilin-2,42611,-0.0323583172341865,0.00301153245418465,-0.0382609208443884,-0.0264557136239846,8.06018126676483e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,42346,0.0448400146210253,0.00417469021459199,0.036657621800425,0.0530224074416256,8.44563202917953e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSE,Cathepsin E,40283,0.0576251035699072,0.00536845607999301,0.0471029296531209,0.0681472774866935,9.53437069701173e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0585521505020069,0.00546107963405405,0.047848434419261,0.0692558665847529,1.03849177987531e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPH,Hephaestin,40511,0.0297431326102378,0.00277660296277419,0.0243009908032004,0.0351852744172752,1.19885377052114e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0381875005870369,0.00357139070073735,0.0311875748135916,0.0451874263604821,1.41321576922516e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0318364240242092,0.00297722634957691,0.0260010603790384,0.0376717876693799,1.4646930886963e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN2,Dynactin subunit 2,42587,0.104582612070196,0.00980482531136038,0.08536515445993,0.123800069680463,1.86579241853987e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0392761261810425,0.00368256289267748,0.0320583029113947,0.0464939494506904,1.98854619590508e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABHD14B,Protein ABHD14B,42460,0.0635625872175623,0.00596308644501864,0.0518749377853258,0.0752502366497988,2.0172213402569e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0318178700020498,0.0029869653987117,0.0259634178205749,0.0376723221835247,2.29276699516726e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,39838,-0.12616982254345,0.0118581956527819,-0.149411886022903,-0.102927759063998,2.63468691106909e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,40449,0.108202584694427,0.0101726226387201,0.0882642443225357,0.128140925066318,2.68252795996156e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KITLG,Kit ligand,42636,-0.0418244702262484,0.00393408053011572,-0.0495352680652752,-0.0341136723872216,2.7098817329741e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0769648519569021,0.00724069324841279,0.062773093190013,0.0911566107237911,2.89595508890177e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APLP1,Amyloid-like protein 1,42636,-0.0574176291566665,0.00540953852229483,-0.0680203246603644,-0.0468149336529687,3.25243859399437e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0639050585847004,0.00602431236897144,0.0520974063415164,0.0757127108278844,3.47229376423434e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0417808901691454,0.00393923600011711,0.0340599876089158,0.0495017927293749,3.55174313148262e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX9,Sorting nexin-9,42636,0.0742557500999584,0.0070059067652381,0.0605241728400917,0.0879873273598251,3.81861336234804e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164,Sialomucin core protein 24,42611,0.0303489966285069,0.00286592783237062,0.0247317780770605,0.0359662151799533,4.22192841887563e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,42652,0.0395244823738677,0.00374239385882257,0.0321893904105755,0.04685957433716,5.69195533751405e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.132085156567973,0.0125209214644976,0.107544150497558,0.156626162638388,6.47617987065098e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0625321683721242,0.00593276510855384,0.0509039487593587,0.0741603879848897,7.15375335945953e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0665174005972381,0.00632317956362202,0.0541239686525389,0.0789108325419372,8.84214504714253e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,42676,0.0277208135808631,0.00263751694304803,0.022551280372489,0.0328903467892373,9.74973278061724e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC4,Syndecan-4,42636,0.0518228417916231,0.00493683139613386,0.0421466522552008,0.0614990313280455,1.11856366952676e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,42689,-0.0645627630212055,0.00616054938165308,-0.0766374398092456,-0.0524880862331655,1.33804264733561e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3C,Protein FAM3C,42613,0.0341787257815668,0.00326169967402411,0.0277857944204796,0.0405716571426541,1.3570723033125e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON2,Spondin-2,42562,-0.0393876219132394,0.00375990439989997,-0.0467570345370434,-0.0320182092894355,1.40327332360995e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0505957580654214,0.00483086497587617,0.0411272627127041,0.0600642534181387,1.49932460697837e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0304666623553654,0.00291914042000251,0.0247451471321605,0.0361881775785703,2.21114016549275e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0634137187704401,0.00608406970025703,0.0514889421579363,0.0753384953829438,2.4460976006642e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB8,Serpin B8,42754,0.0629447031592603,0.00604745231184674,0.0510916966280407,0.07479770969048,2.82442905534516e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX16,Syntaxin-16,42346,0.0626698803259566,0.00606625210331206,0.050780026203465,0.0745597344484482,6.36050521905905e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0480806957381838,0.00465483000216701,-0.0572041625424311,-0.0389572289339365,6.43756067945403e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP6,Platelet glycoprotein VI,42590,0.0939322891619834,0.00909911771056998,0.0760980184492662,0.111766559874701,6.85855502148222e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG2,Bone marrow proteoglycan,40527,-0.0572111585661222,0.00554573886666777,-0.068080806744791,-0.0463415103874533,7.66377897978651e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPB,Natriuretic peptides B,42357,-0.153068053086778,0.0148565189871859,-0.182186830301662,-0.123949275871894,8.47589870997337e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP3,Stromelysin-1,42611,-0.0545489685367245,0.00529552505919302,-0.0649281976527428,-0.0441697394207062,8.62927811899355e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0448140875536045,0.0043557533038191,0.0362768110781191,0.05335136402909,9.79166527884281e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSPN,Persephin,42594,0.100495832060852,0.00977846994957562,0.081330030959684,0.11966163316202,1.101894988706e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,42587,0.0642171788415783,0.00624902061727544,0.0519690984317184,0.0764652592514381,1.11222857077917e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0783175728453634,0.00762403490631963,0.0633744644289769,0.0932606812617499,1.15981530993187e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL1,Growth-regulated alpha protein,42607,0.102759365037772,0.01001081644917,0.0831381647973985,0.122380565278145,1.25181465487185e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPPK1,Epiplakin,40223,0.0780849432117833,0.00760936800261708,0.0631705819266538,0.0929993044969127,1.3524897384905e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0258138478350357,0.00251936326789253,-0.0307517998401051,-0.0208758958299663,1.51449244646765e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0558708765786228,0.00545448877536008,0.045180078578917,0.0665616745783285,1.56233881930734e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0711738191938558,0.00694863375690158,0.0575544970303287,0.0847931413573829,1.56646404406761e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP5,Platelet glycoprotein V,40283,0.0387456420550052,0.00378474055655232,0.0313275505641626,0.0461637335458477,1.73354839185407e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0848704124092265,0.00829692110132925,-0.101132377767832,-0.0686084470506212,1.80470744231062e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,40527,0.0898565999077811,0.00878285951097049,0.0726421952662789,0.107071004549283,1.84149840161461e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,40116,0.0751343867734284,0.00735582092487569,0.060716977760672,0.0895517957861847,2.20271540900283e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0300734579980967,0.00295374616304166,0.0242841155185351,0.0358628004776584,2.93311281719918e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FADD,FAS-associated death domain protein,42636,0.0803442197400188,0.00789923773536369,0.064861713778706,0.0958267257013317,3.26447512751344e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,40404,0.051499157655349,0.00506180798978331,0.0415780139953737,0.0614203013153243,3.29778425409897e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSTN,Growth/differentiation factor 8,42357,0.0567888045327421,0.00559087927651832,0.0458306811507662,0.067746927914718,3.77041364363707e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.062095834452379,0.00612671769647873,0.0500874677672807,0.0741042011374773,4.91049133098448e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0560691412939275,0.00553937413639942,0.0452119679865846,0.0669263146012703,5.38730470858679e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRN1,Secernin-1,42594,0.0586589475525652,0.00579619415961107,0.0472984069997275,0.0700194881054029,5.47901292268592e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0682806176294687,0.00675435409504297,0.0550420836031845,0.0815191516557529,6.39752301695749e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRIB,Protein scribble homolog,40223,0.0962175375131735,0.00951930788932165,0.077559694050103,0.114875380976244,6.4957661994898e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA6,Carbonic anhydrase 6,42581,-0.0662228335561677,0.00655830029960525,-0.079077102143394,-0.0533685649689414,6.89609500340821e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,42587,0.0768043104222093,0.00762027206767471,0.0618685771695668,0.0917400436748517,8.3231044108373e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNF,Tumor necrosis factor,42339,0.0406287524923631,0.0040337782510143,0.032722547120375,0.0485349578643511,8.94841442207565e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR3,Toll-like receptor 3,42754,0.0644380936307072,0.00640126915306334,0.051891606090703,0.0769845811707113,9.41893754228858e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,40302,0.0738011982900241,0.00732905750119162,0.0594362455876885,0.0881661509923596,9.5112956906343e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0462208692549788,0.0045936389860307,0.0372173368423586,0.055224401667599,1.03049957889198e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH1,Acid ceramidase,40418,0.0481865736082354,0.00479040425833003,0.0387973812619085,0.0575757659545622,1.0567194104128e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,40302,0.0363443981374829,0.00361304921470204,0.0292628216766669,0.0434259745982989,1.0568597138638e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0693762807565345,0.00690566932849316,0.0558411688726879,0.0829113926403811,1.16069727860708e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0324722708228028,0.00323279588729782,0.0261359908836991,0.0388085507619066,1.1758799639609e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0551202999118989,0.00548907399867977,0.0443617148744865,0.0658788849493112,1.20959819928128e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,42416,0.0868920405027445,0.00865358480930828,0.0699310142765003,0.103853066728989,1.22121981642174e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.100235549745765,0.00998844915499999,0.0806581894019647,0.119812910089565,1.29625616924567e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,42346,0.0542460849115556,0.0054108589364085,0.043640801396195,0.0648513684269163,1.43223638431473e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENR,Density-regulated protein,40199,0.0599059783385274,0.0059742930669232,0.0481963639273579,0.0716155927496968,1.45958828629002e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,42711,0.0483424236158398,0.00483134978025139,0.038872978046547,0.0578118691851325,1.73152224581481e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,40511,0.0299546637897514,0.00299510060657363,0.0240842666008671,0.0358250609786357,1.88341467323552e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0342829540210195,0.00342873656562625,0.027562630352392,0.0410032776896469,1.93129260403423e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP7,Matrilysin,42333,0.0528922398275613,0.00529276622027837,0.0425184180358157,0.0632660616193069,1.97675407358246e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0697390391801268,0.00698232809488273,0.0560536761141567,0.083424402246097,2.08666929600432e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POMC,Pro-opiomelanocortin,40223,0.0732126824816017,0.00733981222901392,0.0588266505127344,0.087598714450469,2.46860342581947e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARD3,Partitioning defective 3 homolog,40302,0.0777724777308312,0.00779733958740363,0.0624896921395201,0.0930552633221423,2.47703339277472e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0317267524604602,0.00318185538244036,0.0254903159108771,0.0379631890100433,2.54391163875236e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,42679,0.0725688312539076,0.0072853089756691,0.0582896256615962,0.086848036846219,2.71786213628454e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPR,Nucleoprotein TPR,40116,0.0507576693243646,0.0050956865201656,0.04077012374484,0.0607452149038891,2.83996109889771e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,40367,0.035755901503453,0.00359134240866542,0.0287168703824688,0.0427949326244372,2.96312395115068e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,42480,0.0493234349426057,0.0049570098059371,0.0396076957229689,0.0590391741622424,3.0337901623074e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF2,Fibroblast growth factor 2,42594,0.0714045116416822,0.00717813104929986,0.0573353747850544,0.0854736484983099,3.11265911447258e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK4,Dickkopf-related protein 4,42477,0.0483674808070065,0.0048644164148331,0.0388332246339336,0.0579017369800793,3.25708979774663e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,42754,0.0753405736319025,0.007582281874182,0.0604793011585058,0.0902018461052992,3.46957842237823e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDA,Cytidine deaminase,40494,0.0488019591052997,0.0049179571496819,0.0391627630919231,0.0584411551186762,4.10151480896908e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,42346,0.050279685207246,0.00506858556616923,0.0403452574975543,0.0602141129169377,4.11323490076351e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0320768909359521,0.00323517459980604,0.0257359487203323,0.038417833151572,4.29532616616342e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0451871924927241,0.00455582560652666,0.0362577743039319,0.0541166106815164,4.29962324167897e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM2,Paralemmin-2,40483,0.0392443327503325,0.00396057146502734,0.0314816126788789,0.0470070528217861,4.73582850705403e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMMT,MICOS complex subunit MIC60,40451,0.0469400261230259,0.00473976863442984,0.0376500795995434,0.0562299726465083,4.99512529220782e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1F,Protein phosphatase 1F,40511,0.0539526568849194,0.00545115601868443,0.0432683910882979,0.0646369226815408,5.29372615817998e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0600881122212528,0.00607340801868099,0.048184232504638,0.0719919919378675,5.3362020930271e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAL,Integrin alpha-L,40199,0.04627959185152,0.00468021826306135,0.0371063640559198,0.0554528196471203,5.82994906106601e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0682924001553681,0.00691654155876253,0.0547359787001936,0.0818488216105427,6.46230506770866e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP1,Guanylate-binding protein 1,40466,0.0679111463451782,0.00688275486393674,0.0544209468118622,0.0814013458784942,7.17307573282101e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,42346,0.0750600290471031,0.00763496016182112,0.0600955071299338,0.0900245509642725,9.90597908603977e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL18,C-C motif chemokine 18,42477,0.0717134552237839,0.00730162800915278,0.0574022643258445,0.0860246461217234,1.08616608234192e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0903025214378841,0.00919809741231262,0.0722742505097514,0.108330792366017,1.16689655831676e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.123080130565748,0.0125509640700974,0.0984802409883569,0.147680020143139,1.25879513816342e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHPS,Deoxyhypusine synthase,40451,0.0416237542777091,0.00424443761953732,0.033304656543416,0.0499428520120023,1.29831151776344e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SBSN,Suprabasin,40511,-0.0360136535330767,0.0036762609322294,-0.0432191249602463,-0.0288081821059071,1.43612223663401e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TST,Thiosulfate sulfurtransferase,42277,0.0763484575332,0.00780567799260035,0.0610493286677033,0.0916475863986967,1.62048324892846e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.119973406615032,0.0122660090150414,0.0959320289455509,0.144014784284513,1.67057761759599e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11,Coagulation factor XI,40383,0.0308386709344384,0.00315633759222581,0.0246522492536758,0.037025092615201,1.85496788472259e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC79,Protein unc-79 homolog,40080,0.0569657465108016,0.00584026612245842,0.0455188249107831,0.0684126681108201,2.19076089702893e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGRN,Neugrin,40483,0.0237170012266717,0.00243199041169618,0.0189503000197472,0.0284837024335962,2.21449331324952e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML2,Trem-like transcript 2 protein,42611,0.0355109655831063,0.00364766915078083,0.0283615340475759,0.0426603971186368,2.52842333933426e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,40527,0.0397846367412295,0.00408536464388742,0.0317773220392102,0.0477919514432489,2.53101264417057e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,42611,-0.0294704842136354,0.00302991125438277,-0.0354091102722256,-0.0235318581550452,2.7533977400811e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGF,Hepatoma-derived growth factor,42700,0.0947602483869674,0.00974637037403464,0.0756573624538595,0.113863134320075,2.85695692701337e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0592698934466387,0.00609477316695333,0.0473241380394102,0.0712156488538672,2.89287197861379e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA2,Carbonic anhydrase 2,42573,0.0707176987959571,0.0072819281270767,0.0564451196668867,0.0849902779250274,3.19231537247986e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA,Lymphotoxin-alpha,42594,0.0416379962824263,0.00428945979155091,0.0332306550909865,0.0500453374738661,3.32957533660097e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0698592353110272,0.0071975176304845,0.0557521007552776,0.0839663698667768,3.48133781638316e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIT2,Slit homolog 2 protein,42311,0.0534375974828745,0.00551321155656653,0.0426317028320041,0.0642434921337449,3.84446486689221e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0439592056394371,0.00453703322727176,0.0350666205139845,0.0528517907648898,3.97120552132292e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD302,CD302 antigen,42587,0.0325790564779489,0.00336461411488484,0.0259844128127746,0.0391737001431232,4.21363456650195e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0382988148175437,0.00395654583418664,0.0305439849825379,0.0460536446525495,4.48971148842079e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP2,Retinol-binding protein 2,42587,-0.0784202693622763,0.00810735209424978,-0.0943106794670059,-0.0625298592575468,4.64857137367838e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD84,SLAM family member 5,42594,0.0318419206998344,0.00329200126572951,0.0253895982190046,0.0382942431806643,4.65826154804628e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0370274142033702,0.00382818800469127,0.0295241657141754,0.0445306626925651,4.67321436394228e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDCP1,CUB domain-containing protein 1,42495,0.0550140174419787,0.00569780467603165,0.0438463202769567,0.0661817146070007,5.51113272452632e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA13,Carbonic anhydrase 13,42483,0.103797302223717,0.0107507020108621,0.0827259262824269,0.124868678165006,5.53165330661222e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0602885208034205,0.00624455103737442,0.0480492007701666,0.0725278408366744,5.72539977909221e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,42346,0.0436977524200611,0.00454421962689709,0.0347910819513428,0.0526044228887794,8.06475437601224e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.027640201596165,0.00287807290492096,0.0219991787025199,0.0332812244898101,9.38816953373951e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,40223,0.0528034574718122,0.00549963601670473,0.0420241708790709,0.0635827440645535,9.60403755333992e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40LG,CD40 ligand,42754,0.0778983748525938,0.00812145614570301,0.0619803208070159,0.0938164288981718,1.01572018317879e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0551373712149516,0.00575413449812503,0.0438592675986265,0.0664154748312766,1.11469548128143e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,40451,0.0607849231782235,0.00634713966082477,0.0483445294430069,0.07322531691344,1.21090770944018e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO1A,Coronin-1A,42353,0.089423662304556,0.00934316498554762,0.0711110589328827,0.107736265676229,1.24483575591722e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID1,Nidogen-1,42652,0.0384621358820752,0.00401970798781482,0.0305835082259582,0.0463407635381923,1.27216783215667e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,40519,0.0198966485635355,0.0020790940430829,0.0158216242390931,0.023971672887978,1.29207717602552e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA12,Serpin A12,42249,0.103736628490938,0.0108459604341789,0.0824785460399469,0.124994710941928,1.32651403651852e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP1,Interstitial collagenase,42136,0.0914369497525916,0.00957802995650867,0.0726640110378347,0.110209888467349,1.57885324079924e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0268012888200661,0.00280696187334549,0.0212996435483089,0.0323029340918232,1.59123725001472e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0360540392535005,0.00377991118458982,0.0286454133317045,0.0434626651752966,1.69755976721598e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0530642054632537,0.00556174933680338,0.0421631767631191,0.0639652341633884,1.70602256288562e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.045061441323294,0.00472381969827927,0.0358027547146666,0.0543201279319214,1.74268024151944e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0346688609415859,0.00363748701177924,0.0275393863984986,0.0417983354846732,1.82112177184455e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.067364830860316,0.00707932597234697,0.0534893519545159,0.0812403097661161,2.17169461163953e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0413753518606857,0.00434856931743401,0.0328521559985151,0.0498985477228564,2.19350994827059e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGR1,Prostaglandin reductase 1,40511,0.0835995461815122,0.00879178051056121,0.0663676563808122,0.100831435982212,2.31679211872669e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA1,BolA-like protein 1,40136,0.0540997726156975,0.00568957334014116,0.0429482088690208,0.0652513363623741,2.336862176911e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0594125743301198,0.00625388847920059,0.0471549529108867,0.071670195749353,2.45391666309505e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB2,Plexin-B2,42743,0.0240546487229203,0.00253298197002118,0.0190900040616788,0.0290192933841619,2.52698376640887e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA,Adenosine deaminase,42754,0.0344599735648075,0.00363564024788575,0.0273341186789514,0.0415858284506635,3.00492743112455e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0788191006202651,0.00831479033442849,0.0625221115647852,0.0951160896757449,3.06955242257637e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0414316914738758,0.00437156631084111,0.0328634215046272,0.0499999614431244,3.13551317789616e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0409778041116704,0.00435305575267927,-0.0495097933869218,-0.032445814836419,5.56729486090492e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0383792328049548,0.00407821175165458,0.0303859377717118,0.0463725278381977,5.72102108547224e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0863383659882047,0.00919075442257919,0.0683244873199495,0.10435224465646,6.71216270013675e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,42679,0.0370458096213833,0.00395686004493843,0.029290363933304,0.0448012553094626,9.00907238811411e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB2,Calretinin,42311,0.0314926349582579,0.00336369645721748,0.0248997899021116,0.0380854800144041,9.03868053635348e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0673091538642451,0.0071911858781122,0.0532144295431452,0.081403878185345,9.23030160810515e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0395900862571444,0.00422822934104256,0.031302756748701,0.0478774157655879,9.23266433264402e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0292412820077551,0.00312777051096027,0.023110851806273,0.0353717122092373,1.02527204000917e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,40483,0.0223468118757714,0.00238969621615914,0.0176630072920995,0.0270306164594433,1.02839346098372e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPAG1,Sperm-associated antigen 1,40482,0.0562770241833559,0.00601931284342434,0.0444791710102442,0.0680748773564676,1.046994887201e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0228316593311077,0.00244457746704348,0.0180402874957025,0.0276230311665129,1.14584792190488e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0320183373388223,0.00342944321638226,0.0252966286347131,0.0387400460429315,1.15292786059653e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMS,Spermine synthase,40136,0.0625637227146818,0.00669922624114503,0.0494332392820375,0.075694206147326,1.16115633357409e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,40482,0.0580912106442854,0.00622528401196882,0.0458896539808265,0.0702927673077443,1.23841365104248e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL15,C-C motif chemokine 15,42794,0.0437403379318338,0.00469425746219769,0.0345395933059263,0.0529410825577412,1.36732295764868e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,42636,0.0615182616081846,0.00660502981453502,0.0485724031716959,0.0744641200446732,1.42168689195298e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0846720095447601,0.009098038749938,0.0668398535948816,0.102504165494639,1.52221212073168e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,42711,0.0301117482032266,0.00323675092748082,0.0237677163853642,0.0364557800210891,1.57116032577776e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRSF1,G-rich sequence factor 1,40014,0.0787018335937238,0.00847805760089734,0.062084840695965,0.0953188264914826,1.96204590516521e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.055460026771188,0.0059748443501861,0.0437493318448232,0.0671707216975527,1.96599511776442e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0543194432601487,0.0058596291637698,0.0428345700991599,0.0658043164211375,2.20130155224971e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0478815289975683,0.0051693015321556,0.0377496979945434,0.0580133600005933,2.37186510517009e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0434970499157079,0.00470641116568628,-0.052721615800453,-0.0342724840309627,2.77536712878806e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0413784722221018,0.00447852989091778,0.032600553635903,0.0501563908083006,2.93954469792946e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARFIP1,Arfaptin-1,40482,0.0662314194968995,0.00716958186237314,0.0521790390466481,0.0802837999471508,2.9642709372533e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAT,Catalase,40361,0.0525155043592177,0.00568955428998375,0.0413639779508495,0.0636670307675858,3.18845282821384e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,40223,0.0229935336097541,0.00249602536968781,0.018101323885166,0.0278857433343422,3.77781079153182e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0661675041873748,0.00718361748079869,0.0520876139250093,0.0802473944497402,3.8202835956835e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,40102,0.0525428073390204,0.00570575269996957,0.04135953204708,0.0637260826309607,3.90259364769009e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTC,Probetacellulin,42346,0.0722254049300632,0.00784625960565458,0.0568467361029802,0.0876040737571461,3.92384033877839e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,42594,-0.047304743984809,0.00514210878404182,-0.0573832772015309,-0.037226210768087,4.12154043727998e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,42475,0.0391554965128812,0.00425724503776648,0.0308112962388589,0.0474996967869035,4.20762110570419e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0318122089528638,0.00346434993452659,0.0250220830811916,0.0386023348245359,4.82351605803519e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,40511,0.0263779991582598,0.00287188780397194,0.0207490990624748,0.0320068992540448,4.83451190150282e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOL1,Apolipoprotein L1,40532,0.0560227191607853,0.00610125593515085,0.0440642575278896,0.067981180793681,4.95662442919206e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD248,Endosialin,40527,-0.0392819320719793,0.0042833528562986,-0.0476773036703246,-0.0308865604736341,5.50218478162322e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRBP,Acrosin-binding protein,40451,0.0377117463237936,0.00411343838731672,0.0296494070846528,0.0457740855629343,5.65709979799375e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0365471404954121,0.00399683873467206,0.0287133365754549,0.0443809444153694,7.04598894446242e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TF,Serotransferrin,40539,0.0204213403885335,0.00223661632710097,0.0160375723874156,0.0248051083896514,7.97260634804054e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0336919460143224,0.00369143400435352,0.0264567353657895,0.0409271566628553,8.26456053628688e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMD,Osteomodulin,42676,-0.0404757450261362,0.00443865919360526,-0.0491755170456025,-0.0317759730066699,8.64815684167147e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,42370,0.0333846307483145,0.0036641086441401,0.0262029778057999,0.0405662836908291,9.30490243029863e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD83,CD83 antigen,42594,0.0338286886932472,0.00371327224671701,0.0265506750896818,0.0411067022968125,9.37366901518028e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0779470964470253,0.00855636156130332,0.0611766277868708,0.0947175651071799,9.40534755407896e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLMH,Bleomycin hydrolase,42794,0.02988236596872,0.00328167955689746,0.023450274037201,0.036314457900239,9.73999199764343e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0841054757591592,0.00923858769217177,0.0659978438825025,0.102213107635816,1.0221315962418e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,42357,0.0484574985920941,0.00532864334842969,0.0380133576291719,0.0589016395550163,1.09204210714999e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.02391394132859,0.0026309890431784,0.0187572028039604,0.0290706798532197,1.13473692943769e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,40532,0.062099835399965,0.00684640218312686,0.0486808871210364,0.0755187836788937,1.38022350246827e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0600819927622855,0.00663210931951068,0.0470830584960446,0.0730809270285265,1.52818049851103e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX7,Syntaxin-7,40199,0.0475272255265773,0.00524840654400111,0.0372403487003352,0.0578141023528195,1.58768508695728e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTN,Pleiotrophin,42357,0.046966581018677,0.0051921394920377,0.0367899876142831,0.0571431744230708,1.69293245149991e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0315078725827479,0.00348239686776549,-0.0383333704435682,-0.0246823747219275,1.6967456840766e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0330961232419796,0.00366519966648147,0.0259123318956759,0.0402799145882833,1.95061258136506e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.0769327153813337,0.00852536758143563,0.0602229949217199,0.0936424358409476,2.05800494712757e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIT,Citron Rho-interacting kinase,40182,0.0428343277249993,0.0047686570286607,0.0334877599488244,0.0521808955011743,3.07914329223875e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA2,Integrin alpha-2,40283,0.0328359582144086,0.00366104889592422,0.0256603023783971,0.04001161405042,3.47209810619728e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,40482,0.0340937813918862,0.00380386464675074,0.0266382066842547,0.0415493560995176,3.65775180326984e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1R,Complement C1r subcomponent,40539,0.0182677332661752,0.00203947594979409,0.0142703604045787,0.0222651061277716,3.85315311739718e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0283489959016437,0.00316595288827092,-0.0345542635626547,-0.0221437282406327,3.86280438782873e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL5,Insulin-like peptide INSL5,40449,0.0927541065454214,0.0103583852710299,0.0724516714142028,0.11305654167664,3.94812872498641e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0322475874046677,0.00360628783721334,0.0251792632437296,0.0393159115656059,4.31533073670881e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO2,Gamma-enolase,42711,0.0603597572300994,0.00675070374253591,0.0471283778947291,0.0735911365654698,4.34130710551211e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0364629515906399,0.00408237674603419,0.0284614931684128,0.0444644100128669,4.73097302609663e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0517483603436379,0.00579477680594881,0.0403905978039783,0.0631061228832976,4.91263345486063e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXN,Thioredoxin,40384,0.0416826087000737,0.0046704320206787,0.0325285619395434,0.0508366554606039,5.16034182500102e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFB,Complement factor B,40344,0.0302897972688855,0.00339492116859544,0.0236357517784384,0.0369438427593325,5.28932257281394e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA6,Integrin alpha-6,42594,0.0476244392754357,0.00534172675957226,0.037154654826674,0.0580942237241973,5.47474441461454e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPQ,Carboxypeptidase Q,40516,0.0334364283432785,0.00375127518168575,0.0260839289871744,0.0407889276993826,5.70794901481087e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM3,Myomesin-3,40283,-0.0865157580810781,0.00972574670904161,-0.1055782216308,-0.0674532945313566,6.7143260355587e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0856153039480518,0.0096334129146788,0.0667338146352814,0.104496793260822,7.20738679011677e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFC1,Cryptic protein,42346,0.0441456029311391,0.00497947555720857,0.0343858308390103,0.0539053750232679,8.58555148586988e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD209,CD209 antigen,42668,-0.0361072743522384,0.00408088902113857,-0.04410581683367,-0.0281087318708069,1.00170926531428e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN2,Nectin-2,42613,0.0292644586862823,0.00331020849578705,0.0227764500345397,0.035752467338025,1.06876441631024e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,42437,0.0316995308792082,0.00359040239050727,0.0246623421938139,0.0387367195646024,1.18784668048613e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL20,C-C motif chemokine 20,42754,0.0849590038294204,0.00962346438417713,0.0660970136364333,0.103820994022408,1.1914232095746e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0504799305692381,0.00572696243486405,0.0392550841969046,0.0617047769415716,1.34968037424225e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0282234919010386,0.00320347791356747,-0.0345023086116309,-0.0219446751904464,1.39955666646563e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0450917421553045,0.00511820940987317,0.0350600517119531,0.0551234325986559,1.4338360935624e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,42292,0.0613216072794307,0.00696466914639056,0.0476708557525052,0.0749723588063562,1.47556395012356e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.039968402336198,0.00455249714034745,0.031045507941117,0.0488912967312791,1.83920091442928e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,42636,0.0786848327739772,0.0089743632457585,0.0610950808122906,0.0962745847356639,2.03968054942461e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH7,Protocadherin-7,40449,0.0334289259959488,0.00381177180196224,0.0259578532641028,0.0408999987277948,2.04472226377923e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0657273277430716,0.00751116526281269,0.0510054438279587,0.0804492116581845,2.37742037179321e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX6,Syntaxin-6,42346,0.0607059832562045,0.00694430006927791,0.0470951551204198,0.0743168113919892,2.56891853386649e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP8,Caspase-8,42674,0.0561403268463832,0.00642549878483033,0.0435463492281157,0.0687343044646506,2.67070549673649e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,42778,0.0218694668998043,0.00250587341323965,0.0169579550098546,0.026780978789754,2.90947577273702e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH5,Cadherin-5,42794,-0.0275790852177192,0.00316418461491484,-0.0337808870629523,-0.0213772833724862,3.21174841500609e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0540520067049548,0.00621851448008658,0.0418637183239851,0.0662402950859245,3.96723311738464e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAP,Prosaposin,40440,0.0264224511008475,0.00304389810659427,0.0204564108119227,0.0323884913897723,4.48413181192728e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,42613,0.0737104166160893,0.00850070693593961,0.0570490310216477,0.090371802210531,4.76665260046177e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN4,Cerebellin-4,42721,0.029597460344514,0.00341600297145221,0.0229020945204676,0.0362928261685603,5.05118628197958e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0691204317420336,0.0080041983523523,0.0534322029714231,0.0848086605126441,6.64372984717861e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0366869501140954,0.00425231031682656,0.0283524218931153,0.0450214783350754,7.1365110758305e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,42794,0.0343404331366751,0.0039870278563058,0.0265258585383157,0.0421550077350344,7.89063000559643e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL26,C-C motif chemokine 26,42594,0.0844270401587102,0.00980524849107544,0.0652087531162024,0.103645327201218,8.0864612662321e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,42636,0.0680332031846978,0.00790256693010453,0.0525441720016929,0.0835222343677027,8.18204021748133e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,42595,0.0263465901737441,0.00306097815327783,0.0203470729933196,0.0323461073541687,8.31019640525907e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD93,Complement component C1q receptor,42141,-0.0291433681488705,0.00338599972375679,-0.0357799276074338,-0.0225068086903072,8.35696357793377e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.102184374322583,0.0118723496865222,0.078914568937,0.125454179708167,8.50098316326019e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSL,Cathepsin L1,42636,0.0223788670406284,0.00260405688931313,0.0172749155375746,0.0274828185436821,9.33038139089965e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0473581757110585,0.0055126303628356,0.0365534201999007,0.0581629312222163,9.56772681653906e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS27,Serine protease 27,42603,0.0363301599516317,0.00423256918644007,0.0280343243462092,0.0446259955570543,1.02091066209236e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0446218846683102,0.00519936180074252,-0.0548126337977656,-0.0344311355388549,1.05231682585614e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,40116,0.0463465654583868,0.00540254248755469,0.0357575821827796,0.056935548733994,1.08957442790779e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0292127158205107,0.00340753948300072,0.0225339384338293,0.0358914932071922,1.116416588127e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGN,Biglycan,42328,-0.108179259629376,0.012629316194835,-0.132932719371253,-0.0834257998874995,1.19270356340109e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN2,Matrilin-2,42638,0.0266156070027693,0.00310880198235529,0.0205223551173529,0.0327088588881857,1.2354025013124e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX5,Sorting nexin-5,40223,0.0261496039198457,0.00305347938447205,0.0201647843262805,0.032134423513411,1.2363184390002e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,40116,0.104305656362404,0.0122522661623564,0.0802912146841855,0.128320098040623,1.91385526339071e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPA1,Inositol monophosphatase 1,42495,0.0538957013760417,0.00633929402291834,0.0414706850911218,0.0663207176609616,2.0633507209683e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,42711,-0.0270467464297588,0.00318191458172056,-0.0332832990099311,-0.0208101938495865,2.09023671346109e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0469815356446399,0.00552804784921344,-0.0578165094290982,-0.0361465618601815,2.11685868804284e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,42457,0.039385164038257,0.00463930588684864,0.0302921245000337,0.0484782035764804,2.29505636861276e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0340821133868338,0.00401403244039741,0.0262146098036549,0.0419496169700127,2.31426898633524e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRG,Histidine-rich glycoprotein,40479,0.0275222465683603,0.00324205495455211,0.0211678188574381,0.0338766742792824,2.34187520993045e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0464917789362311,0.0054810029348036,0.035749013184016,0.0572345446884462,2.48847507622917e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0602056968300485,0.00710186404488889,0.0462860433020663,0.0741253503580307,2.54114769013541e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASET2,Ribonuclease T2,42749,0.0246103994002132,0.00290469059746736,0.0189172058291771,0.0303035929712492,2.64415205364228e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,40302,0.0310254650743072,0.0036672797475062,0.0238375967691951,0.0382133333794194,3.00666410343536e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0644805524345676,0.00762943063631776,0.0495268683873848,0.0794342364817504,3.17548850746662e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,42346,0.040033462452612,0.00474432436486255,0.0307345866974814,0.0493323382077426,3.55755218984058e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0383497933695481,0.00455058294371147,0.0294306507998736,0.0472689359392226,3.89679562147994e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFA,Protransforming growth factor alpha,42594,0.0419846389503839,0.00498627101760868,0.0322115477558708,0.0517577301448969,4.14278842062558e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL24,C-C motif chemokine 24,42654,0.0731361597124356,0.00869225983327922,0.0560993304392083,0.0901729889856628,4.361325395081e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,40080,0.0466394601285891,0.00554462737581331,0.035771990471995,0.0575069297851832,4.54781822405104e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0621634015002801,0.00739605234520192,0.0476671389036843,0.0766596640968758,4.80328439859181e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLTA,Clathrin light chain A,42357,0.041894885203229,0.00500204340012265,0.0320908801389886,0.0516988902674694,6.04890732206154e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1B,Meprin A subunit beta,42636,0.103752925481751,0.0123975164878462,0.0794537931655727,0.12805205779793,6.38869255617413e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0413159322600059,0.00493618119817024,0.0316410171115922,0.0509908474084196,6.43920846161092e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,40136,0.0416511915156345,0.00498133397785491,0.0318877769190389,0.0514146061122301,6.94565906114543e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID2,Nidogen-2,42611,0.0648294078093738,0.0077572792646121,0.0496251404507341,0.0800336751680136,7.04739381084747e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",40490,0.0196965625286013,0.0023609941121476,0.015069014068792,0.0243241109884105,8.11876364078518e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0344352701194321,0.00413012324788157,0.0263402285535842,0.0425303116852799,8.48682904001686e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,40199,0.0350312957012692,0.0042051779385452,0.0267891469417206,0.0432734444608178,9.00374026810321e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,42454,0.0217695530428066,0.00261541379443463,0.0166433420057147,0.0268957640798985,9.36581497764648e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0335111002936273,0.00402612143101956,0.025619902288829,0.0414022982984257,9.36774769442177e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXN,"Frataxin, mitochondrial",42721,0.0637671967846905,0.00766964539740446,0.0487346918057778,0.0787997017636033,1.01101939926249e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,42689,0.0402327528262057,0.00484306935422739,0.0307403368919201,0.0497251687604914,1.07188111118061e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMD,Dystrophin,40223,0.0449632763859395,0.00541375232099555,0.0343523218367882,0.0555742309350908,1.11125254282772e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_E,,42594,0.0269102569358723,0.00324207008039776,0.0205557995782927,0.0332647142934519,1.13689445590628e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMM2,Phosphomannomutase 2,40116,0.0523350521782298,0.00631316585442501,0.0399612471035567,0.0647088572529028,1.26697494085415e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0790999305076555,0.00955060166676816,0.0603807512407899,0.0978191097745211,1.34788666791553e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0366613960106078,0.00442966352052604,0.0279792555103767,0.0453435365108388,1.39174614089475e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS22,Brain-specific serine protease 4,40199,0.0317996648682776,0.00384419994913831,0.0242650329679665,0.0393342967685887,1.46760132858485e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.04547782594603,0.00550139312429677,0.0346950954224083,0.0562605564696517,1.50967929636213e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN3,Calsyntenin-3,40483,0.0266426329241789,0.00322606661990111,0.0203195423491727,0.0329657234991851,1.63874350131125e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0426328017581572,0.00516624093437531,0.0325069695267816,0.0527586339895328,1.72837468468256e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDK,Midkine,42638,0.0441850003307295,0.00535805734166482,0.0336832079410664,0.0546867927203925,1.78203668289417e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGLAP,Osteocalcin,40527,0.0782091033776353,0.00950797965120693,0.0595734632612697,0.0968447434940009,2.1535397535147e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS2,Growth arrest-specific protein 2,40302,0.0452377359777371,0.00554217966846081,0.0343750638275539,0.0561004081279203,3.63738949750668e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,42311,0.0492752620597705,0.00603860340741549,0.0374395993812362,0.0611109247383049,3.65250458834397e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK7,Kallikrein-7,40009,0.0335671605134467,0.00411301251764782,0.025505655978857,0.0416286650480364,3.68470782791736e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A12,Protein S100-A12,42434,0.0644744944271752,0.00790260043766564,0.0489853975693506,0.0799635912849999,3.69190039811529e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0567624104951805,0.00695926633601673,0.0431222484765877,0.0704025725137733,3.81738006577611e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZU1,Azurocidin,42216,0.0654795753538455,0.00803074122301922,0.0497393225567278,0.0812198281509631,3.85343907569044e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD276,CD276 antigen,42618,-0.0314479507682331,0.0038601451006569,-0.0390138351655206,-0.0238820663709456,4.06409621434249e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0483475485008146,0.0059349866648523,0.0367149746377041,0.0599801223639251,4.16032636067155e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,40451,0.0247129270107315,0.00303701535324271,0.0187603769183758,0.0306654771030872,4.46872135212238e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPK2,Death-associated protein kinase 2,40199,0.046269210207867,0.00568618940686194,0.0351242789704176,0.0574141414453164,4.48334927289122e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0338220854639024,0.00416858872895091,0.0256516515551586,0.0419925193726462,5.33726835808214e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH15,Cadherin-15,42692,0.053042792283227,0.00654962027881824,0.0402055365367432,0.0658800480297107,6.03326764213045e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPF,Centromere protein F,40302,0.0464342966667068,0.00573725413590318,0.0351892785603366,0.057679314773077,6.40301909864782e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY75,Lymphocyte antigen 75,42594,0.0331431772090576,0.00409757869710648,0.0251119229627289,0.0411744314553863,6.55783950279981e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,40199,0.0534074093047815,0.0066047159461612,0.0404621660503056,0.0663526525592575,6.79774885644508e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.0210499638885359,0.00260863955006335,-0.02616289740666,-0.0159370303704117,7.65791606858328e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0378430957297899,0.0046943664463569,0.0286421374949304,0.0470440539646494,8.30609207011495e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0274052393098878,0.003402904042459,0.0207355473866682,0.0340749312331075,8.72249499903859e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,42594,0.0527188289596289,0.00654746868038197,0.0398857903460802,0.0655518675731776,8.84384573105037e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,42370,0.0560174771795855,0.00697090365914678,0.0423545060076578,0.0696804483515132,1.0076233583149e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,40223,0.0274637148708443,0.00343318588943871,0.0207346705275444,0.0341927592141442,1.3743980294113e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,40116,0.0507637977261512,0.00634988064451552,0.0383180316629008,0.0632095637894016,1.43272976842376e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI2,Serpin I2,40449,0.0470385951729456,0.00588905363828534,0.0354960500419063,0.0585811403039849,1.51151066982277e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA4,Annexin A4,42584,0.0596041186710496,0.00748431622888898,0.0449348588624272,0.074273378479672,1.80125523671299e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COLEC12,Collectin-12,42618,0.0233576528897644,0.00294276514897788,0.0175898331977677,0.0291254725817611,2.2292236095134e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAST,Gastrin,40483,0.121381768511777,0.0153042038305108,0.0913855290039755,0.151378008019578,2.37359921366783e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,40223,0.0519442396824566,0.00655175076240241,0.0391028081881479,0.0647856711767654,2.43587732467863e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP9,Caspase-9,40199,0.0520188753057234,0.00657028767545565,0.0391411114618304,0.0648966391496165,2.66065619642012e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,42215,0.0841438010825515,0.0106502169093372,0.0632693759402506,0.105018226224852,2.99606727962346e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM1,Dynamin-1,40449,0.0944757436018149,0.0119609217586992,0.0710323369547644,0.117919150248865,3.08022736970739e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSB,Cathepsin B,42659,-0.0445184935246658,0.00564807327087765,-0.055588717135586,-0.0334482699137456,3.46646844584792e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,40482,0.0553550148214638,0.00704107729269575,0.0415545033277801,0.0691555263151475,4.13320506718472e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF22,Kinesin-like protein KIF22,40116,0.103162423877176,0.0131337364224354,0.0774203004892024,0.128904547265149,4.38063246426423e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,42587,0.0193504730074866,0.00246648128049437,0.0145161696977176,0.0241847763172555,4.64243970166183e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX1,Heme oxygenase 1,42500,-0.0398342076528656,0.00507744489434172,-0.0497859996457754,-0.0298824156599558,4.64650476952244e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGMN,Legumain,42676,0.0293718978776257,0.00374717906803795,0.0220274269042713,0.03671636885098,4.90402473405041e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL8,Interleukin-8,42494,0.0573199522394913,0.00731827423264874,0.0429761347434998,0.0716637697354828,5.14625239029209e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNC,Tenascin,42689,-0.0397685671866381,0.00507758524625001,-0.0497206342692881,-0.0298165001039881,5.15145636580547e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDHB,Succinate dehydrogenase,40449,0.0546609164733864,0.00697804998566021,0.0409839385014923,0.0683378944452804,5.18064208340378e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,40223,0.0664979504981391,0.00849617224100669,0.0498454529057659,0.0831504480905122,5.46149630790391e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL14,C-C motif chemokine 14,42618,0.0330804249469645,0.00423508873322654,0.0247796510298405,0.0413811988640885,6.09163122224731e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0280239313271101,0.00359475208477492,-0.0350696454132689,-0.0209782172409512,6.86970891209032e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0463283852253333,0.00594214844561221,0.0346817742719334,0.0579749961787333,6.92945499246441e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD46,Membrane cofactor protein,42580,0.0236606045511936,0.0030372382055679,0.0177076176682805,0.0296135914341067,7.1829694984287e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA1,Carbonic anhydrase 1,42362,0.0491920195282212,0.00631674903998542,0.0368111914098498,0.0615728476465926,7.34118805968127e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0480855240445944,0.00617714784313804,0.0359783142720439,0.060192733817145,7.51907581432803e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,42616,0.0359646690890599,0.00462854694594151,0.0268927170750145,0.0450366211031052,8.40471139740814e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0435138357812185,0.00561428769334453,0.0325098319022632,0.0545178396601738,9.79989316685166e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0422008747176028,0.00545608660789183,0.0315069449661348,0.0528948044690708,1.1107844696468e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL19,C-C motif chemokine 19,42711,0.10635447027819,0.0137621870857815,0.0793805835900584,0.133328356966322,1.16913046455318e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.0215917198348189,0.00279396078190977,-0.0270678829673621,-0.0161155567022758,1.17008568882695e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0371136163809704,0.00481331828266871,0.0276795125469398,0.0465477202150011,1.36097345153747e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOE,Apolipoprotein E,40539,0.058867541168983,0.00763752387793303,0.0438979943682343,0.0738370879697317,1.38816804657846e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0739290813328888,0.00960740594909986,0.0550985656726531,0.0927595969931245,1.53551189704883e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.081644362913295,0.0106156624340199,0.060837664542616,0.102451061283974,1.56310139549919e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0312122308808542,0.00409197263615469,0.023191964513991,0.0392324972477173,2.5539396397883e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FST,Follistatin,42654,0.0393561773149996,0.0051634106866499,0.0292358923691658,0.0494764622608335,2.66191546749587e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0335331862336305,0.00440327963866201,0.0249027581418529,0.042163614325408,2.83628686788712e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0281634235117688,0.00370331427423185,0.0209049275342743,0.0354219194892632,3.04075180671415e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7,Complement component C7,40251,-0.0262675099847182,0.00346383269280942,-0.0330566220626246,-0.0194783979068117,3.63687195272826e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPT,Dermatopontin,42794,0.0201382639091784,0.00265728830545399,0.0149299788304886,0.0253465489878682,3.72134913276403e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0301917880763291,0.00399379388994696,0.0223639520520331,0.0380196241006251,4.30803616966968e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL1,Fc receptor-like protein 1,42636,0.0373029962092814,0.00493849864296172,0.0276235388690764,0.0469824535494864,4.50997583323885e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0225503876587111,0.00298926656555041,0.0166914251902323,0.0284093501271898,4.85605726632179e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0435045711821443,0.00577704255163361,0.0321815677809425,0.0548275745833462,5.44938605247345e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,40199,0.0233323452808569,0.00311238179140773,0.0172320769696977,0.029432613592016,7.05160840549232e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0221973983745066,0.00296233544103209,0.0163912209100837,0.0280035758389295,7.13905282769812e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0434417692944977,0.00580438787218493,0.0320651690650152,0.0548183695239801,7.74296161105309e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALY,RNA-binding protein Raly,40451,0.0372127457084776,0.00498645254690415,0.0274392987165454,0.0469861927004097,9.09661228046546e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,40283,0.0193742810800797,0.0025989423930617,0.0142803539896788,0.0244682081704806,9.68000980309509e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0295338005294981,0.00396442524559396,0.021763527048134,0.0373040740108623,1.00393940906611e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CX3CL1,Fractalkine,42495,-0.0269421563315912,0.00361928115215279,-0.0340359473898107,-0.0198483652733717,1.03632886765929e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,42679,0.0196476726102513,0.00264818376734487,0.0144572324262553,0.0248381127942472,1.24776223041835e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASS1,Argininosuccinate synthase,40116,0.0606211355670233,0.00817533081157191,0.0445974871763423,0.0766447839577042,1.30506804621806e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0306795284811958,0.00414684353700787,-0.0388073418137312,-0.0225517151486603,1.46158387825363e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300A,CMRF35-like molecule 8,40283,0.0242275419365584,0.00327602526817687,0.0178065324109317,0.030648551462185,1.51145102204143e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,42594,-0.0410225907550169,0.00555399362020385,-0.0519084182506164,-0.0301367632594173,1.60077862559497e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0164507290071243,0.00223184580508703,0.0120763112291537,0.0208251467850949,1.79403401128451e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0405889384487617,0.00551812647144047,0.0297734105647384,0.051404466332785,2.03260168096627e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOB,Elongin-B,40116,0.0309765574410631,0.0042212708747538,0.0227028665265456,0.0392502483555805,2.31845386308563e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0262423991504459,0.00357823640116456,0.0192290558041634,0.0332557424967284,2.36408214689679e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300C,CMRF35-like molecule 6,42711,0.0276244562150555,0.00377673590228998,0.0202220538465671,0.0350268585835438,2.73139791914133e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOBR,Apolipoprotein B receptor,40223,-0.0328251382071067,0.0044869303528886,-0.0416195216987684,-0.024030754715445,2.73772208791723e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XRCC4,DNA repair protein XRCC4,42311,0.0283087467099389,0.00387119929797224,0.0207211960859133,0.0358962973339645,2.77102438962784e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0294914421549922,0.00403383456276844,0.021585126411966,0.0373977578980183,2.80442333652049e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0164139943801389,0.0022500279956338,-0.0208240492515811,-0.0120039395086967,3.15707190756356e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYGD,Gamma-crystallin D,40483,0.0745024495468812,0.0102388570022741,0.0544342898224239,0.0945706092713385,3.65467811097342e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCOR1,REST corepressor 1,42357,0.0338581128170233,0.00465715113692852,0.0247300965886434,0.0429861290454032,3.79400168707371e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPP1,Osteopontin,42771,-0.0360846862550964,0.00497065251044544,-0.0458271651755695,-0.0263422073346234,4.09499875952742e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0478284494301249,0.00658898990143114,0.0349140292233199,0.06074286963693,4.16773199361285e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0404070498171335,0.00557223184766688,0.0294854753957064,0.0513286242385606,4.35218471422993e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,42587,0.016558156690437,0.00228409491861489,0.0120813306499518,0.0210349827309222,4.41796310487654e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0445826755449235,0.00615407346585712,0.0325206915518436,0.0566446595380035,4.57983856199002e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0277348979042282,0.00383318717349608,0.0202218510441759,0.0352479447642806,4.94800031885055e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",42587,0.0766251287239242,0.0105979266395146,0.0558531925104757,0.0973970649373727,5.08437420159618e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,40511,0.0264931291210695,0.00366731986109511,0.0193051821933231,0.0336810760488159,5.36789630079304e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.032315845959897,0.00447420241124718,0.0235464092338525,0.0410852826859415,5.37140697420559e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,40182,0.0463861867234804,0.00642211248815367,0.0337988462466992,0.0589735272002616,5.42637127227992e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL3,Follistatin-related protein 3,42574,0.0255772470939795,0.00356198666596796,0.0185957532286823,0.0325587409592767,7.30639734743575e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMBS,Porphobilinogen deaminase,42721,0.0325556199016688,0.00453756159385773,0.0236619991777076,0.0414492406256299,7.62399428916423e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX6,Peroxiredoxin-6,42721,-0.0457174594200919,0.00637255945265253,-0.0582076759472908,-0.0332272428928929,7.65638240362586e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC3B,Tetranectin,40269,0.0158333630658893,0.00220813290950132,0.0115054225632667,0.0201613035685119,7.95011262723633e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARCL1,SPARC-like protein 1,42644,-0.0208456417077821,0.00291092817445524,-0.0265510609297144,-0.0151402224858498,8.4148968469504e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,42679,-0.0211276513580616,0.00295413992074991,-0.0269177656027315,-0.0153375371133918,9.00098858914854e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR1,Complement receptor type 1,40509,0.0271343042557414,0.00380078355904455,0.0196847684800141,0.0345838400314687,9.96734705808379e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,42587,-0.0177748023461566,0.00249764725569011,-0.0226701909673092,-0.012879413725004,1.16235243214264e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,42524,0.0323921357572381,0.00455189010410773,0.023470431153187,0.0413138403612893,1.16618929046245e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0279785789507561,0.00393761287734455,0.0202608577111608,0.0356963001903514,1.27389083198318e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOC,Brother of CDO,42357,-0.0175096953566375,0.00246479298342013,-0.022340689604141,-0.012678701109134,1.27501706498365e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0468347398319825,0.00659850248561521,0.0339016749601767,0.0597678047037883,1.33293573901066e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHCY,Adenosylhomocysteinase,42636,0.049871166667931,0.00704277844696181,0.0360673209118859,0.0636750124239762,1.50036339236187e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0328750523900335,0.00464831984106306,0.0237643455015499,0.0419857592785171,1.61427828790188e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0504156905057638,0.00714043457785831,0.0364204387331615,0.0644109422783661,1.73937720327825e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PER3,Period circadian protein homolog 3,40199,0.0910739662775996,0.0129458883872917,0.0657000250385078,0.116447907516691,2.11138321283625e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPO,Erythropoietin,42594,0.0547360770669708,0.00778311823313325,0.0394811653300297,0.069990988803912,2.12448018307419e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.02626787912072,0.00373787041394524,-0.0335941051320527,-0.0189416531093874,2.20621790433131e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA7A,Semaphorin-7A,42760,0.0210203340647682,0.00299166202980782,0.0151566764863449,0.0268839916431915,2.22190570843452e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK3,Dickkopf-related protein 3,42794,-0.0222936149916517,0.0031733747485149,-0.0285134294987409,-0.0160738004845625,2.2391452731494e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML1,Trem-like transcript 1 protein,40532,0.0386065605546733,0.00550611156204763,0.0278145818930599,0.0493985392162867,2.4902952899771e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0286232610841657,0.00408409110062264,0.0206184425269454,0.0366280796413861,2.5501924645182e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPO,Myeloperoxidase,42611,0.0341682160573605,0.00488580960994447,0.0245920292218693,0.0437444028928516,2.81091469508951e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST5,Cystatin-D,42357,0.0419499191677945,0.00600302874070669,0.0301839828360094,0.0537158554995796,2.91993523142535e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFP,Alpha-fetoprotein,42459,0.0491573453783413,0.0070376975493432,0.0353634581816287,0.062951232575054,2.98729268599148e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAM,Integrin alpha-M,42611,-0.0232253359515951,0.00332630481459144,-0.0297448933881943,-0.0167057785149959,3.03998726337879e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0537346509723094,0.00769989026011012,0.0386428660624936,0.0688264358821253,3.15059324966303e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN5,CCN family member 5,42611,0.0283126406774049,0.00405941411141338,0.0203561890190347,0.0362690923357751,3.21194713889391e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F3,Tissue factor,42636,-0.0199791601819962,0.00287002112804545,-0.0256044015929653,-0.0143539187710272,3.52718623046255e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0420753509673225,0.00604626916770158,0.0302246633986274,0.0539260385360176,3.59200621408132e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA4,Laminin subunit alpha-4,42676,0.0241587622753163,0.00348111601017427,0.0173357748953747,0.0309817496552578,4.1016829622919e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.035816735084768,0.00516254359365256,0.0256981496412089,0.045935320528327,4.16459805632943e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0834048366973829,0.0120588975647953,0.0597693974703841,0.107040275924382,4.84329896052345e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0331335418084239,0.00479335822254188,0.0237385596922418,0.0425285239246059,4.98145797625476e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0324876011848499,0.00471635743755554,-0.0417316617624588,-0.0232435406072411,5.89866586862335e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,42734,-0.0260915286350311,0.0037938665422084,-0.0335275070577595,-0.0186555502123026,6.36770840398937e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0185886407584648,0.0027026765357619,0.0132913947483715,0.0238858867685582,6.39770098419212e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,40136,0.0547948627132403,0.00798120839210289,0.0391516942647186,0.0704380311617619,6.98549758344431e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0493191556061215,0.00719913270371965,0.035208855506831,0.063429455705412,7.66705063258791e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN1,Contactin-1,42794,-0.0200228716710517,0.0029273507746583,-0.025760479189382,-0.0142852641527214,8.2618197630576e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C5,Complement C5,40539,0.0108209688082928,0.00158264683848563,0.00771898100486094,0.0139229566117246,8.48658811904946e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN1,Tetraspanin-1,42357,0.0486554026455622,0.0071404111979916,0.0346601966974987,0.0626506085936258,9.89904268226256e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0195886889320928,0.0028781832374244,0.013947449786741,0.0252299280774446,1.05506242007818e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,42794,-0.0179378179273155,0.00263743482332942,-0.0231071901810412,-0.0127684456735899,1.08058076458129e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAP,Prolyl endopeptidase FAP,42794,0.0195228414971877,0.00287100083890707,0.0138956798529299,0.0251500031414456,1.08977013429003e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,40532,-0.019523224424077,0.0028743179817155,-0.0251568876682394,-0.0138895611799146,1.15882401470517e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0246724965225231,0.00364293763078082,0.0175323387661927,0.0318126542788535,1.31615678323244e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0414204305147991,0.00611762018731385,0.029429894947664,0.0534109660819343,1.3361826305214e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAM,Basal cell adhesion molecule,42611,-0.0175349196873688,0.00259248874375843,-0.0226161976251353,-0.0124536417496023,1.40045639151165e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAM,Signal transducing adapter molecule 1,40451,0.0266162662392466,0.00393665068471969,0.0189004308971961,0.0343321015812972,1.43678882645103e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0353821439395451,0.00523551586623076,0.0251205328417329,0.0456437550373574,1.45703891689853e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0365163031228559,0.00540659470347188,0.025919377504051,0.0471132287416608,1.50829781431859e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0398494082725489,0.00590200481129926,0.0282814788424023,0.0514173377026955,1.53352442691953e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17D,Interleukin-17D,42370,0.0243967353482539,0.00362757698752947,0.0172866844526962,0.0315067862438117,1.82393665067642e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR15L,Protein GPR15L,40449,0.0430418262938649,0.00640197391686816,0.0304939574168033,0.0555896951709265,1.8636241057717e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.058763208300424,0.00874345746245996,0.0416260316740025,0.0759003849268455,1.88014454996492e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2,Brorin,42456,0.0290705615367931,0.00432915221669762,0.0205854231920658,0.0375556998815204,1.95632116360885e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL2,Fc receptor-like protein 2,42681,0.0369314414141298,0.00553956497749404,0.0260738940582415,0.0477889887700181,2.71522553493446e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0334760554262704,0.00502207993911199,0.0236327787456109,0.0433193321069299,2.73773696646848e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,40419,0.0362181843658211,0.00543276080992448,0.0255699731783692,0.0468663955532731,2.74027178629375e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0469159879632024,0.00705077609792407,0.0330964668112712,0.0607355091151336,2.98849538218312e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0276932887025447,0.00416358642445851,0.019532659310606,0.0358539180944834,3.01780509800256e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0365450748482804,0.0054944499977264,0.0257759528527367,0.0473141968438241,3.02063382745289e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0332210321425775,0.00500011272271071,0.0234208112060645,0.0430212530790905,3.17180449925465e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0243329572186829,0.00366343881890894,0.0171526171336214,0.0315132973037444,3.21045911255183e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,40283,-0.0222120725175313,0.00334910586100929,-0.0287763200051095,-0.0156478250299531,3.46010625208471e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL3,Fc receptor-like protein 3,42370,0.0394130912492907,0.00594558617972894,0.027759742337022,0.0510664401615594,3.51210729964996e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC3,Membrane primary amine oxidase,42689,-0.0210716504608956,0.00317884382633527,-0.0273021843605127,-0.0148411165612785,3.51490017295411e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,40449,0.030404582650498,0.00458714121535389,0.0214137858684044,0.0393953794325916,3.552865421852e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0455923805153929,0.00688424075987696,0.0320992686260341,0.0590854924047517,3.69275202650643e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,42464,0.0249085080952704,0.00376376483843437,0.0175315290119391,0.0322854871786018,3.78135315989643e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO1,Roundabout homolog 1,42638,0.0170516216688696,0.00257998427897288,0.0119948524820827,0.0221083908556564,4.00982592819991e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX2,Sorting nexin-2,40451,0.0570864916113731,0.0086400944645769,0.0401519064608023,0.0740210767619438,4.09436751013457e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBS,Cystathionine beta-synthase,40223,0.0357014767788614,0.00540418222796884,0.0251092796120424,0.0462936739456803,4.12276544676106e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH1,Cadherin-1,42188,0.0276798875227399,0.004190611600332,0.0194662887860892,0.0358934862593906,4.12399457141609e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0225405524184348,0.00341262557599708,0.0158518062894805,0.0292292985473891,4.15675614204092e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE6,Ribonuclease K6,40468,0.0235720783301494,0.00358087470265995,0.0165535639129359,0.0305905927473629,4.82256838780907e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL21,C-C motif chemokine 21,42676,0.0291843600750872,0.0044412689895233,0.0204794728556216,0.0378892472945529,5.175361834734e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMPD3,AMP deaminase 3,40483,0.0489872110347654,0.00745522030496947,0.0343749792370252,0.0635994428325056,5.2226956633027e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNLY,Granulysin,42611,0.0369888227434699,0.00563046498306586,0.0259531113766608,0.048024534110279,5.23788770706659e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.037296193116825,0.00567949136840146,0.0261643900347582,0.0484279961988919,5.33314532802656e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOC1,Apolipoprotein C-I,40516,0.0254407818768371,0.00387604888551409,0.0178437260612295,0.0330378376924448,5.4823474235647e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSG,Basigin,42746,0.0149760612599749,0.00228575553265965,0.010495980415962,0.0194561421039878,5.88584964687769e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,42679,0.024727780447681,0.00377418926980314,0.0173303694788668,0.0321251914164951,5.89066250106432e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNG,Interferon gamma,42370,0.077925129170379,0.0118953915977265,0.0546101616388351,0.101240096701923,5.9329082488114e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDK2,Protein sidekick-2,40283,0.0278252596616525,0.00425271109045059,0.0194899459243693,0.0361605733989356,6.29763643044118e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.033290779540285,0.00508945034035686,0.0233154568731856,0.0432661022073845,6.3322273723654e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CABP2,Calcium-binding protein 2,40182,0.0445280258419603,0.0068094496924779,0.0311815044447036,0.057874547239217,6.46139554459905e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0295609495017585,0.00453600039295324,0.0206703887315701,0.0384515102719468,7.43556736272229e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A11,Protein S100-A11,42531,0.0311548968811513,0.00478616237194237,0.0217740186321442,0.0405357751301583,7.81672352125141e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.026784905316342,0.00411905950148593,0.0187115486934296,0.0348582619392545,8.23491186696966e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP6,Gastrotropin,42334,0.0401515655724313,0.00617730372619732,0.0280440502690845,0.052259080875778,8.33019795756039e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE3,Eosinophil cationic protein,42578,0.0749447359371024,0.0115472945489178,0.0523120386212235,0.0975774332529813,8.87183001542833e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH3,Cadherin-3,42711,0.0255833417922012,0.00394315144302944,0.0178547649638635,0.0333119186205389,8.99870007309329e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRN,Progranulin,42552,0.0167236123765486,0.00258189067469621,0.011663106654144,0.0217841180989531,9.66660022573032e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0255707891982445,0.00395379230395901,0.0178213562824849,0.0333202221140042,1.03146938431662e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0450097268411016,0.00696761081376657,0.0313532096461192,0.0586662440360841,1.09128063818967e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN4,Contactin-4,42611,-0.0163292681799725,0.00253003576282861,-0.0212881382751165,-0.0113703980848284,1.12558169301617e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN2,Alpha-actinin-2,40116,-0.0404823245952991,0.00627253611466848,-0.0527764953800494,-0.0281881538105489,1.13625833208694e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB44,Ras-related protein Rab-44,40451,0.0285033999731947,0.00441890825011435,0.0198423398029706,0.0371644601434188,1.16185037262667e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRDT,Bromodomain testis-specific protein,40116,0.0252511852520479,0.00391785297943003,0.0175721934123651,0.0329301770917308,1.20345671707586e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD6,Programmed cell death protein 6,42636,-0.047740949431095,0.00740964202343403,-0.0622638477970257,-0.0332180510651643,1.21059219203709e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0324633365192447,0.00504814231469598,0.0225689775824406,0.0423576954560489,1.32105008235814e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,40116,0.0308549421858288,0.00481308794228168,0.0214212898189567,0.0402885945527009,1.50893849065145e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,42587,0.0260008291882655,0.00405836770472916,0.0180464284869964,0.0339552298895347,1.53655527981918e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,40116,-0.0296182674815293,0.00462239238655965,-0.0386781565591862,-0.0205583784038724,1.53952131651642e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI3,Elafin,42446,0.0383193314312852,0.00598242958076486,0.0265937694529861,0.0500448934095844,1.55130398916245e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYZL2,Lysozyme-like protein 2,40080,0.0242747770814716,0.00379612175443544,0.0168343784427781,0.031715175720165,1.6753616849914e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0414099330288739,0.00648258503893595,0.0287040663525594,0.0541157997051883,1.7504912773803e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0291695129613625,0.00456903714417627,0.020214200158777,0.0381248257639479,1.79110532415941e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0202413026930368,0.00317270360197152,0.0140228036331726,0.026459801752901,1.8440599579002e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,42346,0.0363660836948657,0.00572013568335897,0.0251546177554821,0.0475775496342493,2.11762109646182e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPB2,Coatomer subunit beta',40116,0.0290205752550817,0.00456630967602995,0.020070608290063,0.0379705422201004,2.16215255136602e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS4,Galectin-4,42618,0.0377836290065809,0.00594858243859203,0.0261244074269405,0.0494428505862213,2.1981064943736e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A14,Protein S100-A14,40482,0.0366458656609319,0.00577927411724498,0.0253184883911317,0.047973242930732,2.37132613607551e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,40539,0.0123152128473617,0.00194277525989837,0.00850737333796086,0.0161230523567624,2.40068967004674e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0359476395224511,0.00568112031400797,0.0248126437069955,0.0470826353379068,2.56980431888706e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0311056058615926,0.00493455554125179,0.0214338770007391,0.0407773347224461,3.00083616475832e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARCO,Macrophage receptor MARCO,42636,0.0173542707835555,0.00275703734529693,0.0119504775867736,0.0227580639803375,3.1789974262362e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0270207932031565,0.00430402434069774,0.0185849054953889,0.0354566809109241,3.55514014146404e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0276568467302288,0.00440689517302817,0.0190193321910936,0.036294361269364,3.58761078005447e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTB,Lymphotoxin-beta,40451,0.0236030297182039,0.00377348897416615,0.0162069913288383,0.0309990681075696,4.12036541452968e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0554109608119484,0.00886934052368539,0.038027053385525,0.0727948682383718,4.30044156007636e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AREG,Amphiregulin,42587,0.0279816839530352,0.00448006782455405,0.0192007510169092,0.0367626168891611,4.34338710869352e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,42551,0.0394801135779463,0.00632799497240818,0.0270772434320262,0.0518829837238663,4.53784993289703e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEK,Angiopoietin-1 receptor,42679,0.014375358687819,0.0023088091107204,0.00985009283080703,0.018900624544831,4.91716319607262e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR2,Complement receptor type 2,42689,0.0313742536643788,0.00504215260301723,0.021491634562465,0.0412568727662926,5.0410500579415e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.031060326818379,0.00499552066836693,-0.0408515473283782,-0.0212691063083798,5.19663462115591e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0281316800821925,0.00452499192863534,0.0192626959020672,0.0370006642623178,5.2228123748881e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0317708606105945,0.00511577686431161,0.0217439379565437,0.0417977832646452,5.4763400517407e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB1A1,Uteroglobin,42646,0.0363780042056332,0.00586737626261086,0.0248779467309159,0.0478780616803505,5.80971012312808e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMH,Granzyme H,42357,0.0505809695470497,0.0081659320909491,0.0345757426487895,0.0665861964453099,6.03472447324535e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D17,TBC1 domain family member 17,42311,0.0294819092877316,0.00476922227063715,0.0201342336372828,0.0388295849381804,6.52943484687538e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0386186931171826,0.00624796870865835,0.0263726744482123,0.050864711786153,6.55184133408204e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENAH,Protein enabled homolog,42370,0.0306892929814783,0.00496823865058462,0.0209515452263324,0.0404270407366241,6.72121428389885e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,40199,0.0365623636919994,0.00592397815111533,0.0249513665158133,0.0481733608681854,6.98372471867124e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENSA,Alpha-endosulfine,40451,0.0345090288440102,0.00559229855656475,0.0235481236731432,0.0454699340148771,7.0275334826642e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,42616,-0.0640447144948064,0.0104048077084009,-0.0844381376032722,-0.0436512913863406,7.70695424296438e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0379138847761951,0.00616052539525273,0.0258392550014998,0.0499885145508905,7.80214575674035e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPG,Macrophage-capping protein,42461,0.0377484617694313,0.00615092338633144,0.0256926519322217,0.0498042716066409,8.64676976065201e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0229205742474524,0.00374082138765049,-0.0302525841672473,-0.0155885643276574,9.24579304804169e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLVRB,Flavin reductase,42611,0.0422404460633065,0.00691234502298036,0.0286922498182649,0.055788642308348,1.0183246364332e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,40483,0.0314072734004419,0.00514522080814343,0.0213226406164808,0.0414919061844031,1.06733134295346e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,42663,-0.0179406216342452,0.0029404383481242,-0.0237038807965686,-0.0121773624719218,1.08064066638598e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0179915643235355,0.00295090828236035,0.0122077840901092,0.0237753445569618,1.11057532071934e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,42600,0.0309042673269748,0.00507044397649261,0.0209661971330493,0.0408423375209003,1.12451134292401e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL3,Myosin light chain 3,40223,-0.0469041607515668,0.00773170742565341,-0.0620583073058475,-0.0317500141972861,1.35042749531867e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0169873381444642,0.00280120731340855,0.0114969718101834,0.0224777044787449,1.36067381015023e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR2,Folate receptor beta,42711,-0.0188724215081968,0.00311313370790668,-0.0249741635756939,-0.0127706794406997,1.3785191898288e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP12,Macrophage metalloelastase,42592,0.0357297874189875,0.00589587438374727,0.0241738736268429,0.0472857012111322,1.39657211642203e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0171643266022675,0.00284619790112732,-0.022742874488477,-0.0115857787160579,1.67619989659358e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0531636604065622,0.00881617617895092,0.0358839550958184,0.070443365717306,1.6901333219471e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFIC,Nuclear factor 1 C-type,40482,0.0301766841014452,0.00500549588906225,0.0203659121588832,0.0399874560440072,1.70440057889227e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAX,Apoptosis regulator BAX,42292,0.0562080859997399,0.00933360330644047,0.0379142235191166,0.0745019484803632,1.76755839955591e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0186780571505003,0.00310275320422243,0.0125966608702244,0.0247594534307763,1.79120196710777e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0135753002420203,0.00225701314725902,0.00915155447339265,0.017999046010648,1.84871700578272e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0234452093963438,0.00389794528905072,0.0158052366298044,0.0310851821628833,1.85865600547138e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE1,Ribonuclease pancreatic,40532,0.0167171326784767,0.00278095390073243,0.0112664630330412,0.0221678023239123,1.89710590696677e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0233854181614579,0.00389760168442663,0.0157461188599817,0.0310247174629341,2.03589977399558e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR3,Small proline-rich protein 3,40483,0.0442663625489037,0.00738384481467911,0.0297940267121327,0.0587386983856748,2.0966965194275e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB6,Heat shock protein beta-6,42721,0.024806529550614,0.00414805294242178,0.0166763457834673,0.0329367133177607,2.28367249543382e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDM1,Nuclear protein MDM1,40182,0.0196852755583775,0.00330215666756753,0.0132130484899451,0.0261575026268098,2.57867469163268e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0161320546198049,0.00270894860331145,0.0108225153573145,0.0214415938822954,2.66411581863641e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG4,Regenerating islet-derived protein 4,42638,0.032966382981728,0.00554197163682224,0.0221041185735564,0.0438286473898996,2.77345007262717e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0231467675269769,0.00389492579497122,-0.0307808220851205,-0.0155127129688333,2.88448075859492e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSN,Gelsolin,40488,-0.0121146059157326,0.00204140509401256,-0.0161157598999972,-0.00811345193146794,3.03497668514103e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0607566664176779,0.0102500896176336,0.0406664907671159,0.0808468420682398,3.15232489722059e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRELP,Prolargin,42618,0.0151813099805324,0.00256385677191095,0.0101561507075869,0.0202064692534778,3.27254715858818e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0267634781534617,0.00452178987707102,0.0179007699944025,0.0356261863125209,3.33767544468933e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,40527,0.0174260563695982,0.00294889526169456,0.0116462216566769,0.0232058910825195,3.53340555504409e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,40223,0.019267406120872,0.0032624514123331,0.0128730013526991,0.0256618108890449,3.61280006051877e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,42292,0.0445396006561966,0.00756226267451729,0.0297175658141427,0.0593616354982505,3.96342817763569e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0211437903961505,0.003600735976227,0.0140863478827456,0.0282012329095554,4.40473867780962e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0176366694770716,0.00300970080065729,0.0117376559077833,0.0235356830463599,4.7376287303708e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBD,Thrombomodulin,42636,0.0186101866312482,0.00317585629678027,0.0123855082895589,0.0248348649729375,4.74006683167334e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,40080,0.037776110963053,0.00646865524569675,0.0250975466814873,0.0504546752446186,5.37355119541677e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0252665410331322,0.00433362176205469,0.016772642379505,0.0337604396867594,5.68257354325352e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KEL,Kell blood group glycoprotein,42311,0.0222395254390282,0.00381653208595654,0.0147591225505534,0.029719928327503,5.77042692203634e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0223450396376258,0.00384685126401581,0.0148052111601548,0.0298848681150968,6.43884576013328e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,42311,0.0217038080106802,0.00374290186669954,0.0143677203519491,0.0290398956694113,6.83877052539745e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDI2,Protein DDI1 homolog 2,40283,0.0475934346055535,0.00824554574474054,0.031432164945862,0.0637547042652449,8.04278549445497e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA1,Annexin A1,40235,0.0252192644621424,0.00437384182436269,0.0166465344863916,0.0337919944378933,8.33865425916239e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0182098551706301,0.00316077630372881,0.0120147336153216,0.0244049767259385,8.53432339104516e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.026205748633282,0.0045503419774347,0.01728707835751,0.035124418909054,8.64205557272574e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0616937156306975,0.010720759130541,0.0406810277348372,0.0827064035265578,8.91119044410691e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,40223,0.0265752588096139,0.00463696494800968,0.0174868075115149,0.0356637101077129,1.02351608433451e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.0174587266942152,0.00304680977125947,-0.0234304738458838,-0.0114869795425466,1.02459175979148e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSF,Cathepsin F,42679,0.0238592733073081,0.00416581493030597,0.0156942760439084,0.0320242705707079,1.04160133435038e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ULBP2,UL16-binding protein 2,42495,0.0240661908465128,0.00420547339327243,0.0158234629956989,0.0323089186973268,1.07176322149313e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.021163184048207,0.00371008268691376,0.013891421981856,0.0284349461145579,1.19338370201864e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3,Galectin-3,42669,0.0179400144593916,0.00314649823871999,0.0117728779115004,0.0241071510072828,1.21191887040001e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX1,Peroxiredoxin-1,42261,-0.0537246252412377,0.00942665763605275,-0.072200874207901,-0.0352483762745743,1.2295519769721e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMB,RGM domain family member B,42711,0.0170708855255223,0.00299565787039884,0.0111993960995406,0.0229423749515041,1.23357685783156e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRH,Corticoliberin,42322,0.0515295070408733,0.00904935897444445,0.0337927634509622,0.0692662506307844,1.26555340997843e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0185982007761151,0.00326883063489529,-0.0250051088205099,-0.0121912927317203,1.30082539235464e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM2,Myomesin-2,40116,-0.0301958874870876,0.00531760429061086,-0.0406183918966849,-0.0197733830774903,1.3936957980523e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0257913465612302,0.00456449046761558,0.0168449452447037,0.0347377478777568,1.64020849563446e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP4,Guanylate-binding protein 4,42311,0.0293594957499588,0.00519666241540114,0.0191740374157725,0.039544954084145,1.64087346317255e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL25,C-C motif chemokine 25,42754,0.0284187000054736,0.00504030638859284,0.0185396994838316,0.0382977005271156,1.75176321335488e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF2,Growth/differentiation factor 2,42636,0.0212525192356366,0.00376971771492934,0.0138638725143751,0.0286411659568981,1.75809519808036e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0271234024940405,0.00481630488546745,0.0176834449185243,0.0365633600695567,1.82846728577734e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0198336481916233,0.00352674351969271,0.0129212308930256,0.026746065490221,1.91374164011364e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPE,Carboxypeptidase E,42588,-0.0228407192962874,0.00406198883370809,-0.0308022174103552,-0.0148792211822195,1.91378710436489e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSM,Oncostatin-M,42534,0.0413426149924931,0.00736923718687893,0.0268989101062104,0.0557863198787758,2.06158562138932e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0138974917670529,0.00248699959689446,-0.018772010976966,-0.00902297255713972,2.35076231601716e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.0189710306932882,0.00339905439407149,0.012308884080908,0.0256331773056683,2.43400656279101e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0321293340503559,0.00575644174430039,0.0208467082315271,0.0434119598691846,2.44167450615592e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LF,CMRF35-like molecule 1,42721,0.035607075591361,0.00641008587052581,0.0230433072851304,0.0481708438975916,2.83090824010326e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,42676,0.0395082669652643,0.00713249684420933,0.025528573150614,0.0534879607799146,3.09561171107378e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHISA5,Protein shisa-5,40527,0.0162375679804102,0.0029313492716396,0.0104921234079966,0.0219830125528238,3.10491780999707e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,42676,0.0161997025518397,0.00293047277300236,0.0104559759167551,0.0219434291869244,3.29888140574752e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0202306399809414,0.00366615351510173,0.0130449790913421,0.0274163008705408,3.50205102590416e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VGF,Neurosecretory protein VGF,40482,0.0182809030518135,0.0033249615115572,0.0117639784891614,0.0247978276144656,3.92302409041182e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B2M,Beta-2-microglobulin,40539,0.0181501028584567,0.00330370026531681,0.0116748503384357,0.0246253553784776,4.017034806152e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0159798695314479,0.00291105530232868,0.0102742011388836,0.0216855379240121,4.10653089717252e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLFM4,Olfactomedin-4,39870,0.071300003466743,0.0129893168224253,0.0458409424947893,0.0967590644386966,4.13162963028456e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSHB,Thyrotropin subunit beta,42636,0.0457329802844682,0.00834110623080449,0.0293844120720914,0.062081548496845,4.26096030674e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18BP,Interleukin-18-binding protein,42689,0.0186449014284929,0.00340177259212119,0.0119774271479354,0.0253123757090505,4.30673157096015e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0192975872934416,0.00352937610674879,0.0123800101242139,0.0262151644626692,4.65632044554027e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNU13,NHP2-like protein 1,40116,0.0364728716897463,0.00668269189173622,0.0233747955819433,0.0495709477975493,4.9257310194053e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMB,Granzyme B,42594,0.0380582218720226,0.00699485135691857,0.0243483132124622,0.051768130531583,5.39461448825244e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0226897420682432,0.00417209039063857,-0.0308670392338948,-0.0145124449025916,5.48592472054767e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCT,Secretin,40182,0.0286690775311314,0.00527172554018285,0.018336495472373,0.0390016595898898,5.49520291680143e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,40483,0.022170323436743,0.00408049530698517,0.014172552635052,0.0301680942384339,5.64880590845434e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM,Paralemmin-1,40384,0.0180429425294535,0.00332133601988737,0.0115331239304742,0.0245527611284327,5.67541620564974e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1,Programmed cell death protein 1,42689,0.0257202394501648,0.00474119865800221,0.0164274900804805,0.0350129888198492,5.90069726007198e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1A,Protein phosphatase 1A,42346,0.0181892383639174,0.00335348311446583,0.0116164114595643,0.0247620652682704,5.93158812278211e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAN,Versican core protein,42711,-0.0174270543331004,0.00321603272412231,-0.0237304784723801,-0.0111236301938207,6.10270465688697e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,40327,-0.0046626265526362,0.000861909470694551,-0.00635196911519752,-0.00297328399007488,6.44562895039789e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,40451,0.0335213949443984,0.00620178005858476,0.0213659060295723,0.0456768838592245,6.60849235652705e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROCR,Endothelial protein C receptor,40116,-0.0199185125853198,0.00368670183293085,-0.0271444481778642,-0.0126925769927753,6.69865838217102e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0315842737130588,0.00587135886184999,0.0200764103438328,0.0430921370822848,7.59992129601644e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0200020028575081,0.00371869687116147,0.0127133569900316,0.0272906487249846,7.6257540812605e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX3,Syntaxin-3,40483,0.0218168752268815,0.0040917673480867,0.0137970112246316,0.0298367392291314,9.90680371745812e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,40532,0.01510639102002,0.00283479554877804,0.009550191744415,0.0206625902956249,1.00693618023775e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SATB1,DNA-binding protein SATB1,40482,0.0164231392559334,0.00308923276321636,0.0103682430400293,0.0224780354718374,1.07946978036396e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0152431543992584,0.00287179434208971,0.00961443748876254,0.0208718713097542,1.12661916537727e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0445103748582183,0.00842380396016264,0.0279997190962996,0.0610210306201371,1.28918894122124e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0157178267581984,0.00297604841897018,0.00988477185701683,0.02155088165938,1.30163747380781e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,42689,-0.0168064417702542,0.00318234869429676,-0.0230438452110759,-0.0105690383294326,1.30373197192205e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSH,Pro-cathepsin H,42332,0.0413948739026329,0.00784111542554963,0.0260262876685556,0.0567634601367102,1.31810747442612e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIF,Leukemia inhibitory factor,42311,0.0285604530777767,0.00541416346876172,0.0179486926790038,0.0391722134765497,1.34767338050412e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRUNE2,Protein prune homolog 2,40302,0.0166667522134896,0.00317214634552056,0.0104493453762693,0.0228841590507099,1.51509964989682e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0156260982834021,0.00297877170034266,0.00978770575073045,0.0214644908160737,1.58473162989645e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,40199,0.0693249825772819,0.013215595894592,0.0434224146238815,0.0952275505306822,1.58586363660694e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.0221148379679466,0.00422053933598784,0.0138425808694104,0.0303870950664827,1.63172776996616e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL6,Fc receptor-like protein 6,42594,0.0386623525562919,0.00738682198739529,0.0241841814609971,0.0531405236515866,1.68419281602933e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0590329218354736,0.0112856592229972,0.0369130297583991,0.0811528139125481,1.71348453128481e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAA4,Serum amyloid A-4 protein,40539,0.0178322202626427,0.00340947470782359,0.0111496498353085,0.024514790689977,1.72345854948435e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0199971719118291,0.0038331395792789,-0.0275101254872157,-0.0124842183364425,1.84658506564201e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTPN,Myotrophin,42357,0.0182289627241777,0.00349508111498489,0.0113786037388073,0.0250793217095481,1.85996918474216e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP1,Dipeptidase 1,42476,-0.0273849340695797,0.00525724147287056,-0.037689127356406,-0.0170807407827534,1.92707845848577e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD1,Leiomodin-1,40482,-0.0196013451759988,0.00377055472550507,-0.0269916324379887,-0.0122110579140089,2.04380734318533e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",40302,0.0248660203231242,0.00478958452813242,0.0154784346479847,0.0342536059982638,2.1208098716177e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF16,Fibroblast growth factor 16,40199,0.0258884123888787,0.0049906736072839,0.0161066921186023,0.0356701326591552,2.17090907177408e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS2,Thrombospondin-2,42611,0.0211808719878609,0.00408557301762543,0.0131731488733151,0.0291885951024067,2.19968502957687e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0220734941583628,0.0042779545223475,0.0136887032945617,0.0304582850221639,2.51359447802583e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0157023836560455,0.00304377596210609,-0.0216681845417735,-0.00973658277031759,2.5200718919171e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0180646677987701,0.00350559811885779,0.0111936954858088,0.0249356401117314,2.60543753219357e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPL,Periplakin,40199,0.0180604199215344,0.00350899908358339,0.011182781717711,0.0249380581253578,2.69413477041022e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB6,Integrin beta-6,42370,0.0169062902376203,0.00329048761152213,0.0104569345190369,0.0233556459562037,2.81753572702254e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG1,Arginase-1,42488,0.0278503517713272,0.00544539337870305,0.0171773807490692,0.0385233227935851,3.18985319849573e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAP,Cartilage-associated protein,40182,0.0258329389241511,0.00505856077745501,0.0159181598003392,0.0357477180479629,3.3319224075061e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSR,Insulin receptor,40199,0.00930626765803232,0.001830168697592,0.00571913701075199,0.0128933983053127,3.7382572879346e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WIF1,Wnt inhibitory factor 1,42721,-0.0184407660328874,0.00362918917123102,-0.0255539768085002,-0.0113275552572746,3.79986554255673e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB37,Ras-related protein Rab-37,42370,0.0432529239631658,0.00851814532172668,0.0265573591325815,0.0599484887937501,3.87166259177048e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.0215731426714469,0.00425041005274821,0.0132423389680605,0.0299039463748334,3.91508646009405e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0272740531155139,0.00538215761556268,0.016725024189011,0.0378230820420167,4.09484603813339e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0308353540074053,0.00608598787621117,-0.0427638902447792,-0.0189068177700314,4.10342982808097e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,40527,0.0294344525791708,0.0058134620551214,0.0180400669511328,0.0408288382072087,4.18855451114839e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,42439,0.0154939382014726,0.00306047910530224,0.00949539915508019,0.021492477247865,4.19160129780978e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,40199,0.0169018732159993,0.00333944767472161,0.0103565557735449,0.0234471906584536,4.2318457627454e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LUZP2,Leucine zipper protein 2,40451,0.0245063364318629,0.00484585582290291,0.0150084590189732,0.0340042138447526,4.32214367035926e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0164244992580216,0.00324790159000333,-0.0227903863744281,-0.0100586121416151,4.32934959378822e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB2,Lamin-B2,40483,0.0152399075775936,0.00302186692794581,0.00931704839881981,0.0211627667563674,4.64898225238911e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVALB,Parvalbumin alpha,42654,0.0582145494106215,0.0115501276259709,0.0355762992637185,0.0808527995575245,4.7116944361846e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0431051254991599,0.00855609899105688,0.0263351714766884,0.0598750795216314,4.78076909133884e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLGN,Calmegin,40182,0.0246783060806197,0.00490374237043141,0.0150669710345741,0.0342896411266652,4.91671550728358e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,40080,0.0298344834624108,0.00593716022680896,0.0181976494178653,0.0414713175069564,5.11316557190159e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0216803121207546,0.00432297519259107,-0.0301533434982331,-0.0132072807432761,5.36740236233082e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR2,Complement factor H-related protein 2,40451,0.0305121111579979,0.0060875361694554,0.0185805402658653,0.0424436820501305,5.46220188303853e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0465396986632111,0.00929493233551337,0.0283216312856049,0.0647577660408173,5.59854138794832e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300E,CMRF35-like molecule 2,42677,0.0227711820470287,0.00455183173649898,0.0138495918434907,0.0316927722505667,5.72620665840534e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,40182,0.0358383569270864,0.00716381681393146,0.0217972759717808,0.0498794378823921,5.74102120303892e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN1,Nectin-1,40199,0.0172464300637058,0.00344778595097777,0.0104887695997893,0.0240040905276222,5.75620919198111e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0147752649054236,0.00295499353194267,0.00898347758281594,0.0205670522280312,5.80406361209584e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0255103578741094,0.00510595936370949,0.0155026775212388,0.03551803822698,5.93730782289222e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0405571425176762,0.00814243433583498,0.0245979712194396,0.0565163138159127,6.40726230261275e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0203242586365665,0.00408425895449954,0.0123191110857474,0.0283294061873856,6.5813148587669e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0229016582602787,0.00461017997372274,0.0138657055117822,0.0319376110087753,6.86550339244844e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,40182,-0.0165829277615132,0.00334121583121897,-0.0231317107907023,-0.010034144732324,7.04022607820784e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN8,Septin-8,40470,0.0169307370634349,0.00342049667721358,0.0102265635760963,0.0236349105507736,7.53683562785204e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,40302,0.0233411409063996,0.00472042038618099,0.0140891169494848,0.0325931648633143,7.73698156609011e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.0141161324844465,0.00286067911221465,-0.0197230635443872,-0.00850920142450574,8.14825306477795e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0227297348978047,0.00460682189115402,0.0137003639911428,0.0317591058044665,8.15775708126517e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO2,Roundabout homolog 2,42711,0.0121489736140651,0.00246320603990781,0.00732108977584576,0.0169768574522844,8.22838882259897e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH1,Protocadherin-1,42721,0.0112581554732259,0.00228562022074055,0.00677833984057441,0.0157379711058774,8.50758606890411e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD59,CD59 glycoprotein,42130,0.0129759817910734,0.00263803729992777,0.00780542868321498,0.0181465348989318,8.81462034552217e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0284538491446628,0.00578780300767906,0.0171097552496118,0.0397979430397137,8.93161957391045e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,42721,0.0434115977173479,0.00885188784999968,0.0260618975313485,0.0607612979033472,9.48896604283201e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0519535401358978,0.0105956522198021,0.0311860617850856,0.07272101848671,9.56021852401593e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0227416697956012,0.00464560250582344,0.0136362888841873,0.0318470507070152,9.9530787027698e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00820202933920784,0.00167871761340943,0.00491174281692535,0.0114923158614903,1.0413558809239e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX5,Syntaxin-5,40199,0.0211373985145268,0.00432706828034109,0.0126563446850583,0.0296184523439954,1.04925849149287e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,42587,0.0215653147368886,0.00442219212577437,0.0128978181703708,0.0302328113034064,1.09162757047504e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0390940218855899,0.00803171195982781,0.0233518664443274,0.0548361773268524,1.14615030586528e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC16,Mucin-16,42587,0.0981501520017449,0.0202121391960495,0.0585343591774878,0.137765944826002,1.21133664278792e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX2,Peroxiredoxin-2,40333,0.0319608507484903,0.00658286720987029,0.0190584310171445,0.044863270479836,1.21925888062689e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0205151840375406,0.00423386112297516,0.0122168162365092,0.0288135518385719,1.2797632461964e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0329003165553608,0.00679020428888626,0.0195915161491438,0.0462091169615779,1.281727535501e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA12,Carbonic anhydrase 12,42587,-0.0168771980909558,0.00348592029443403,-0.0237096018680465,-0.0100447943138651,1.30280026697523e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GC,Vitamin D-binding protein,40539,0.0131727888163707,0.00272320322527596,0.0078353104948298,0.0185102671379116,1.33385103074271e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,40116,0.0183059031620599,0.00379005555638001,0.0108773942715551,0.0257344120525647,1.38399222859411e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0181472859371243,0.00375796069588635,0.010781682973187,0.0255128889010615,1.38701337196891e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFAP1,Actin filament-associated protein 1,40283,0.0420658517303073,0.00874300180020514,0.0249295682019052,0.0592021352587094,1.51871371781791e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA7,Carbonic anhydrase 7,40302,-0.0178798575894437,0.00371730482414265,-0.0251657750447633,-0.0105939401341241,1.52991252379697e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFLAM,Pikachurin,40449,0.0156889040999656,0.00326643266951623,0.00928669606771381,0.0220911121322174,1.5826627004338e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99,CD99 antigen,42611,-0.0102063440891772,0.00212702358031681,-0.0143753103065981,-0.00603737787175621,1.61647385373631e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN10,Ataxin-10,42311,0.0363750331480362,0.00760114901174199,0.0214767810850219,0.0512732852110505,1.72451458101979e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0152804635228302,0.00319666536731859,0.00901499940288574,0.0215459276427746,1.77060342276364e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,42311,0.042889316004362,0.00900925331623639,0.0252311795045387,0.0605474525041853,1.95094941314754e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0354876035909325,0.00745670543121098,-0.050102746236106,-0.020872460945759,1.96818973770316e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0289040339856573,0.00607813729323902,0.0169908848909088,0.0408171830804057,2.00145570823171e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK14,Kallikrein-14,42721,-0.0236023592948347,0.00496392293517982,-0.0333316482477872,-0.0138730703418823,2.00711267503678e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,40483,0.119799816805716,0.0252781980518318,0.0702545486241253,0.169345084987306,2.17124628189114e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD3,Extracellular superoxide dismutase,40532,-0.0291397322288756,0.00615132586953919,-0.0411963309331724,-0.0170831335245788,2.19378577038139e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST2,Bone marrow stromal antigen 2,42711,0.0254241156738082,0.0053795896485555,0.0148801199626394,0.035968111384977,2.31256559413794e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIM,Vimentin,42357,0.0576659467296236,0.0122022721776767,0.0337494932613773,0.0815824001978699,2.31541453615708e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0182733193313035,0.00387277948532005,0.0106826715400762,0.0258639671225308,2.40657187441968e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,40182,0.027600676340133,0.00585357956853995,0.0161276603857947,0.0390736922944713,2.44468674463048e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0132394810957502,0.00280849730846131,0.00773482637116608,0.0187441358203344,2.4527189677808e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0195686280494792,0.00416920155820878,0.01139699299539,0.0277402631035685,2.7112657468749e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PZP,Pregnancy zone protein,40539,0.0251463890263947,0.00536496866934199,0.0146310504344844,0.035661727618305,2.80266858607692e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG3,Desmoglein-3,42651,0.0173049894320128,0.00370019707853571,0.0100526031580828,0.0245573757059428,2.94255192128029e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.015594417971796,0.00333655508334532,-0.0221340659351528,-0.00905477000843915,2.98503255137836e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICOSLG,ICOS ligand,42587,0.00951428672626662,0.00203793146181524,0.00551994106110874,0.0135086323914245,3.06202146923333e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.021960758450716,0.00470375522020811,0.0127413982191081,0.0311801186823239,3.06588067303955e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLASP1,CLIP-associating protein 1,40080,0.0357820245039171,0.00767236478383682,0.020744189527597,0.0508198594802373,3.14187423217673e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,40482,0.015985808842358,0.00343145153363966,0.00926016383642424,0.0227114538482917,3.21983020077223e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0201705561368285,0.00433269069981981,-0.0286626299084753,-0.0116784823651816,3.27107534834922e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECM1,Extracellular matrix protein 1,40269,0.0183183820518289,0.00393504946300986,0.0106056851043296,0.0260310789993283,3.27450092794336e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC2,Stanniocalcin-2,42591,0.0121804779790279,0.00261847418882384,0.0070482685689332,0.0173126873891227,3.32284528245904e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0356877930016862,0.00768410607503721,0.0206269450946133,0.0507486409087592,3.44356877122369e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.0115323970999037,0.00248319992456018,0.00666532524776569,0.0163994689520416,3.44719765950405e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1B,Interleukin-1 beta,42293,0.0277879139169931,0.00599118350422422,0.0160451942487137,0.0395306335852726,3.54969974613187e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0526072094418218,0.0113482738154038,0.0303645927636305,0.0748498261200132,3.59826974433749e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00984227266186521,0.00212700834789045,-0.0140112090237305,-0.00567333629999993,3.73935401170803e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2,Ataxin-2,40136,0.053883074583384,0.0116523668147254,0.0310444356265222,0.0767217135402458,3.80324279519381e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200,OX-2 membrane glycoprotein,42594,-0.0133512140697191,0.00289428989010972,-0.0190240222543341,-0.00767840588510403,4.00670911268461e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBI3_IL27,Interleukin-27,42689,-0.0149727114012078,0.0032476856300741,-0.021338175236153,-0.00860724756626256,4.05833983726534e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0129604692229689,0.00281472934264755,-0.0184773387345581,-0.00744359971137968,4.18022001598637e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN2,Prefoldin subunit 2,42311,0.026825680194383,0.00583004916452351,0.0153987838319169,0.0382525765568491,4.23840049467078e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP1,Caspase-1,42311,0.0333817676221568,0.00727728964983422,0.0191182799084818,0.0476452553358319,4.53573694621528e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.0144297601767034,0.00315661744599051,0.00824278998256204,0.0206167303708449,4.89187884982606e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0207655835337845,0.00454943814353417,0.0118486847724575,0.0296824822951115,5.05387482401639e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0181745321114449,0.00398187336969668,0.0103700603068394,0.0259790039160504,5.06415563209753e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD9,Enhancer of filamentation 1,40199,0.0159892267134546,0.00350993631024795,0.00910975154536859,0.0228687018815405,5.28437452302902e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,40516,0.00875901666323007,0.00192595442315897,0.0049841459938385,0.0125338873326216,5.47508143626967e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCC,Netrin receptor DCC,40182,0.0111170632145941,0.00244797615096051,0.00631902995871151,0.0159150964704767,5.6495856971402e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,40199,0.0272156017577603,0.00600264747031541,0.0154504127159421,0.0389807907995785,5.85067510999228e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPS10,40S ribosomal protein S10,40116,-0.019474868304468,0.0042983441450372,-0.0278996228287409,-0.0110501137801951,5.93888517697104e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD7,T-cell antigen CD7,40166,0.0212989012193207,0.00471016429302593,0.0120669792049898,0.0305308232336515,6.19289715612149e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,40116,0.0440227894951627,0.0097448349113613,0.0249229130688946,0.0631226659214309,6.32153908830136e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL,Podocalyxin,42587,0.00725208314870945,0.00160806069031381,0.00410028419569439,0.0104038821017245,6.54302118104658e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB2A2,Mammaglobin-A,40116,-0.0151357931019944,0.00335603590395913,-0.0217136234737543,-0.00855796273023453,6.54969873071439e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0160587291891999,0.00357089935974098,-0.0230576919342922,-0.00905976644410758,6.94620278359122e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,42346,0.0167843123238969,0.00373524478356531,0.00946323254810888,0.0241053920996849,7.06606541167283e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0194701107292245,0.00433567716522655,0.0109721834853804,0.0279680379730685,7.16025624051796e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,42701,-0.0104074729316169,0.00231936699740571,-0.0149534322465321,-0.00586151361670174,7.27601785374191e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.0213867754827603,0.00476967935668938,0.0120382039436491,0.0307353470218715,7.39034800548707e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAFB2,Scaffold attachment factor B2,40482,0.0129967096905114,0.00289843401899419,0.00731577901328282,0.01867764036774,7.39636356303619e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC1,Glypican-1,42721,0.0140893395909533,0.00314669916386878,0.00792180922977052,0.0202568699521361,7.61407804154367e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,42713,0.0136198357533714,0.00304682653272953,0.00764805574922152,0.0195916157575213,7.87928773073108e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,40483,0.0268632877085738,0.00602176386491959,0.0150606305333314,0.0386659448838162,8.23543787737977e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0229673209591108,0.00515866239250201,0.0128563426698068,0.0330782992484147,8.57001013419243e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN8,Tetraspanin-8,40449,0.0480382444656431,0.0107997003623713,0.0268708317553953,0.0692056571758909,8.74606532193766e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0168095991672922,0.00378992221896072,-0.0242378467164552,-0.00938135161812919,9.26534796069454e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0160452351226291,0.00361978418878194,0.00895045811261654,0.0231400121326417,9.39630352089282e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOB,Apolipoprotein B-100,40532,0.0104082347894619,0.00234953075129641,0.00580315451692097,0.0150133150620029,9.51514870220266e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK8,Kallikrein-8,42154,0.0174216902858213,0.0039394742209505,0.00970032081275831,0.0251430597588843,9.84332897149898e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOSB,Protein fosB,42311,0.0178302339393574,0.00403885226726871,0.00991408349551069,0.025746384383204,1.01968822816106e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCP1,Plastin-2,40527,0.0222985079949392,0.0050539146041306,0.0123928353708432,0.0322041806190352,1.03305819295992e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERC2,ERC protein 2,40182,0.0353013966880489,0.00801541473308087,0.0195911838112104,0.0510116095648874,1.0718515420512e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRL,Prolactin,42711,-0.0346417321557951,0.00787734656112429,-0.0500813314155987,-0.0192021328959915,1.10270695019779e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK6,Kallikrein-6,42656,0.0146834209413826,0.00333965366466666,0.00813769975863592,0.0212291421241292,1.10756961302595e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0320541122743256,0.00729058929516241,0.0177645572558072,0.0463436672928439,1.10967768255655e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,42443,0.0141861793038197,0.0032311521260636,0.007853121136735,0.0205192374709043,1.13998019571885e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROK1,Prokineticin-1,42594,0.0255776595073611,0.00582660956707673,0.0141575047558907,0.0369978142588315,1.14322782463487e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMS1,PMS1 protein homolog 1,40182,0.0240808984627045,0.00549135009585891,0.0133178522748211,0.034843944650588,1.16935063237819e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST7,Cystatin-F,42642,0.0432182616220802,0.00987045950997397,0.0238721609825312,0.0625643622616292,1.2037620032025e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGT,Angiotensinogen,40532,0.0109991997943996,0.00251525703366165,0.00606929600842279,0.0159291035803764,1.23648338054844e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,42346,0.0217461366807937,0.00501300244043932,0.0119206518975326,0.0315716214640547,1.44892143508282e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD48,CD48 antigen,42654,0.0141624169945427,0.00326764296506332,0.00775783678301858,0.0205669972060668,1.47394221704613e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A13,Protein S100-A13,40199,0.0162275388633476,0.00375053894461742,0.0088764825318975,0.0235785951947978,1.52680497649189e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,40449,0.0367931881403194,0.00856828576347007,0.019999348043918,0.0535870282367207,1.76863248082945e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0176855217389397,0.00412220652955813,-0.0257650465368736,-0.00960599694100575,1.79914399917866e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0171322656725386,0.00400418623631267,-0.0249804706957115,-0.00928406064936579,1.89674884580532e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.03124770299697,0.0073158290015657,0.0169086781539012,0.0455867278400388,1.95724378218477e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM2,Junctional adhesion molecule B,42711,0.0127726952003935,0.0029923899388742,0.00690761092020003,0.0186377794805869,1.98228846523802e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,40370,0.0293847699586383,0.00689264018801495,0.015875195190129,0.0428943447271476,2.03166097285383e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD1,Bromodomain-containing protein 1,40302,-0.0137667800601784,0.0032295054658904,-0.0200966107733235,-0.00743694934703316,2.0353614119279e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.025562069588954,0.00600223527359614,-0.0373264507252024,-0.0137976884527056,2.06966299753314e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0295727380046689,0.00695421313012525,0.0159424802696234,0.0432029957397144,2.1311145660977e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAV,Integrin alpha-V,42721,-0.0073244019196803,0.00172479778901824,-0.010705005586156,-0.00394379825320455,2.18559115701951e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,40483,0.0138177687041174,0.00326584520699245,0.00741671209841216,0.0202188253098226,2.34499145907459e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.014657835573722,0.00347240136725109,0.0078519288939099,0.0214637422535342,2.44554762009593e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH17,Protocadherin-17,42636,0.0165497184715411,0.00392090529545012,0.00886474409245883,0.0242346928506233,2.44935824440667e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP13,Collagenase 3,42311,-0.0148133685403039,0.00351346264868784,-0.0216997553317321,-0.00792698174887573,2.50148203906909e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0175928068383874,0.00418000318080516,0.00940000060400933,0.0257856130727656,2.58429808518054e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH1,Neurexophilin-1,42311,0.0171350383787136,0.0040979629203832,0.0091030310547625,0.0251670457026646,2.9165890612427e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGCR6,Protein DGCR6,40136,0.019535509996877,0.00467777469139667,0.0103670716017396,0.0287039483920145,2.98664911439223e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0297164015466735,0.00712678799092091,0.0157478970844685,0.0436849060088785,3.07347747733623e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX2,Neuronal pentraxin-2,40527,-0.0144322270134183,0.00346268376293311,-0.0212190871887672,-0.00764536683806936,3.0966029171948e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0244746839845673,0.00587245908820709,0.0129646641716814,0.0359847037974532,3.09981201677771e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS1,Nephrin,40199,0.0147219012677941,0.00354325547399879,0.00777712053875647,0.0216666819968317,3.27878254565103e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.0126224382963891,0.00304172999229681,0.00666064751148737,0.0185842290812908,3.35277438618132e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD109,CD109 antigen,42611,-0.0146872414162827,0.00354222312344609,-0.0216299987382371,-0.00774448409432837,3.39917822851555e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN2,Calsyntenin-2,42754,-0.0172938271440905,0.00417643875604833,-0.0254796471059452,-0.00910800718223579,3.48180934307786e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.0187370658896613,0.00453228091742139,0.00985379529151539,0.0276203364878072,3.58458848104007e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN3,Perilipin-3,42636,0.018279946402711,0.00442566847850834,0.00960563618483463,0.0269542566205873,3.64263785951029e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0141588620121506,0.00342900875796458,-0.0208797191777612,-0.00743800484654007,3.66829135091698e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA11,Serpin A11,42794,-0.0177336935439618,0.00430391336081453,-0.0261693637311582,-0.00929802335676529,3.80513284927239e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,42357,0.024057363983427,0.00584156668976848,0.0126078932714808,0.0355068346953732,3.83997647417599e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGA,Chromogranin-A,40527,-0.0423088296855054,0.0103192014974648,-0.0625344646205364,-0.0220831947504743,4.1601502942546e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,40199,0.0167390610256157,0.00408381580673314,0.00873478204441875,0.0247433400068127,4.18138923135628e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00906316239299405,0.0022151600621358,-0.0134048761147802,-0.00472144867120787,4.31779550265168e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGA4,Pepsin A-4,40532,0.0346956765973827,0.00849882800258245,0.0180379737123211,0.0513533794824443,4.48774453319884e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRTN,Neurturin,42370,0.0211735747130333,0.00519001753877862,0.0110011403370272,0.0313460090890394,4.53646012083172e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL4,Delta-like protein 4,40223,0.0368849755687573,0.00904468275719791,0.0191573973646494,0.0546125537728652,4.57274092974504e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0109557068257668,0.0026930768518834,0.00567727619607538,0.0162341374554583,4.77186885776261e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0219930892451312,0.00541255230650463,0.0113844867243821,0.0326016917658803,4.87100893554049e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIT,Vitrin,40511,0.0164916387314611,0.00406018598038291,0.00853367420991058,0.0244496032530116,4.90254360895342e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL34,Interleukin-34,42292,0.0156216740314121,0.00385216499721348,0.00807143063687364,0.0231719174259505,5.03604592993436e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0209734500863448,0.00518297770280373,0.0108148137888495,0.0311320863838401,5.23243897790685e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.0091403612541336,0.00227001017953466,0.00469114130224567,0.0135895812060215,5.69669805523153e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,40080,0.0155966201091465,0.00389426833920226,0.00796385416431006,0.0232293860539829,6.24245300525233e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,40223,0.0398757827317534,0.0099646322136333,0.0203451035930322,0.0594064618704747,6.32918125138718e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,42476,0.0141480595124866,0.00353710928610833,0.00721532531171426,0.0210807937132589,6.37144308724967e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK11,Kallikrein-11,42543,0.0137914380259544,0.00344998974736132,0.00702945812112626,0.0205534179307826,6.43511340584371e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0236345232435179,0.00592164231165323,0.0120281043126776,0.0352409421743582,6.61538166558322e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,42370,0.0237439832295533,0.00595397008351632,0.0120742018658613,0.0354137645932452,6.70138131436707e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0294822164223074,0.0074345187404966,-0.0440538731536808,-0.0149105596909341,7.36693989961799e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF8,SLAM family member 8,42346,0.0231014464742047,0.00583312667310021,0.0116685181949283,0.0345343747534811,7.52223320118923e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,42636,0.0191172682047484,0.00482872709671641,0.00965296309518428,0.0285815733143126,7.56296668789365e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDRG1,Protein NDRG1,42311,0.0271029261697317,0.00686023392677302,0.0136568676732566,0.0405489846662068,7.83213593340156e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.0117537611057273,0.00297942244113701,0.00591409312109872,0.0175934290903558,8.02149516772094e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNXB,Tenascin-X,42611,-0.0106728277658639,0.00271830163540002,-0.0160006989712479,-0.00534495656047986,8.66990891898708e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0264408813393334,0.00676412221196207,0.0131832018038878,0.0396985608747791,9.32247966008227e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MBL2,Mannose-binding protein C,40379,-0.0446719769142222,0.0114653129622321,-0.0671439903201971,-0.0221999635082474,9.82539313580929e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK4,Kallikrein-4,42721,-0.0260745072242209,0.00669542541409675,-0.0391975410358506,-0.0129514734125913,9.89249685316557e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0160130709174489,0.00411916539050675,-0.0240866350828422,-0.00793950675205571,0.000101900049363391
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,40342,0.0177515425686379,0.00456859233925376,0.00879710158370053,0.0267059835535753,0.000102684710272695
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF7,SLAM family member 7,42594,-0.0243736092364282,0.00627345946541154,-0.0366695897886348,-0.0120776286842216,0.000102739893528321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB1,Calbindin,42587,0.0186345297709907,0.00480462817386538,0.00921745855021452,0.0280516009917668,0.000105624974149717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCA2A,Guanylin,42563,-0.0148717969210571,0.00383550285731016,-0.022389382521385,-0.0073542113207292,0.000106081823266629
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,40109,-0.025644054630318,0.00662806489824879,-0.0386350618308856,-0.0126530474297504,0.000109913258947066
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0150981686375636,0.00391105529605907,0.00743250025728784,0.0227638370178394,0.000113750345271039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XG,Glycoprotein Xg,42734,0.0140050644895818,0.00363005884757302,0.00689014914833867,0.0211199798308249,0.000114810143396757
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTG,Protogenin,42721,0.0100966879378484,0.00262056343981116,0.00496038359581853,0.0152329922798783,0.000117280780226347
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.0117740022387671,0.00305678357380925,0.00578270643410096,0.0177652980434332,0.00011794336404809
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS4,Thrombospondin-4,42652,0.0185452637155963,0.00481702468223966,0.00910389533840652,0.027986632092786,0.000118692682199894
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,42438,-0.015401413061603,0.00400899199421308,-0.0232590373702607,-0.00754378875294537,0.000122746479520877
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0179406815861087,0.00468380705087934,0.00876041976638519,0.0271209434058322,0.000128648873941969
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK2,Protein AHNAK2,40223,0.0121995837903733,0.00318777421195813,0.00595154633493535,0.0184476212458112,0.000130435494603891
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G1B,Phospholipase A2,42782,-0.0183030010098343,0.00480234778433042,-0.0277156026671219,-0.00889039935254664,0.000138869601917468
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD9,COMM domain-containing protein 9,40451,0.0159357645240943,0.00418860450940823,0.00772609968565413,0.0241454293625344,0.000142812645794381
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0232714825087637,0.00611861180200879,0.0112790033768265,0.0352639616407009,0.000143372240117069
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF5,Fibroblast growth factor 5,42370,-0.0132407324243984,0.003485742817906,-0.0200727883474941,-0.00640867650130264,0.000146205035668068
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,40080,0.0167668357767935,0.00441640084321766,0.00811069012408689,0.0254229814295001,0.000147554046846722
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRLB,Fc receptor-like B,42346,0.0259948116084671,0.00685032786422588,0.0125681689945844,0.0394214542223499,0.000148496005860632
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,42370,0.0117957203268002,0.00310852129487268,0.00570301858884977,0.0178884220647507,0.000148519329733329
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCC1,Regulator of chromosome condensation,40451,0.0210136466182408,0.00553787812209268,0.0101594054989392,0.0318678877375425,0.000148698151649079
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG3,Proteoglycan 3,40527,-0.0199142976867609,0.00525230897071695,-0.0302088232693661,-0.00961977210415569,0.000150497628664706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASN,Vasorin,42449,-0.0109920942470763,0.0029004176829174,-0.0166769129055944,-0.00530727558855817,0.000151416938805907
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0217300194994763,0.00573712499793258,0.0104852545035284,0.0329747844954241,0.000152889557743022
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,40116,0.0176128784081721,0.00465107445405436,0.00849677247822553,0.0267289843381186,0.00015339241426834
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0104575816557029,0.00276318723597506,-0.015873428638214,-0.00504173467319178,0.00015477667307901
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4C,Semaphorin-4C,42587,-0.0110788368057238,0.00293007976750133,-0.0168217931500264,-0.00533588046142117,0.000156834009939031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.013514468657281,0.00357574931360915,0.00650600000260706,0.0205229373119549,0.000157831765890553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO4,Roundabout homolog 4,40223,-0.00724498467129433,0.00192036756245333,-0.0110089050937029,-0.0034810642488858,0.000162330672162956
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP2,Guanylate-binding protein 2,42370,0.0241378588422127,0.00640308012718614,0.0115878217929279,0.0366878958914976,0.000164140183296666
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,42370,0.019366071176084,0.00515128710404824,0.00926954845214947,0.0294625939000186,0.000171014491583814
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0162223611839178,0.0043221816850048,0.00775088508130842,0.0246938372865272,0.000175411204717585
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.0221030059568547,0.00589037773559062,0.0105578655950971,0.0336481463186123,0.000176062174807811
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.0133998374249521,0.00357385067867726,0.00639509009474467,0.0204045847551595,0.000178135062063935
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YY1,Transcriptional repressor protein YY1,40199,0.0111376866293244,0.00297375396548855,0.00530912885696681,0.0169662444016819,0.00018107674927779
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0255573201850605,0.00682902331529857,0.0121724344870752,0.0389422058830457,0.000183155366060889
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0250026999043957,0.00668608145837849,0.0118979802459739,0.0381074195628175,0.000185283931204548
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLC,Galectin-10,42611,-0.0259307368712926,0.0069348023638065,-0.0395229495043533,-0.0123385242382318,0.000185361196160342
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TG,Thyroglobulin,40451,-0.0453498757472589,0.012155201938185,-0.0691740715461015,-0.0215256799484164,0.000191732762284927
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN3,CCN family member 3,42779,0.0139272733261422,0.00373652539926017,0.00660368354359223,0.0212508631086921,0.000194302100508011
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6,Interleukin-6,42587,0.0301105368765627,0.00809862933980367,0.0142372233705475,0.0459838503825779,0.000201641393272646
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0276987782615962,0.00745861887693082,0.0130798852628118,0.0423176712603806,0.000205266810910891
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN5,Contactin-5,42640,-0.0148716891527432,0.00401140309995679,-0.0227340392286585,-0.0070093390768279,0.000210277911256919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.016031206392063,0.0043252226783211,0.0075537699425536,0.0245086428415723,0.000211195550271194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,40428,0.0108168901748489,0.00292109552977535,0.0050915429364892,0.0165422374132086,0.000214063931176509
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.011076385263452,0.0029930414012889,0.00521002411692576,0.0169427464099782,0.000216014634179364
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0160102978365963,0.00432668988986031,0.00752998565247005,0.0244906100207225,0.00021631542055592
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD160,CD160 antigen,42754,0.0190272607220891,0.00516614752893329,0.0089016115653799,0.0291529098787984,0.000231341323338777
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.0126099104885355,0.00342937902905895,-0.019331493385491,-0.00588832759157993,0.000237100268658846
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLNS1A,Methylosome subunit pICln,40182,0.0129411393311052,0.00352475673543767,0.00603261612964741,0.0198496625325631,0.000242275642884191
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0280520200093969,0.00764729620156452,0.0130633194543305,0.0430407205644634,0.00024536144836511
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,40199,0.024597064134405,0.00673263640368911,0.0114010967831743,0.0377930314856356,0.000259985554466142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0174935304257038,0.0048199129040533,-0.0269405597176483,-0.00804650113375934,0.000285093410133985
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6,Seizure protein 6 homolog,40182,-0.012018518587409,0.00331596323422243,-0.0185178065264849,-0.00551923064833303,0.000290893291392265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLU,Clusterin,40539,0.0119892847293978,0.00332190586992374,0.00547834922434722,0.0185002202344483,0.000308514610953193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPTC,Opticin,42587,-0.0175264274352513,0.00488073869922414,-0.0270926752857306,-0.00796017958477198,0.000330669637015914
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",40511,0.0198474663769515,0.00552873155550758,0.00901115252815668,0.0306837802257464,0.000332233648050342
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP10,Bone morphogenetic protein 10,40283,-0.0108714680959193,0.00302981817846644,-0.0168099117257135,-0.00493302446612509,0.000334457053190633
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.016899637499554,0.00472195957782341,0.00764459672702007,0.0261546782720879,0.000346478151641149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALCAM,CD166 antigen,42794,0.00736543872719205,0.0020693906201057,0.00330943311178487,0.0114214443425992,0.000373210391729942
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0191767119316687,0.00538795651119057,-0.0297371066936022,-0.00861631716973517,0.000373545682999067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0142063228761105,0.00399859463629688,0.00636907738896863,0.0220435683632524,0.000382670526857192
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C4BPB,C4b-binding protein beta chain,42679,0.0150512127237545,0.00424031087248127,0.00674020341369118,0.0233622220338177,0.000387197270815755
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0323688661324431,0.00911875217816638,0.014496111863237,0.0502416204016492,0.000387259085202595
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0125361905649306,0.00353452781065735,0.00560851605604219,0.019463865073819,0.000391589047686266
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0112372586579555,0.00316948650243993,0.00502506511317324,0.0174494522027378,0.000393307269849684
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACHE,Acetylcholinesterase,40283,0.0124051376339459,0.00350482945734448,0.0055356718975507,0.0192746033703411,0.000402617146041337
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,42636,0.0108309876501128,0.00306039852609283,0.00483260653897082,0.0168293687612547,0.000402883511505321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,40439,-0.010176039786854,0.00287555894889772,-0.0158121353266936,-0.00453994424701451,0.000403566033714018
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO3,R-spondin-3,42721,0.0110376676420492,0.00313076927322925,0.00490135986651982,0.0171739754175785,0.000424010182135817
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0326050394207201,0.00926731111225308,0.0144411096407041,0.0507689692007362,0.000436120161295954
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL28,C-C motif chemokine 28,42538,0.0217381651258439,0.0061930909821164,0.0095997068008958,0.0338766234507921,0.000449471008948253
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGN,Mimecan,42611,0.0163834288911752,0.00466758216397361,0.00723496784978688,0.0255318899325634,0.000449498373204865
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MILR1,Allergin-1,42370,-0.0190545676452232,0.00543210025472617,-0.0297014841444864,-0.00840765114595986,0.000453382212735011
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0123198055420911,0.00351339280468054,-0.019206055439265,-0.00543355564491727,0.000455479433016683
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.0178683453653662,0.00509750798906793,-0.0278594610239394,-0.00787722970679308,0.000457881789531161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00728853698170852,0.00208299228087264,-0.0113712018522189,-0.00320587211119815,0.000468673269336095
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,40483,0.0105826328399345,0.00303388176952883,0.00463622457165796,0.016529041108211,0.000488228778117098
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.007805980566528,0.00223842691549756,-0.0121932973209032,-0.00341866381215278,0.00048984320425426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,40235,-0.0127805597444644,0.00366728265338441,-0.0199684337450978,-0.00559268574383095,0.000494007138925264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPS,Colipase,42590,0.0267285725774316,0.00767343366838623,0.0116886425873946,0.0417685025674687,0.000496926446647551
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOC,Myocilin,42611,-0.0163526791650506,0.00470711975420525,-0.0255786338832929,-0.00712672444680827,0.000514320205251207
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0669731629837959,0.0192879196320711,0.0291688405049366,0.104777485462655,0.000517677870866414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.021285242873011,0.00613205610296979,0.00926641291119023,0.0333040728348318,0.000519875661914643
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JUN,Transcription factor AP-1,42370,0.0175259856011218,0.00505199321199815,0.0076240789056054,0.0274278922966381,0.000523829721214898
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0184701718973648,0.00534318087502528,0.00799753738231525,0.0289428064124144,0.000548409667246782
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0271403039756946,0.00785976065331827,0.0117351730951908,0.0425454348561984,0.000555954371015696
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY2,Protein canopy homolog 2,42357,0.022434454516254,0.00649987173357588,0.00969470591844524,0.0351742031140627,0.000559183270795888
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA1,Ephrin-A1,42590,0.0109909122181791,0.00319129852834127,0.00473596710263022,0.017245857333728,0.000574876471400236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTP1,Glutathione S-transferase P,42237,-0.0254063929690696,0.00739070020047403,-0.0398921653619987,-0.0109206205761405,0.000588690109247085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0224697410069375,0.00655686068852639,0.0096182940574258,0.0353211879564492,0.000612368312956824
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,40223,0.0142865015942549,0.00417689395307877,0.00609978944622051,0.0224732137422893,0.000627637970730602
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF2,Trefoil factor 2,42654,0.0209274937500723,0.00613631532385557,0.0089003157153154,0.0329546717848293,0.000650502312045252
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPACAM2,HEPACAM family member 2,40483,-0.0151569083283911,0.00444615548736741,-0.0238713730836312,-0.00644244357315096,0.000654313846133267
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0209033249832291,0.00613657024111436,0.00887564731064499,0.0329310026558133,0.000660750171540466
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH12,Protocadherin-12,40482,0.00926922685496474,0.00272297736239956,0.0039321912246616,0.0146062624852679,0.000666187392386025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,42416,0.0148660057065039,0.00439525469632137,0.00625130650171402,0.0234807049112938,0.000720938066548939
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0192953210156997,0.00570642402104937,0.00811072993444295,0.0304799120969565,0.000723797048478446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00864049290441265,0.00256659726590637,0.00360996226323616,0.0136710235455891,0.000763845418121625
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EP300,Histone acetyltransferase p300,40199,0.0109713521525478,0.00326583247267122,0.00457032050611222,0.0173723837989834,0.00078367295793536
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0135545745713241,0.00404191526910931,0.00563242064386984,0.0214767284987784,0.000800661811355247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0251767572535388,0.00751188362174731,0.010453465354914,0.0399000491521635,0.000805690357550085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0130816434867983,0.00393045149574232,-0.0207853284184532,-0.00537795855514333,0.00087671138543555
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.011513136291817,0.00346111583810965,-0.0182969233345119,-0.0047293492491221,0.000882562863381302
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN2,Neuroligin-2,40136,-0.0168424778149993,0.00507779117989211,-0.0267949485275878,-0.00689000710241075,0.000913218604621968
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,40449,0.0199978605685341,0.00603302670941114,0.00817312821808829,0.03182259291898,0.000920212447197397
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,40527,0.00813857645398709,0.00246228414866144,0.00331249952261066,0.0129646533853635,0.000951709792738026
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX18,Sorting nexin-18,40449,0.0152276752285428,0.00462243468225237,0.00616770325132813,0.0242876472057574,0.000989727377258819
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0101771023394244,0.00309108889847628,0.00411856809841086,0.0162356365804379,0.000995927232282708
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKAP12,A-kinase anchor protein 12,40283,-0.00763904637170061,0.00232304716663277,-0.0121922188183008,-0.00308587392510038,0.00101081910189967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPJ,Centromere protein J,40302,0.0245717215207587,0.00748262471961263,0.00990577707031793,0.0392376659711994,0.00102720773852451
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,40136,0.0154022494485123,0.00469187126942689,0.0062061817604356,0.024598317136589,0.00103121461674958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0135514365196847,0.00413221831425998,0.00545228862373515,0.0216505844156343,0.00104272119896015
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,42594,0.0168301540906035,0.00514522750361069,0.00674550818352657,0.0269147999976805,0.00107430196296362
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH6,Cadherin-6,42636,-0.0133235616251606,0.00407626909012154,-0.0213130490417988,-0.00533407420852239,0.0010836480193568
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG3,Secretogranin-3,42638,-0.0117716967626305,0.00360185498054314,-0.0188313325244951,-0.00471206100076599,0.00108493394953841
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0262337991468404,0.0080477671075264,0.0104601756160887,0.0420074226775922,0.00111844058680177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0295121402003008,0.00905808811755159,-0.047265992910702,-0.0117582874898997,0.00112449937791032
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.0106611936634828,0.00327608308703442,0.00424007081289531,0.0170823165140702,0.00114035383350249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.0106700686354475,0.00328298456678629,0.00423541888454639,0.0171047183863486,0.00115641059825325
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,42611,-0.0215331376281016,0.00663635465827712,-0.0345403927583248,-0.00852588249787848,0.00117852550538739
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0121113750472277,0.00374458317264478,0.00477199202884398,0.0194507580656115,0.00122205622279764
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWF,von Willebrand factor,42794,-0.0244626312371087,0.00756634470232726,-0.0392926668536701,-0.00963259562054724,0.00122753355886613
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,40116,-0.0093012171312942,0.00287689238936836,-0.0149399262144562,-0.00366250804813221,0.0012282782745014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00792641172813922,0.00245238892623288,0.00311972943272278,0.0127330940235557,0.00123170524287651
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.0154935620990225,0.00480244225929358,0.00608077527080704,0.0249063489272379,0.00125816110977705
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RETN,Resistin,42598,0.0147431074967247,0.00457389813213591,0.0057782671577383,0.023707947835711,0.00127019946070553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.0120393735076788,0.00373938357313859,0.00471018170432712,0.0193685653110304,0.00128735601933559
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0177003868378622,0.00550242837894694,0.0069156272151262,0.0284851464605982,0.00129981081738627
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0281921738169615,0.00878341411721413,0.0109766821472218,0.0454076654867012,0.0013325219276233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,40511,-0.00938474738662909,0.00293631110176934,-0.015139917146097,-0.00362957762716118,0.0013968085022096
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,40511,0.01070050433594,0.00334920930041786,0.00413605410712097,0.017264954564759,0.0014024621028621
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0500699866901122,0.0157287152595069,0.0192417047814787,0.0808982685987458,0.00145922031929382
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSAP,Gamma-secretase-activating protein,42346,0.028682141467352,0.00902863469971918,0.0109860174559024,0.0463782654788016,0.0014925525042203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,40124,0.0330842350844751,0.0104160544712866,0.0126687683207534,0.0534997018481969,0.00149595004199185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST1,Cystatin-SN,39042,0.0367705405348735,0.0116012854509471,0.0140320210510172,0.0595090600187298,0.00153156778474843
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3D,Protein FAM3D,40449,0.0286670921313105,0.00904575859503244,0.0109374052850469,0.0463967789775741,0.0015331067345641
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0189995927060626,0.00599546490810238,0.00724848148618195,0.0307507039259433,0.0015331719314844
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSC2,Desmocollin-2,42488,-0.0118238870737547,0.00373208790362472,-0.0191387793648592,-0.00450899478265026,0.0015374927410968
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LXN,Latexin,42461,-0.0225767129572472,0.00713525917259295,-0.0365618209355294,-0.008591604978965,0.00155911541281882
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,40136,0.0260714865980839,0.00826647870596926,0.00986918833438418,0.0422737848617837,0.00161550816907364
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.012805061695885,0.00408323797941767,0.00480191525622636,0.0208082081355436,0.00171636473674036
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",42562,0.0233166683462801,0.00744024747272813,0.00873378329973301,0.0378995533928273,0.00172898258007284
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA4,Apolipoprotein A-IV,40539,0.0119107944069492,0.00380115998040913,0.00446052084534734,0.0193610679685511,0.00173196708884509
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00957227246821411,0.00305969665949973,-0.0155692779208336,-0.00357526701559463,0.00176153215968286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPOCK1,Testican-1,42495,0.00847750091755592,0.00271169919802653,0.00316257048942392,0.0137924313456879,0.00177420946022129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0173752132652295,0.00557619555229269,0.00644586998273583,0.0283045565477232,0.00183741582103058
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.00839338377535013,0.0026937881712907,0.00311355895962036,0.0136732085910799,0.00183814703361909
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,40199,0.00675782842654092,0.00218439281428229,0.00247641851054763,0.0110392383425342,0.00198181008730752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0212577329620765,0.00688916908310759,-0.0347605043649673,-0.0077549615591856,0.00203498869050423
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI1,Neuroserpin,40267,0.00980229247429694,0.00318431219008614,0.00356104058172811,0.0160435443668658,0.00208688912295389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO1,R-spondin-1,42495,0.0109963966083148,0.00357248909498757,0.00399431798213915,0.0179984752344904,0.00208764972807162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.0107173927354309,0.00348293101392354,-0.0175439375227211,-0.00389084794814079,0.00209432272877732
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00675286156809481,0.00219444234325558,-0.0110539685608757,-0.00245175457531387,0.00209432806119341
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC1,Syndecan-1,42636,0.0131563092780018,0.0042818734927445,0.0047638372322226,0.021548781323781,0.00212656316530576
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00767961610047458,0.00249994675482474,0.00277972046101808,0.0125795117399311,0.00213118398898965
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNR,Tenascin-R,42495,-0.0136893243994448,0.00446417371187448,-0.0224391048747188,-0.00493954392417086,0.00217025891576473
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA6C,Semaphorin-6C,40199,0.0084630879922415,0.00276910020246739,0.00303565159540542,0.0138905243890776,0.00224654448853307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0159235637929326,0.00521909266583208,0.00569414216790177,0.0261529854179635,0.00228593710448074
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL19,Interleukin-19,42261,0.0232229596730961,0.00761532741108724,0.00829691794736514,0.0381490013988271,0.00229679563772664
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR5,Proline-rich protein 5,40199,0.0153214076161639,0.0050429385395273,0.00543724807869038,0.0252055671536374,0.00238561561794113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAVL4,ELAV-like protein 4,40136,0.0272380332939899,0.00897355579964882,0.0096498639266782,0.0448262026613016,0.0024080795438806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL1,Chordin-like protein 1,42654,0.0103299823081203,0.0034061144685907,0.00365399794968257,0.0170059666665581,0.00242776839909108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.018861343178372,0.00624448532818539,0.00662215193512866,0.0311005344216154,0.00252959929903883
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.0110075141886182,0.00367209254673075,0.00381021279702592,0.0182048155802105,0.00272599679581081
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0165436398946517,0.0055363907157451,0.00569231409179128,0.0273949656975121,0.00281283537767204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNW1,Interferon omega-1,40116,-0.0115998323884658,0.00389362856882641,-0.0192313443833655,-0.00396832039356601,0.00289653634264446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,42125,0.0105714536432565,0.00355350083514347,0.00360659200637535,0.0175363152801377,0.00293586825483572
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB1,Lamin-B1,40434,0.0186611800322607,0.00630172485846296,0.00630979930967335,0.0310125607548481,0.00307002425653473
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0178881344513896,0.00605222594795052,0.00602577159340661,0.0297504973093727,0.00312687669738488
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDN1,Endothelin-1,40223,0.00938880410388183,0.00320995999521578,0.0030972825132589,0.0156803256945048,0.00345271449112203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0144067843925412,0.00493017096152377,0.00474364930795459,0.0240699194771278,0.00348296046469484
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST6,Cystatin-M,42332,0.0155778965842944,0.005344532076715,0.00510261371393303,0.0260531794546558,0.00356591243432478
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,42611,-0.00904479953008033,0.00310413633222537,-0.0151289067412421,-0.0029606923189186,0.00357660259021808
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXTL1,Exostosin-like 1,40116,0.0145668956768041,0.00499950691847244,0.00476786211659808,0.02436592923701,0.00357935798422948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKLR,Pyruvate kinase PKLR,42636,0.019945660916966,0.00687145447657003,0.00647761014288876,0.0334137116910433,0.00370581085517642
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP8,Neutrophil collagenase,42681,0.0222718214038001,0.00768600150613176,0.00720725845178182,0.0373363843558183,0.00376500312237222
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,40302,0.0216674247705292,0.00747754667125289,0.0070114332948735,0.0363234162461848,0.0037668686078717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRK1,Protein BRICK1,42311,0.0136758641360713,0.00473282737341612,0.0043995224841757,0.0229522057879669,0.00386393861342348
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,42590,-0.00717017240881077,0.00248192351350062,-0.012034742495272,-0.00230560232234957,0.00387140501225427
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",40116,0.0172244424615313,0.00596203720781365,0.00553884953421651,0.028910035388846,0.00387204910936224
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLN,Mesothelin,42553,0.0181248172628058,0.00627966783725232,0.00581666830179123,0.0304329662238203,0.00390462042544068
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JCHAIN,Immunoglobulin J chain,42370,-0.0190672855348757,0.00660848163866266,-0.0320199095466545,-0.00611466152309691,0.00391706580443381
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0256176160507471,0.00888483170288771,0.00820334591308718,0.043031886188407,0.00394298882044507
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEG1,Protein LEG1 homolog,39926,-0.0212795272250644,0.00738096334617885,-0.0357462153835749,-0.00681283906655382,0.00394654237773962
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA4,Carboxypeptidase A4,40060,0.0134248499303834,0.00466325023225552,0.00428487947516262,0.0225648203856043,0.00399892900631245
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,40283,0.00883000624502014,0.00307340818559355,0.00280612620125679,0.0148538862887835,0.0040732209408589
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRP15,RRP15-like protein,40136,-0.0278356798930393,0.00970382323156204,-0.0468551734269009,-0.00881618635917773,0.0041317671859772
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL1,Interferon lambda-1,42311,0.0138265356201639,0.00482568527941085,0.00436819247251863,0.0232848787678092,0.00417412967040139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.0128387702855436,0.00448680619238625,0.00404463014846654,0.0216329104226206,0.00422354281632981
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC1,Sialoadhesin,42676,0.0129749572171994,0.00455274492905944,0.00405157715624292,0.0218983372781559,0.00437965784819268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO1,Alpha-enolase,42588,0.0235796841084411,0.00827583335830381,0.00735905072616563,0.0398003174907166,0.00438931534781031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0150312555797255,0.00527590193550855,0.00469048778612873,0.0253720233733223,0.00439309136873761
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKKL1,Dickkopf-like protein 1,42587,-0.0263661729949277,0.00926404276229194,-0.0445236968090199,-0.00820864918083553,0.00443288068170804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMA,Repulsive guidance molecule A,42711,-0.00953175204772768,0.00337325376257558,-0.0161433294223758,-0.00292017467307954,0.00472488341361122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0110039865460558,0.00389889166911316,0.00336215887459402,0.0186458142175176,0.00477580612048043
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF1,Trefoil factor 1,42556,0.0246312573588235,0.00873558508218019,0.00750951059775032,0.0417530041198967,0.00481474184135199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,42587,0.00774909968019776,0.00275480478792858,0.00234968229585773,0.0131485170645378,0.00491623286264878
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42611,0.0135091157965663,0.00480801091561193,0.00408541440196694,0.0229328171911657,0.00496579377277058
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,42794,-0.00796127270393418,0.00283352921147845,-0.0135149899584319,-0.00240755544943643,0.00496636287316711
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR1,Cadherin-related family member 1,42311,0.0126537435926779,0.00450997180515508,0.0038141988545739,0.0214932883307818,0.00502773536828803
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100G,Protein S100-G,40482,-0.0142764185641252,0.00509389411178628,-0.0242604510232263,-0.00429238610502414,0.00507705431405142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI16,Peptidase inhibitor 16,40532,-0.00741432472449734,0.00264560445371523,-0.0125997094537792,-0.0022289399952155,0.00507931771554119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0120518298180709,0.00430892464933015,-0.020497322130758,-0.00360633750538379,0.005167837132597
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,40116,0.011883836901679,0.00425290096944235,0.00354815100157197,0.020219522801786,0.00521045364006991
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRXN3,Neurexin-3,40182,0.0105000251267634,0.00375806317720852,0.00313422129943473,0.0178658289540921,0.00521507855624012
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,42370,0.0163844861026667,0.00587716304964157,0.00486524652536922,0.0279037256799642,0.00531396681368928
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.0140974039377555,0.00506249019565058,-0.0240198847212307,-0.0041749231542804,0.00536731769559386
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD1,Polycystin-1,40511,0.00787007511679551,0.00282888534876288,0.00232545983322028,0.0134146904003708,0.00541076466519998
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0124802056322141,0.00448827747762961,-0.0212772294883681,-0.00368318177606003,0.00543479898032327
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0191081132300268,0.006883344448901,0.0056167581101808,0.0325994683498727,0.00551255687328282
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0180602215520653,0.00651022936119026,-0.0308202710999982,-0.00530017200413235,0.00554433970824792
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0440504714382396,0.0159138670812732,0.0128592919589441,0.0752416509175351,0.00564692356286387
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OBP2B,Odorant-binding protein 2b,42462,-0.0178993616519481,0.00646745683288018,-0.0305755770443933,-0.005223146259503,0.00565482265900125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP7,Retinoid-binding protein 7,40449,0.0174899730992574,0.0063302982612816,0.00508258850714549,0.0298973576913694,0.00573835702527089
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00943990401145626,0.00342583409420915,0.00272526918680632,0.0161545388361062,0.00586985005490002
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,42794,-0.00765128169819846,0.00277982331254156,-0.0130997353907799,-0.002202828005617,0.00592323840383053
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171B,Protein FAM171B,40451,0.00766578209947376,0.00278853095997394,0.00220026141792484,0.0131313027810227,0.00598654625057025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT2,Angiopoietin-2,42721,0.0109345655215687,0.00397943541441186,0.00313487210932148,0.018734258933816,0.00600819187561802
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,40116,0.0130036531476169,0.00473889160665379,0.00371542559857549,0.0222918806966583,0.00607893732368301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5L,CD5 antigen-like,40479,0.013797031587665,0.00502964244796033,0.00393893238966273,0.0236551307856672,0.0060950108281462
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,40182,-0.0084282997813133,0.00308000975279547,-0.0144651188967924,-0.00239148066583418,0.00622053877837529
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0151845083942098,0.00555322594275452,0.00430018554641099,0.0260688312420087,0.00626010956626799
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL3,Insulin-like 3,40483,0.0225461953310606,0.00825277263200869,0.00637076097232357,0.0387216296897976,0.00630578118679507
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK1,Kallikrein-1,42505,-0.0372996850165615,0.0136613765923501,-0.0640759831375677,-0.0105233868955553,0.00633595604080744
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM1,Myomesin-1,40136,0.0138709141122883,0.00508576100140451,0.00390282254953547,0.0238390056750411,0.00639370214189919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0162784462149467,0.00597295499098115,0.00457145443262361,0.0279854379972697,0.00643165888176553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POF1B,Protein POF1B,40199,0.0133141865190452,0.00492177718117445,0.00366750324394331,0.0229608697941471,0.00683769377350199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTL1,Cytokine-like protein 1,40527,0.00729450877568652,0.00269654478449693,0.00200928099807253,0.0125797365533005,0.00683793723580343
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,0.00855068699712276,0.00316554481962656,0.00234621915065469,0.0147551548435908,0.00691819812143246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1,DNA topoisomerase 1,40449,0.0319626338968385,0.0118407134055585,0.00875483562194375,0.0551704321717332,0.00695717041803987
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,42741,0.0148888131525263,0.0055210796182012,0.00406749710085195,0.0257101292042006,0.00701124333636275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTN,Titin,40116,-0.0186383751340254,0.00693302127200778,-0.0322270968271607,-0.00504965344089017,0.00719153960155917
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR1,Toll-like receptor 1,40199,0.00754184326661213,0.00282481973468727,0.00200519658662508,0.0130784899465992,0.00759967197889163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,42370,0.018586151161434,0.00696472393836993,0.00493529224222895,0.0322370100806391,0.0076258473530512
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0244177347593353,0.00915329033665956,0.00647728569948256,0.042358183819188,0.00764766338444281
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00717455420486202,0.00270558092062933,-0.0124774928092955,-0.00187161560042854,0.00801876991272371
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.0110112700917035,0.00418080317772651,-0.0192056443200475,-0.00281689586335953,0.00845607681459928
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00808306175474485,0.00306944023899722,0.0020669588863103,0.0140991646231794,0.00846530965084919
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0145364898093496,0.00552912167908753,0.00369941131833802,0.0253735683003611,0.00857347328304236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0148902928756304,0.00566781409558134,0.00378137724829095,0.0259992085029698,0.00862158202769689
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXDNL,Peroxidasin-like protein,40451,-0.0153234160165133,0.00588466339886879,-0.0268573562782962,-0.00378947575473051,0.00922750774558779
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,42754,-0.00700540836933403,0.00269059578634735,-0.0122789761105748,-0.00173184062809322,0.00923335328393669
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF4,Neurotrophin-4,42346,0.0107178468569311,0.00411695597043123,0.00264861315488589,0.0187870805589763,0.00924233205473316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.00951508786300865,0.00365810413361526,0.00234520376112274,0.0166849719648946,0.0093029020138995
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0196456652724012,0.00755927791962893,-0.0344618499948739,-0.00482948054992853,0.00936494563866977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0188170645355138,0.0072623681403398,0.00458282298044779,0.0330513060905798,0.00957916772432543
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUK1,Guanylate kinase,40116,-0.0104801344905083,0.00405866167856375,-0.0184351113804933,-0.00252515760052337,0.00983115768188007
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0251967238470922,0.00976838266332572,0.00605069382697382,0.0443427538672106,0.00990974250790295
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.00412566045593193,0.00160132284204897,-0.00726425322634792,-0.000987067685515948,0.00999585231396759
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAN,Brevican core protein,42495,-0.00939681447733773,0.00364808852205207,-0.0165470679805598,-0.00224656097411568,0.0100110001277449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,42587,0.00576429055479647,0.00224414837386854,0.00136575974201413,0.0101628213675788,0.0102221399540493
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNG,Uracil-DNA glycosylase,40451,0.00925183927253358,0.00360201121937992,0.00219189728254893,0.0163117812625182,0.0102261441931141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0228113270661118,0.00888769183493199,0.00539145106964511,0.0402312030625785,0.0102826344537214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR1,Folate receptor alpha,42600,0.00820207839821165,0.00319815036876261,0.00193370367543694,0.0144704531209864,0.0103393205244003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSV,Cathepsin L2,42677,0.0112780300492704,0.00440962355268034,0.00263516788601696,0.0199208922125239,0.0105507242290754
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTO1,Protein LTO1 homolog,42370,0.0113518741377395,0.0044425652995554,0.00264444615061097,0.0200593021248681,0.0106222242094255
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00812175117319837,0.00317986832126168,0.00188920926352548,0.0143542930828713,0.0106591628326665
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1,Methionine aminopeptidase 1,42311,0.00784096911065205,0.00307737104502544,0.00180932186240219,0.0138726163589019,0.0108472893717439
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00918830734312102,0.00361457113085554,-0.0162728667595979,-0.00210374792664416,0.0110326895196153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.010432372002597,0.00410476910010566,-0.0184777194388041,-0.00238702456638988,0.0110507192571096
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",40116,0.0165820136969516,0.00654271391241624,0.00375829442861577,0.0294057329652874,0.0112770702045652
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",42618,0.025091077787691,0.00993481754308483,0.00561883540324476,0.0445633201721373,0.0115624858589961
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN2,Transcobalamin-2,42771,-0.00819593491173927,0.00325099721354036,-0.0145678894502784,-0.00182398037320015,0.0117117931142318
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,42600,-0.00471345922614394,0.00187031695093094,-0.00837928044996859,-0.0010476380023193,0.0117423567994614
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,42721,-0.0155254243336118,0.00616075831647598,-0.0276005106339048,-0.00345033803331892,0.0117452024486789
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBLN2,Fibulin-2,40527,-0.00865712926691101,0.00344455221744591,-0.015408451613105,-0.00190580692071704,0.0119751436750929
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEO1,Neogenin,40482,0.00588468354246593,0.00234634518212492,0.00128584698550108,0.0104835200994308,0.0121548536983565
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG4,Desmoglein-4,42543,0.0131975933566528,0.00527583082680929,0.0028569649361066,0.023538221777199,0.0123780419068279
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2,T-cell surface antigen CD2,40116,0.0101764902138503,0.0040695031216462,0.00220026409542379,0.0181527163322769,0.012410345685299
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0142540277980689,0.00570834892551219,-0.0254423916920728,-0.00306566390406504,0.0125377411559206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,40302,0.0142695975096604,0.0057364285566719,0.00302619753858347,0.0255129974807373,0.0128775416523406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,40080,0.0109492385444518,0.00440617667485597,0.00231313226173408,0.0195853448271695,0.0129709616941587
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL25,Interleukin-25,40036,0.00918365308440524,0.00369685795363845,0.00193781149527387,0.0164294946735366,0.0130000721327284
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00995987672617482,0.00402593524321071,0.00206904364948183,0.0178507098028678,0.0133761967818669
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTR,Methionine synthase,40116,0.0173020741151172,0.00701034282269768,0.00356180218262973,0.0310423460476046,0.013599271394621
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRV1,Acrosomal protein SP-10,40199,0.0207897147083317,0.0084587452020233,0.00421057411236602,0.0373688553042974,0.0139952753337239
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMOD4,Tropomodulin-4,40080,-0.0107105370191106,0.00436169890376365,-0.0192594668704874,-0.00216160716773386,0.0140809349528931
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1,Integrin beta-1,42638,-0.00552261274458311,0.00225145777619955,-0.00993546998593422,-0.00110975550323199,0.014183373503594
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,42711,0.00778011818089717,0.00317212115089048,0.00156276072515183,0.0139974756366425,0.0141931810295273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1B,Protein phosphatase 1B,40199,0.0157377069763138,0.00643750917777484,0.00312018898787509,0.0283552249647525,0.0145132912551703
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B4,Protein ATP1B4,40080,-0.0109209239452314,0.00447007354848883,-0.0196822681002695,-0.00215957979019334,0.014576693356544
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,40302,0.0140445587427144,0.00576116269453097,0.0027526798614337,0.0253364376239951,0.014792546664623
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEF,Thyrotroph embryonic factor,40116,0.0111718184973709,0.00458897520241882,0.00217742710062999,0.0201662098941118,0.0149286619075484
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36G,Interleukin-36 gamma,40154,0.017647461154278,0.00726100487154725,0.00341589160604541,0.0318790307025106,0.015096300284667
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR4,Proline-rich protein 4,40198,-0.0178180128912257,0.00734028743075833,-0.032204976255512,-0.00343104952693933,0.0152222781133808
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00902816046106574,0.0037242011107766,0.0017287262839436,0.0163275946381879,0.0153586999449951
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0221790128170469,0.00915262108127851,0.00423987549774099,0.0401181501363528,0.0153988876677065
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON1,Spondin-1,42638,0.00864454497114376,0.00357360001592916,0.00164028893992261,0.0156488010023649,0.0155763503421712
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC1,Hamartin,40199,0.0187235836980414,0.00774525433799932,0.0035428851955627,0.03390428220052,0.0156468317297413
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR5,Complement factor H-related protein 5,40382,0.0107527110371412,0.00445244255629165,0.00202592362680953,0.0194794984474728,0.0157505358922568
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.00869951213470422,0.00360561222962369,0.00163251216464179,0.0157665121047667,0.0158451779907582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD3,Bromodomain-containing protein 3,40116,0.0126579500631973,0.00525349407022703,0.00236110168555235,0.0229547984408423,0.0159936982135355
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,40283,0.0104766057876401,0.0043531840346272,0.0019443650797708,0.0190088464955094,0.0161156812876419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GL3,Endophilin-A3,40250,0.0216764366813771,0.00901811132143529,0.00400093849136391,0.0393519348713902,0.0162484008625261
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0128420389205225,0.00535334535706693,0.00234948202067129,0.0233345958203736,0.0164591256072738
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF15,Growth/differentiation factor 15,42794,0.0116404455995052,0.00487282977123844,0.00208969924787784,0.0211911919511325,0.0169148809366994
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMI,N-myc-interactor,40421,0.0181219541420452,0.0075919018423757,0.00324182653098885,0.0330020817531016,0.0170024289966488
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15,Interleukin-15,42594,0.00833527655527787,0.00350068524242294,0.00147393348012891,0.0151966196304268,0.0172776574684798
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM3,Paralemmin-3,40116,0.0179146640563657,0.00755826806508824,0.00310045864879271,0.0327288694639386,0.0177953702346394
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANPEP,Aminopeptidase N,42666,-0.00692296850478352,0.00292347661724913,-0.0126529826745918,-0.00119295433497522,0.017895664216288
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,42679,-0.0108974332118986,0.00460828097924613,-0.019929663931221,-0.00186520249257617,0.018056317147564
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.0100002421718795,0.00424071924469123,0.0016884324522847,0.0183120518914743,0.0183833420785353
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTTG1,Securin,40302,0.0101976913483296,0.00432760305179177,0.00171558936681776,0.0186797933298415,0.0184688386552315
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0191848603067364,0.0081430832453411,0.0032244171458678,0.0351453034676049,0.0184890371281174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0734481756284468,0.0312660189135333,0.0121667785579216,0.134729572698972,0.0188313737933046
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00941099325525461,0.00400896784861577,-0.0172685702385415,-0.0015534162719677,0.0189183362649871
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX9,Transcription factor SOX-9,40182,0.00685964846283983,0.00292780309554215,0.00112115439557721,0.0125981425301024,0.0191505255795243
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0186544300401092,0.00796959766309048,0.00303401862045187,0.0342748414597666,0.0192649889499022
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKCQ,Protein kinase C theta type,42370,0.0107971146058157,0.00462297706281419,0.00173607956269993,0.0198581496489316,0.0195305297711735
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,42370,0.0149235892424916,0.00639206746450361,0.00239513701206455,0.0274520414729187,0.0195737987595023
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.0121703829215128,0.00527498993733616,-0.0225093631986917,-0.00183140264433391,0.0210629517884577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,40199,-0.00716387404415222,0.0031205063304788,-0.0132800664518907,-0.00104768163641376,0.0217094112788565
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM25,Transmembrane protein 25,40482,-0.011053844442936,0.00481650314957156,-0.0204941906160963,-0.00161349826977577,0.0217517423116635
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0170893268463405,0.00746954674350892,0.00244901522906304,0.031729638463618,0.0221639907342545
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0232854892511612,0.0102019845932776,0.00328959944833704,0.0432813790539853,0.0224815289649903
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBH,Dopamine beta-hydroxylase,40515,0.0263335379666574,0.0115524939253186,0.00369064987303301,0.0489764260602819,0.0226577941827407
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP9,Fatty acid-binding protein 9,42594,0.013643296684813,0.00599077339024501,0.00190138083993283,0.0253852125296933,0.0227789371865167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,40199,-0.00528735440064022,0.00232280840095298,-0.00984005886650806,-0.000734649934772386,0.0228485815292931
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00957730935025664,0.00422085130146694,0.00130444079938144,0.0178501779011318,0.0232847085776882
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,40223,0.0133254933631295,0.00587497003247389,0.00181055209948066,0.0248404346267783,0.0233374479161475
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.00780399641435193,0.00345456649373084,0.00103304608663948,0.0145749467420644,0.0238973044089369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA3,Carbonic anhydrase 3,42770,0.0141649943764326,0.00627479970638265,0.00186638695192261,0.0264636018009426,0.0239963104970918
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GM2A,Ganglioside GM2 activator,40269,0.00973610681523576,0.00431589925837583,0.00127694426881913,0.0181952693616524,0.0240982124483938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5A,Cytochrome b5,40080,0.0174235969710549,0.00772808173746315,0.0022765567656271,0.0325706371764827,0.0241793449379959
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00671805302540422,0.00298721894491088,0.000863103893378899,0.0125730021574295,0.0245328830111764
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.0169756855734658,0.00755223380165989,0.00217330732221236,0.0317780638247191,0.0246069497837839
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00828684427394655,0.00370002582087443,-0.0155388948828604,-0.00103479366503266,0.0251288513951168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGF,Beta-nerve growth factor,42495,0.00282652012051538,0.00126451299730922,0.000348074645789306,0.00530496559524146,0.0254165664968283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.0121314982514368,0.00542823895686096,-0.0227708466068842,-0.00149214989598928,0.0254449008028879
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00895059278900542,0.00401085110876308,0.00108932461582978,0.0168118609621811,0.0256613354898122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN7,Septin-7,40302,0.012824994703019,0.00574856692641801,0.00155780352723971,0.0240921858787983,0.0257016816876374
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22,Interleukin-22,40451,0.0164863313264389,0.00739096073340383,0.00200004828896736,0.0309726143639104,0.0257267772432107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAN,Neurocan core protein,42711,-0.00891365899102703,0.00400138920837818,-0.0167563818394483,-0.0010709361426058,0.0259208545947805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,40483,0.00962094957386866,0.00432926148155226,0.00113559707002624,0.0181063020777111,0.0262822823031665
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.0074442465545147,0.00335801390152796,0.000862539307519903,0.0140259538015095,0.0266493940943682
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,40199,0.023712691167289,0.0107208574033226,0.0026998106567767,0.0447255716778013,0.026999027012329
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00914509740403179,0.00413761134163741,-0.0172548156336411,-0.00103537917442248,0.027109444866014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00516655365051115,0.00234573364673091,0.000568915702918563,0.00976419159810373,0.0276446931682041
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.00918004513736216,0.00416987625776429,0.00100708767214416,0.0173530026025802,0.0277169346870662
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,40302,0.0088644543303593,0.00402777177097143,0.000970021659255286,0.0167588870014633,0.0277683263576129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,42441,0.00652035975936673,0.00296974616271033,0.000699657280454479,0.012341062238279,0.0281382255701277
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR4,Toll-like receptor 4,40199,0.00677055701304059,0.00309233044651624,0.000709589337868763,0.0128315246882124,0.0285838037474142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,40451,0.0144504877369718,0.0066064417793416,0.00150186184946224,0.0273991136244813,0.0287387272291513
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPN1,Epsin-1,40302,0.0102750261802673,0.00470287907487798,0.00105738319350643,0.0194926691670281,0.0289215944766369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYMP,Thymidine phosphorylase,42563,0.0148898629175794,0.00683558583489408,0.00149211468118701,0.0282876111539718,0.0294021417560578
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT1,Diamine acetyltransferase 1,40116,-0.0118223794858899,0.00542870066747897,-0.0224626327941487,-0.00118212617763114,0.0294456141594679
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.00769647251440842,0.00353776018734568,0.000762462547210885,0.014630482481606,0.029612239798165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0170678633504028,0.00785533568436108,0.00167140540905511,0.0324643212917506,0.0298180654786638
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTNNA1,Catenin alpha-1,40136,-0.0080752292975674,0.00371695444671058,-0.0153604600131201,-0.000789998582014674,0.0298364075162148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0141020506559233,0.00649136463778039,-0.0268251253459729,-0.00137897596587376,0.0298443378915713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RA,Interleukin-17 receptor A,42611,0.0100417522250359,0.0046341991064946,0.000958721976306436,0.0191247824737653,0.0302615638530609
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00936886738545958,0.00433578979395706,0.000870719389303734,0.0178670153816154,0.0307306446418286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0227575330110419,0.0105590349641866,-0.0434532415408477,-0.00206182448123606,0.0311627778703398
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.00608770546686682,0.00282912784804279,-0.0116327960490307,-0.000542614884702944,0.0314345833628095
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB118,Beta-defensin 118,40136,0.012878491277746,0.00602552532380885,0.00106846164308062,0.0246885209124113,0.0325938665511299
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALB,Ras-related protein Ral-B,40199,0.00671554672394673,0.0031631660837203,0.000515741199854949,0.0129153522480385,0.0337722644952925
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00844032509603744,0.00397731779577921,0.000644782216310189,0.0162358679757647,0.0338502025793712
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.0101376385914143,0.00478660367948509,-0.019519381803205,-0.000755895379623478,0.0342037301362657
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRING1,SREBP regulating gene protein,40080,0.0132248185880815,0.00625591314542623,0.000963228823046135,0.0254864083531169,0.0345404291264557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00603829213973985,0.00287031327308337,0.000412478124496451,0.0116641061549832,0.035426261354756
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,42794,-0.00661371457032908,0.00314699019974657,-0.0127818153618324,-0.000445613778825803,0.0356066781151969
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH23,Cadherin-23,40483,-0.00578796137968013,0.00275725536250104,-0.0111921818901822,-0.000383740869178092,0.0358236305918239
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0158953432082217,0.00761514275601166,0.000969663406438807,0.0308210230100045,0.0368803628284381
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0251371997698412,0.0121728337670841,0.00127844558635633,0.0489959539533261,0.0389434645136148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0267382376052972,0.012953091763928,0.00135017774799832,0.0521262974625961,0.0390149153138127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD55,Complement decay-accelerating factor,42201,0.0059283033538321,0.00287460702045525,0.000294073593739806,0.0115625331139244,0.0391989529176494
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1A,Lithostathine-1-alpha,42575,-0.0113221100775427,0.0055004222189867,-0.0221029376267567,-0.000541282528328819,0.0395703553467934
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,42311,-0.00746952871832499,0.0036383112636676,-0.0146006187951135,-0.000338438641536497,0.0400903500764707
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00806218222618017,0.00392726834608173,0.000364736267859975,0.0157596281845004,0.0401082915496535
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.0109071709698508,0.00532110823018393,0.000477798838690289,0.0213365431010113,0.0404044644909771
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,42676,0.00622761795161382,0.00305338612829363,0.000242981140158302,0.0122122547630693,0.0414118693778799
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0133113109361296,0.00653352340576178,0.000505605060836564,0.0261170168114227,0.041635358281694
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNN,Tenascin-N,40527,0.00943064403722219,0.00464826880031809,0.000320037188598729,0.0185412508858456,0.042496816389423
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.0104165920225998,0.00513826270914881,-0.0204875869325315,-0.000345597112668171,0.0426601156693612
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP350,Centrosome-associated protein 350,40080,0.00814718968847759,0.00401961602453192,0.000268742280395026,0.0160256370965602,0.0427012922408219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN3,Matrilin-3,42475,-0.00698495697847753,0.00344947071643391,-0.013745919582688,-0.000223994374267065,0.0428939162229103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00620215551521013,0.00306700869702337,-0.0122134925613759,-0.000190818469044321,0.043178276006901
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00615506789378619,0.0030567463794188,-0.012146290797447,-0.000163844990125341,0.0440715316276263
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCG22,Protein PBMUCL2,40116,-0.0120673917361515,0.00602233358620109,-0.0238711655651056,-0.000263617907197354,0.0451189936740618
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0115745629296891,0.00577749973678809,0.000250663445584434,0.0228984624137937,0.0451616573268574
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,42587,0.00960356747568876,0.00479656065190854,0.000202308597948017,0.0190048263534295,0.0452857338032744
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00717900131892856,0.00359544481459534,-0.0142260731555354,-0.000131929482321685,0.0458832172812812
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJP3,Tight junction protein ZO-3,40136,-0.00885283820726094,0.00444661033975408,-0.0175681944731789,-0.000137481941342941,0.0465146906128978
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00908766495042849,0.00457554608488421,-0.0180557352768015,-0.000119594624055433,0.0470429821695515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM25,RNA-binding protein 25,40080,-0.00992041713595528,0.00501913076430484,-0.0197579134339928,-8.29208379177857e-05,0.0481210045895183
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE,Angiotensin-converting enzyme,40532,-0.00557693967294887,0.00282909548425998,-0.0111219668220984,-3.1912523799308e-05,0.0487161236727571
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.0100397576785823,0.00511358970400068,-0.0200623934984236,-1.71218587409795e-05,0.0496310505868926
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TUBB3,Tubulin beta-3 chain,40136,-0.00579273050191146,0.0029727899672151,-0.011619398837653,3.39378338301329e-05,0.0513706689494292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA9,Carbonic anhydrase 9,42721,-0.00981076228797266,0.00510634830025797,-0.0198192049564783,0.000197680380532967,0.0547164836732485
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.0100969189602592,0.00527774941668577,-0.000247469896444946,0.0204413078169633,0.0557599516198634
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCL2,Phosducin-like protein 2,40080,0.0107305110577493,0.00560964074194119,-0.000264384796455422,0.021725406911954,0.0557909614537152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD70,CD70 antigen,42594,-0.00873482139127115,0.00456821648115522,-0.0176885256943354,0.000218882911793072,0.0558865044632128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0134100605823918,0.00703777057206323,-0.000383969738852149,0.0272040909036357,0.0567447726788898
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRAXIN,Draxin,42495,0.00879267595958461,0.00461924739915914,-0.000261048942767312,0.0178464008619365,0.0569986319391775
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00556148169860998,0.00292200828969057,-0.000165654549183546,0.0112886179464035,0.0570221618976392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLON5,IgLON family member 5,40080,-0.0189718309149847,0.0100207292896359,-0.038612460322671,0.000668798492701732,0.058349996253717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,40199,0.0126963296886081,0.00677200960687989,-0.000576809140876525,0.0259694685180927,0.0608433317274906
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBR1,T-box brain protein 1,40182,0.00959480976340276,0.00513051532700772,-0.000461000277532377,0.0196506198043379,0.0614901934971481
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB5,Integrin beta-5,42679,-0.00732940323108587,0.00391943353601847,-0.0150114929616821,0.000352686499510342,0.0615032521879832
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,40182,0.00712548261511417,0.00382798755433122,-0.000377372991375025,0.0146283382216034,0.0627119391708647
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",42357,0.016545293712029,0.00889047348010357,-0.000880034308974011,0.033970621733032,0.0627645081852882
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0115922866801701,0.00625473505370567,-0.000666994025092982,0.0238515673854332,0.0638574755441499
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP6,Guanylate-binding protein 6,40116,-0.00902068939377014,0.00487449777801267,-0.018574705038675,0.000533326251134688,0.0642557641143877
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX1B,Syntaxin-1B,40182,0.00793631515006062,0.00428988624277632,-0.000471861885780968,0.0163444921859022,0.0643395194312415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MB,Myoglobin,42794,-0.010307617958731,0.00559215849930541,-0.0212682486173696,0.000653012699907628,0.0653176090225582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00898186731546858,0.00487319965817966,-0.0185333386455007,0.000569604014563557,0.0653391403989104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTOA,Otoancorin,40136,-0.0105536069499144,0.00577500907206904,-0.0218726247311698,0.000765410831340865,0.067657625102262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.00863537971690372,0.00472560364410408,-0.0178975628593477,0.000626803425540275,0.0676677273531994
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00415446926480013,0.00227928424464712,-0.000312927854708233,0.00862186638430849,0.0683699838544629
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFD,Complement factor D,40539,0.00402491415228612,0.00220980654907923,-0.000306306683909172,0.00835613498848141,0.0685742882052855
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF3,Neurotrophin-3,42594,0.00687667777745068,0.00378576583139912,-0.000543423252091593,0.0142967788069929,0.069322755304446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHB,Lutropin subunit beta,42346,0.0161305685364143,0.00888714404737198,-0.00128823379643476,0.0335493708692634,0.0695397242091571
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3G,Semaphorin-3G,40283,0.00856265088884619,0.00471914904045686,-0.000686881230449262,0.0178121830081416,0.0696357799666674
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP2,Dipeptidase 2,42587,-0.00563748215563092,0.00311029580855218,-0.0117336619403932,0.00045869762913136,0.0699278311126497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDHB15,Protocadherin beta-15,40451,-0.00768284636005714,0.00425381983525273,-0.0160203332371525,0.000654640517038206,0.0709285982690309
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.0126961460763186,0.00704790391287693,-0.00111774559292016,0.0265100377455574,0.0716616503654197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00702761962038936,0.0039131624243039,-0.000642178731246283,0.014697417972025,0.0725389530230466
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00493627173573489,0.0027587506728582,-0.010343423054537,0.000470879583067184,0.0735910276299547
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,0.00901962080348421,0.00504834174538321,-0.000875129017466881,0.0189143706244353,0.0740163746703073
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOP56,Nucleolar protein 56,40116,0.0211185291262974,0.0118227983816914,-0.00205415570181778,0.0442912139544125,0.0740857592225339
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,40482,-0.0140960866338931,0.00791175044388225,-0.0296031175039023,0.00141094423611616,0.0748308005534835
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00644494618786789,0.00361791142516979,-0.000646160205464894,0.0135360525812007,0.0748740631645707
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,40451,0.0103048712641474,0.0058060645274294,-0.00107501520961418,0.0216847577379091,0.0759503116223707
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAN,Aggrecan core protein,42488,-0.005172992342979,0.00292598701494617,-0.0109079268922735,0.000561942206315495,0.0770925616657674
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,42594,-0.00450303898454194,0.00254745156324516,-0.00949604404850246,0.000489966079418578,0.0771398085935527
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0119960132667008,0.0067963287951631,-0.00132479117181893,0.0253168177052204,0.0775793070342641
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL4,Myosin light chain 4,40223,0.0097143195391337,0.00550688941747936,-0.00107918371912584,0.0205078227973932,0.077754565566332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOH,Beta-2-glycoprotein 1,42611,-0.00676768138107406,0.00383704067436319,-0.0142882811028259,0.00075291834067779,0.0777924054581269
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00493802306059874,0.00279991679802806,-0.000549813863536269,0.0104258599847337,0.0778220460600575
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0224888405932303,0.0127561264657548,-0.00251316727964905,0.0474908484661096,0.0779311809815944
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.0108045483353609,0.00613354890679401,-0.00121720752195538,0.0228263041926772,0.0781734121355145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUOX2,Dual oxidase 2,42357,0.0132535511197003,0.00753858899517276,-0.00152208331083834,0.0280291855502389,0.0787546864025127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00803111919175043,0.00458879150596247,-0.0170251505434369,0.000962912159936017,0.0801183228898799
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00893264386739733,0.00511843912130657,-0.00109949681036355,0.0189647845451582,0.0809753025086053
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0136905614400955,0.00787015017630137,-0.0291160557856462,0.00173493290545519,0.0819653048984114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELENOP,Selenoprotein P,40539,-0.0042066154645066,0.00242592593896651,-0.00896143030488096,0.000548199375867751,0.0829408679398314
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL33,Interleukin-33,42370,0.00706745894588797,0.00409048368121539,-0.000949889069294202,0.0150848069610701,0.0840509723304306
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00762159207600864,0.00441556777754443,-0.0162761049199957,0.00103292076797844,0.0843573415712518
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00948640615482268,0.00550304462098877,-0.0202723736119607,0.00129956130231531,0.0847639249113137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0126864020834515,0.00740270590233257,-0.00182290148512032,0.0271957056520234,0.0865970689417841
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00660474730820744,0.00385410025186996,-0.0141587838018726,0.000949289185457668,0.0866132000703777
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00905837046408706,0.00530290223258463,-0.0194520588399529,0.00133531791177881,0.0876288642601472
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,0.00687559725853363,0.00403541214614263,-0.00103381054790593,0.0147850050649732,0.0884387409070583
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00737358847277629,0.00433457398715898,-0.00112217654205531,0.0158693534876079,0.0889451359764269
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,42635,0.00674375265560889,0.00396501808320213,-0.00102768278746728,0.0145151880986851,0.0890013169457499
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0088342760437427,0.00519618202424371,-0.0190187928112604,0.00135024072377497,0.0891262674359557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX101,Testis-expressed protein 101,40182,0.00948113032610077,0.00559531681955747,-0.00148569064023187,0.0204479512924334,0.0902031971201475
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH7B,Myosin-7B,40080,-0.0080173114650947,0.00474304082412069,-0.0173136714803713,0.00127904855018185,0.0909931755495214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00651010814847303,0.00386536222959564,-0.00106600182153442,0.0140862181184805,0.0921634558783946
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP1,Retinol-binding protein 1,40182,0.0121652821791169,0.00722624410857426,-0.00199815627368862,0.0263287206319225,0.0923094162878735
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,42679,-0.0050116570127952,0.00298168475987299,-0.0108557591421462,0.000832445116555857,0.092822238605419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00795192989677168,0.00474532098924187,-0.00134889924214239,0.0172527590356858,0.0938126224072884
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.00971429006931289,0.0058013758712492,-0.0210849867769613,0.00165640663833553,0.0940648053767983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYAL1,Hyaluronidase-1,42544,0.00408190562423645,0.00244409805096828,-0.000708526555661375,0.00887233780413428,0.094921609377705
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00484043940671462,0.00290217288588595,-0.000847819449621846,0.0105286982630511,0.0953652801466062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00633702788523253,0.00380813416917036,-0.00112691508634138,0.0138009708568064,0.0961208967213031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAPPA,Pappalysin-1,42370,0.00819639986591,0.00493139628560922,-0.00146913685388408,0.0178619365857041,0.0965195175062018
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00569598108334907,0.00343121635815247,-0.00102920297862977,0.0124211651453279,0.0969327352010075
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,40451,0.00778021958181032,0.00470172263618632,-0.00143515678511487,0.0169955959487355,0.0980011965571841
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00697471176195645,0.00421564302239686,-0.00128794856194139,0.0152373720858543,0.0980571159094637
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,42346,0.0128488598844172,0.0078012397281066,-0.00244156998267169,0.0281392897515062,0.0995761910623771
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RYR1,Ryanodine receptor 1,40116,-0.00600076585252989,0.00364425399883152,-0.0131435036902397,0.00114197198517989,0.0996613159136801
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00552005484631556,0.00335249369235532,-0.012090942483332,0.00105083279070087,0.0996787820745749
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.0105097497717121,0.00639973208396456,-0.00203372511285848,0.0230532246562826,0.100573746089474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,42711,-0.0220254368642455,0.0134195734570238,-0.0483278008400121,0.00427692711152103,0.100760107022704
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDNRB,Endothelin receptor type B,40199,0.00771418334980754,0.00470560732461314,-0.00150880700643421,0.0169371737060493,0.101166937589685
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.00889319692324879,0.00544609961559466,-0.00178115832331675,0.0195675521698143,0.102508875521275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSHB,Follitropin subunit beta,40223,-0.00930451356760247,0.00571505599964086,-0.0205060233268986,0.00189699619169362,0.103538519916178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00705715876908097,0.00435314050404156,-0.0014749966188405,0.0155893141570024,0.105005616284713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBN,Ameloblastin,42370,-0.00489112387117629,0.00302379845590406,-0.0108177688447483,0.00103552110239568,0.105785070018358
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00585339748868368,0.00362720589881029,-0.0012559260729845,0.0129627210503519,0.106610928943249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITM2A,Integral membrane protein 2A,42594,-0.0105043314622929,0.00651331209193263,-0.0232704231624809,0.00226176023789501,0.106822802431349
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP73,Tumor protein p73,40182,0.00588396260619757,0.003655790850498,-0.00128138746077851,0.0130493126731737,0.107537739920245
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.0132138365041635,0.00821759398099075,-0.00289264769857836,0.0293203207069054,0.107865634085168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,40116,-0.00846590723166927,0.0052776606179452,-0.0188101220428419,0.00187830757950333,0.108720431447582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP9,Matrix metalloproteinase-9,42594,0.0101371123702871,0.00632786352552138,-0.0022655001397348,0.022539724880309,0.109183548662936
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELB,Transcription factor RelB,40199,0.00838781894416841,0.00524407023688036,-0.00189055872011709,0.0186661966084539,0.109741277638939
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2B,Alpha-amylase 2B,41779,-0.00847049338668955,0.00529674394456942,-0.0188521115180456,0.00191112474466651,0.109803769597028
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY6D,Lymphocyte antigen 6D,42548,0.00688100618374169,0.00430535921857383,-0.00155749788466301,0.0153195102521464,0.110012775547893
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42547,0.00470417879117265,0.0029628346888448,-0.00110297719896316,0.0105113347813085,0.112371291332362
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLNL,Mesothelin-like protein,40182,-0.00659649815911676,0.00416233181257863,-0.0147546685117709,0.00156167219353735,0.113038664776274
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.0109264051865,0.00691956091012733,-0.00263593419734954,0.0244887445703496,0.114346297761949
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A3,Protein S100-A3,40451,0.00724860119229997,0.00459544476366649,-0.00175847054448635,0.0162556729290863,0.114744293774588
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPS,Calcyphosin,40483,0.0172303000353267,0.0109315174021606,-0.00419547407290802,0.0386560741435614,0.115006847484898
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,40080,0.0146549393372757,0.00931246298707831,-0.00359748811739781,0.0329073667919492,0.115587960302219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00308048011501052,0.00197439921031082,-0.00078934233719869,0.00695030256721973,0.118737830303605
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42611,0.00603511214579692,0.00387023880516311,-0.00155055591232277,0.0136207802039166,0.118933771329286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM19,Probable RNA-binding protein 19,40116,-0.00793497987500345,0.005101549166608,-0.0179340162415551,0.00206405649154823,0.119878394456089
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00426030139080254,0.0027543890019903,-0.00113830105309846,0.00965890383470353,0.121951568929082
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.0104515006872108,0.00676882552233005,-0.00281539733655612,0.0237183987109777,0.122601865272007
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX2,Transcription factor SOX-2,40461,0.00389151802280515,0.00252772912191598,-0.00106283105615017,0.00884586710176046,0.123702732389004
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRC1,Macrophage mannose receptor 1,40532,0.00473601359600653,0.00307784135038935,-0.00129655545075659,0.0107685826427696,0.123894419363192
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00764673690453803,0.00498093888931189,-0.00211590331851327,0.0174093771275893,0.124763479247722
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.00978121747364904,0.00637360344011014,-0.00271104526896683,0.0222734802162649,0.12490006332231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00383469947787133,0.00250714537820938,-0.00874870441916171,0.00107930546341906,0.126166522483426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0124974778167154,0.00819627410143053,-0.00356721942208847,0.0285621750555192,0.127339131067407
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0119684290833259,0.0078603718208428,-0.0273747578521778,0.00343789968552594,0.127880479875627
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,40182,0.00793020479367543,0.005209532958875,-0.00228047980571957,0.0181408893930704,0.127975552063723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO6,Coronin-6,40136,-0.00598492534624578,0.00393271879476909,-0.0136930541839932,0.00172320349150163,0.128080840098973
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00687067260711575,0.00452723233457579,-0.00200270276865281,0.0157440479828843,0.129135967002996
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00855750883869268,0.00566248306809713,-0.00254095797477769,0.0196559756521631,0.130749823320021
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L,Seizure 6-like protein,42679,-0.00446897584117426,0.00295859895317855,-0.0102678297894042,0.00132987810705569,0.130938275379415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,42676,0.0034836489315677,0.00230905118883959,-0.00104209139855789,0.00800938926169329,0.131400736038746
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0101208328401782,0.00671248006453433,-0.0232772937666655,0.00303562808630905,0.131643577586702
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB5,Serpin B5,42357,0.00770681819164475,0.00513159850784463,-0.00235111488373073,0.0177647512670202,0.133163515481139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARTN,Artemin,42370,0.00708639095730751,0.00471878676041471,-0.00216243109310532,0.0163352130077203,0.133188225704781
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.00969513629558179,0.00646584183205722,-0.0223681862864139,0.00297791369525036,0.133783813311558
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA1,Laminin subunit alpha-1,40116,-0.00852649056122049,0.00569685449915071,-0.0196923253795559,0.0026393442571149,0.134499846492651
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QL2,Complement C1q-like protein 2,40199,0.00689316065338503,0.00465103805920711,-0.0022228739426609,0.016009195249431,0.13835049279014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00685172096787675,0.00463678457429452,-0.0022363767977405,0.015939818733494,0.139519286566204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00419692607878898,0.00284425726678767,-0.00137781816411486,0.00977167032169282,0.140085888233451
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.00673330251072104,0.00456342702695677,-0.0156776194835563,0.00221101446211422,0.140108565981259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.00992214296663966,0.00672881730722654,-0.00326633895552435,0.0231106248888037,0.140354917767185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,42311,0.00903041912247266,0.00612989707929131,-0.00298417915293831,0.0210450173978836,0.140727497944557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.0056223833397311,0.00381672521384312,-0.00185839807940141,0.0131031647588636,0.140750403004821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",42357,-0.00680659556741973,0.00463373089246234,-0.0158887081166459,0.00227551698180645,0.141877474070442
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMCH,Pro-MCH,40116,-0.0130989293631148,0.00895354716874442,-0.0306478818138538,0.00445002308762431,0.143499520322349
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MELTF,Melanotransferrin,40511,0.00465149260485196,0.00318354506898748,-0.00158825573036351,0.0108912409400674,0.144014478423682
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00750467685031296,0.00513777278361406,-0.0175747115061965,0.00256535780557059,0.144130180101265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,40136,-0.00932249208997793,0.00638360791370933,-0.0218343636008482,0.00318937942089236,0.144214430496839
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00730196696149724,0.00504072798445554,-0.0171817938110301,0.00257785988803562,0.147479874795143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00620093100263086,0.00428178871848055,-0.00219137488559102,0.0145932368908527,0.147586438147186
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00611525418182905,0.00422266095422609,-0.00216116128845409,0.0143916696521122,0.14758988321226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,40199,0.0112343237867983,0.0077694920135247,-0.00399388055971015,0.0264625281333067,0.148218735600365
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00445496448683575,0.00308893704699141,-0.00159935212526741,0.0105092810989389,0.149261433534982
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_DRA,,42549,-0.00556739324174124,0.00389737651681404,-0.0132062512146968,0.00207146473121428,0.153172053147506
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00570399007289092,0.00401135522747852,-0.00215826617296699,0.0135662463187488,0.155066014075634
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,0.00525101565552847,0.00369309947651493,-0.00198745931844081,0.0124894906294977,0.155094330345742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0132033949849693,0.00929636602656547,-0.00501748242709905,0.0314242723970376,0.155556220423803
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0170352973326431,0.012027468111613,-0.00653854016611843,0.0406091348314046,0.156692002746151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHPK,Sedoheptulokinase,40302,-0.00612951515386871,0.00434001798210051,-0.0146359503987857,0.00237692009104828,0.157882353352696
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.00857769144269065,0.00609481670529722,-0.00336814929969189,0.0205235321850732,0.159339601489737
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,40199,0.00320050737371772,0.00228102529341581,-0.00127030220137727,0.0076713169488127,0.160615130938538
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL21R,Interleukin-21 receptor,40199,0.00828432191487921,0.00590604850324295,-0.00329153315147697,0.0198601769812354,0.160739189947072
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA10,Annexin A10,42311,0.0127223309238472,0.00909416328977364,-0.0051022291241091,0.0305468909718036,0.161849933756338
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBX2,Chromobox protein homolog 2,40116,-0.00592131583230852,0.00424113314064944,-0.0142339367879814,0.00239130512336438,0.162693602097869
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD27,CD27 antigen,42679,0.00651323774551592,0.00466660518994935,-0.00263330842678479,0.0156597839178166,0.162824161768764
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC2,Mucin-2,40527,0.0136801178600297,0.00980717166643039,-0.00554193860617387,0.0329021743262332,0.163070440324152
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,40116,0.0105324083574937,0.00756455029143658,-0.00429411021372202,0.0253589269287094,0.16384851420104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.00931712140043773,0.00670476161745814,-0.0224584541706557,0.00382421136978023,0.164670162743027
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00488717222734242,0.00353105845161918,-0.00203370233783117,0.011808046792516,0.166365676330742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,40483,-0.00457602234857877,0.00331131458781928,-0.0110661989407046,0.00191415424354702,0.167018927687613
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO6,Unconventional myosin-VI,40482,0.00530047698264487,0.0038393685587601,-0.00222468539252493,0.0128256393578147,0.167441758974652
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN7,Tetraspanin-7,40136,-0.0136836409683151,0.00996210769885202,-0.033209372058065,0.0058420901214349,0.169603708906762
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS2,Podocin,40199,-0.0151738503054731,0.0110867934847472,-0.0369039655355775,0.00655626492463135,0.171139170839221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.00870474647351348,0.00637717638560563,-0.00379451924227355,0.0212040121893005,0.172280874501241
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00434011362954179,0.0031858187180427,-0.00190409105782191,0.0105843183169055,0.173118965367517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,40449,0.00718657922267467,0.00528020250523084,-0.00316261768757777,0.0175357761329271,0.173527556287967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,42754,0.00871604672304059,0.00640859315288585,-0.00384479585661568,0.0212768893026969,0.17383475678693
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH3,Neurexophilin-3,40199,0.00439845459505691,0.00324330507102946,-0.00195842334416084,0.0107553325342747,0.175074717263874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,42346,0.0046329504870937,0.00342662330770833,-0.00208323119601462,0.011349132170202,0.176384021923792
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTF,Ciliary neurotrophic factor,40136,-0.00490963755651012,0.00363260122904021,-0.0120295359654289,0.00221026085240868,0.176547662742122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA2,Adenosine deaminase 2,42572,0.00631305725578305,0.00467580588810636,-0.00285152228490542,0.0154776367964715,0.176989483863432
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD82,CD82 antigen,40302,-0.00583079962500901,0.00432863084831203,-0.0143149160877006,0.00265331683768256,0.177997751201713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.0111528979686182,0.00829182957065357,-0.0274048839270992,0.00509908798986282,0.178638031431512
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00817693781969367,0.00608200768061429,-0.0200976728736977,0.00374379723431033,0.178831709740795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NINJ1,Ninjurin-1,42346,0.00763720362312527,0.00569410034605575,-0.003523233055144,0.0187976403013945,0.179862940591391
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDSN,Corneodesmosin,42710,-0.00629306820831904,0.0046958920859989,-0.0154970166968769,0.0029108802802388,0.180228218185527
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF3,Trefoil factor 3,42613,0.00607091998707051,0.00453851094230344,-0.00282456145984423,0.0149664014339853,0.181034604824725
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBN2,Fibrillin-2,40182,0.00858943833265504,0.00643907136188403,-0.00403114153663765,0.0212100182019477,0.182245900957724
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.00441458680416143,0.00331231325900071,-0.00207754718347997,0.0109067207918028,0.182626146200174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,42357,0.00853967760640056,0.00643486421120812,-0.00407265624756737,0.0211520114603685,0.184500201272047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,42511,-0.00470100680978982,0.00354518230163868,-0.0116495641210016,0.002247550501422,0.184853557127383
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH4,Myosin-4,40116,-0.0063249625737831,0.00479137591801675,-0.0157160593730959,0.00306613422552972,0.186838548636941
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00378096091682694,0.00288804606753952,-0.00187960937555053,0.00944153120920441,0.190496820996182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00931031841359082,0.00713698339209708,-0.00467816903491945,0.0232988058621011,0.192084581834653
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0124864562598449,0.00960159760793318,-0.0063326750517041,0.031305587571394,0.19347207918411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRAS,GTPase Hras,40286,0.0136287395891946,0.0105318730476793,-0.00701373158425675,0.0342712107626459,0.19567610076306
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,H2AP,Huntingtin-interacting protein M,40080,-0.00719624478388,0.00556974579195351,-0.0181129465361089,0.00372045696834888,0.196376288830004
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF9,Fibroblast growth factor 9,40065,0.00559096652525131,0.00435745163697398,-0.00294963868321769,0.0141315717337203,0.199490801572057
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00689462237834279,0.00537841821768746,-0.0174363220850102,0.00364707732832463,0.199903107522212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLINT1,Clathrin interactor 1,40080,0.00625514980144529,0.00488474242553243,-0.00331894535259827,0.0158292449554888,0.200379566344449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL1,Delta-like protein 1,42679,-0.00424425621093805,0.00331655143213874,-0.01074469701793,0.00225618459605389,0.200665748969245
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD7,FERM domain-containing protein 7,40182,0.00451377138677472,0.00353944606350133,-0.00242354289768789,0.0114510856712373,0.202238454507385
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC4A1,Band 3 anion transport protein,40527,0.00629639428971991,0.0049475330771183,-0.00340077054143196,0.0159935591208718,0.203174380021951
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",40116,-0.0053475571290666,0.00420901641232739,-0.0135972292972283,0.00290211503909508,0.203933494759599
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00426568294667088,0.00336139560483918,-0.0108540183321557,0.00232265243881392,0.20445589013311
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00853135764901479,0.00672530901540483,-0.00465024802117867,0.0217129633192083,0.204629947053682
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,40302,0.0107050796136946,0.00844312093629468,-0.00584343742144299,0.0272535966488322,0.204858268971534
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1A,Interleukin-1 alpha,42370,0.00779745412516281,0.00615350933991096,-0.00426342418106266,0.0198583324313883,0.205122036345881
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLMP,CXADR-like membrane protein,42721,0.00292942557046932,0.00231368744851676,-0.00160540182862352,0.00746425296956217,0.205488891749418
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00801116491051203,0.00632945132160347,-0.0204168895008548,0.00439455967983078,0.205648730335222
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00547241293216719,0.00433435866948181,-0.0139677559243515,0.00302293006001715,0.206772066595039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHH,Sonic hedgehog protein,40199,-0.00561786470255811,0.00445862481855799,-0.0143567693469318,0.00312103994181556,0.20769628809231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GKN1,Gastrokine-1,42017,0.00372144342414806,0.00296051884281531,-0.00208117350776994,0.00952406035606606,0.208767817683912
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,40199,0.0117573980945138,0.00935373011081456,-0.00657591292268268,0.0300907091117104,0.208789628895042
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,40136,0.0148253024295273,0.0118386141784952,-0.00837838136032337,0.0380289862193779,0.210493306551303
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,42474,-0.00379515374434133,0.00303207273772966,-0.00973801631029146,0.0021477088216088,0.210712271093938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,0.00408069880051719,0.00326212785818209,-0.00231307180151971,0.0104744694025541,0.21098543863847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPN3,Calpain-3,40451,-0.00503881250888482,0.00403740573030005,-0.0129521277402729,0.00287450272250327,0.212045209919067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL1,Follistatin-related protein 1,40223,-0.00297406548398085,0.00239014964748394,-0.00765875879304937,0.00171062782508766,0.213415262882215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0166323546931816,0.0133866491475454,-0.00960547763600728,0.0428701870223705,0.214089631863588
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00414075437539503,0.00333560931751364,-0.0106785486377218,0.00239703988693169,0.214492629627192
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.0049139127589449,0.0039760188211197,-0.00287908413044971,0.0127069096483395,0.216525913813009
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,42114,-0.00636529176330529,0.00516185964586918,-0.0164825366692089,0.0037519531425983,0.217546248775736
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLI2,Zinc finger protein GLI2,40199,-0.00417684676025829,0.003387354079489,-0.0108160607560567,0.00246236723554014,0.217575759564739
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,40182,0.0133849968120135,0.0108795175329804,-0.00793885755262805,0.034708851176655,0.218613654869507
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOM,Apolipoprotein M,42663,0.00365196807645357,0.00296929497408765,-0.00216785007275823,0.00947178622566537,0.218751976311069
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42674,-0.00313937870157743,0.00255563247924666,-0.00814841836090088,0.00186966095774601,0.219312456222717
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.00792887360770395,0.00650668482141633,-0.00482422864227206,0.02068197585768,0.223027729827434
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH17,Cadherin-17,42636,0.0089225695368174,0.00732449596446419,-0.00543344255353241,0.0232785816271672,0.223176178768893
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,42594,0.00622237715780837,0.00512849152903752,-0.00382946623910517,0.0162742205547219,0.225038140069328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGB,Secretogranin-1,42664,-0.0054631355760347,0.00452774021506665,-0.0143375063975653,0.00341123524549593,0.227610460543864
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR2,Toll-like receptor 2,40302,0.0029629007296722,0.0024745004875431,-0.00188712022591229,0.00781292168525668,0.231186650008752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,42292,0.00709574923869215,0.00593111737035175,-0.00452924080719728,0.0187207392845816,0.23157791286819
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.0106905258351805,0.00894400594305745,-0.0282207774835731,0.00683972581321212,0.232006553159213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,40136,0.0105621340252873,0.00888450275056567,-0.00685149136582137,0.0279757594163961,0.234533671030826
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00925906629409504,0.00782545719507579,-0.0245969623964436,0.00607882980825351,0.236755957214904
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.0067962160340253,0.00575609869338614,-0.0180781694730621,0.00448573740501154,0.237747919474938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.00611738874194776,0.00518378354162264,-0.0162776044835281,0.00404282699963262,0.237980857652889
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00960832345902213,0.00814788322764779,-0.00636152766716753,0.0255781745852118,0.238327488518088
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.00510024553667357,0.00433204471890052,-0.0135910531857186,0.00339056211237145,0.239084593458755
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,40116,0.00414864493045816,0.00353046638607831,-0.00277106918625533,0.0110683590471717,0.239981020928445
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAG,S-arrestin,40136,-0.00649771795400704,0.00553833135170232,-0.0173528474033436,0.0043574114953295,0.240730464757232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00350980372754532,0.00299875735495596,-0.009387368143259,0.00236776068816837,0.241852874388227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00740970276371014,0.00633591008032357,-0.0198280865211443,0.00500868099372406,0.242236918489641
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERVV_1,,40116,-0.00537462020337238,0.00461133180289953,-0.0144128305370555,0.0036635901303107,0.243832200696125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00456951544558013,0.00392401652930301,-0.012260587843014,0.00312155695185376,0.244246911448671
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH22,Cadherin-22,40302,-0.00345390284443577,0.00296982969412927,-0.00927476904492914,0.00236696335605761,0.244855727453788
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0173340359925681,0.014983086892626,-0.0467008863021151,0.0120328143169789,0.247334800528894
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1B,Lithostathine-1-beta,42794,0.00713826836926825,0.00617037705663374,-0.00495567066173387,0.0192322074002704,0.247349487349251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,42679,-0.00356654866124856,0.00308551997028269,-0.00961416780300264,0.00248107048050551,0.247743054705646
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTKN2,Rhotekin-2,40116,-0.00630255657291626,0.00545262524474549,-0.0169897020526174,0.00438458890678491,0.247757320828821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00330062433542077,0.002870820651064,-0.00232618414066468,0.00892743281150622,0.250285701179406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,40080,0.00764816655499228,0.00667665427517455,-0.00543807582434983,0.0207344089343344,0.2520236135303
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C8B,Complement component C8 beta chain,40539,0.00364046407462619,0.00320058154064516,-0.00263267574503832,0.0099136038942907,0.255379119440672
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,42240,0.00483979455807836,0.00425677562832318,-0.00350348567343507,0.0131830747895918,0.255574815738528
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCN,Decorin,42357,-0.00287336536547083,0.00253411363996528,-0.00784022809980279,0.00209349736886112,0.256868088202491
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,40080,0.00408656268854527,0.00361329591331475,-0.00299549730155163,0.0111686226786422,0.258088741958092
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5,Interleukin-5,42370,0.0165475001366232,0.0147144997434659,-0.01229291936057,0.0453879196338164,0.260791341608871
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00516455053792918,0.00459289377413044,-0.0141666223352248,0.00383752125936648,0.260840129166445
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRC,Chymotrypsin-C,42626,0.00783755060145602,0.00697898740897061,-0.00584126472012638,0.0215163659230384,0.261448575825774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY96,Lymphocyte antigen 96,42495,0.00422318332349364,0.00376205207693079,-0.0031504387472907,0.011596805394278,0.261638559130223
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20,Interleukin-20,42370,-0.00581115916799444,0.0051901846997164,-0.0159839211794386,0.00436160284344971,0.262885906062745
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00335951332090386,0.00300122531784322,-0.00252288830206885,0.00924191494387658,0.26300224503829
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00567967275202499,0.00509525689271332,-0.0156663762617431,0.00430703075769312,0.265004378618678
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,40080,-0.0049665051895363,0.00445651502866707,-0.0137012746457238,0.00376826426665115,0.265116365811587
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00399212163139274,0.0035861965135581,-0.0110210667979666,0.00303682353518114,0.265650911969815
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.00726810397799771,0.00655537424518841,-0.00558042954257157,0.020116637498567,0.267573281831336
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,40136,0.0113552120535116,0.0103051561611698,-0.00884289402238132,0.0315533181294044,0.270531052599951
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,40116,-0.00403591994886588,0.00366804980228857,-0.0112252975613515,0.00315345766361972,0.27122986740991
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,40482,0.00417904848905352,0.00381174349313813,-0.00329196875749722,0.0116500657356043,0.272944031724442
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,0.00504706519111436,0.00461254092664051,-0.00399351502510103,0.0140876454073298,0.273884766262791
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB7,Integrin beta-7,42721,0.00530611274410467,0.00485508701675664,-0.00420985780873834,0.0148220832969477,0.274458243388058
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAL,Galanin peptides,42676,-0.0073721562938635,0.00677269196404226,-0.0206466325433863,0.00590231995565932,0.276388611170729
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00565227043074767,0.00519566225431726,-0.0158357684492095,0.00453122758771416,0.276666443183065
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00452100869985909,0.00416377061146081,-0.0126819990983223,0.0036399816986041,0.277592041237691
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUCL3,Mucin-like protein 3,40080,-0.00488117758178608,0.00450180078178745,-0.0137047071140895,0.00394235195051732,0.278268125982434
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00419987174779898,0.00389312005979882,-0.00343064356940672,0.0118303870650047,0.280703317141079
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00613982610386807,0.00571173599436455,-0.00505517644508644,0.0173348286528226,0.282420815911053
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.00476772377106569,0.00445780683741413,-0.00396957763026601,0.0135050251723974,0.28485353877558
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00339791920666426,0.003189959295594,-0.0096502394260285,0.00285440101269998,0.28681254509413
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.0046882086695305,0.00443079708993528,-0.0133725709658037,0.00399615362674265,0.290035036628052
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD10,Frizzled-10,40182,0.00676826939603641,0.00641684519229297,-0.00580874718085781,0.0193452859729306,0.29155560229874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,40182,0.00579615706797969,0.00551082753332229,-0.00500506489733199,0.0165973790332914,0.292925384845993
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX1,Neuronal pentraxin-1,42611,-0.00443441991216009,0.00422223283567725,-0.0127099962700875,0.00384115644576733,0.293619939275431
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD2,Bromodomain-containing protein 2,40136,0.0039622338992782,0.00377977109052459,-0.00344611743815,0.0113705852367064,0.294535765281646
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,40199,0.00784401807507395,0.00749409768269812,-0.00684441338301436,0.0225324495331623,0.295264274272514
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",40136,0.00946015159499447,0.00904749876231867,-0.00827294597915012,0.0271932491691391,0.295764411101144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00659632034901136,0.00631355478458046,-0.00577824702876634,0.0189708877267891,0.296140582281087
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MN1,Transcriptional activator MN1,40182,-0.00652258767714416,0.00627015276371439,-0.0188120870940244,0.00576691173973605,0.298242117589953
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBZ,Hemoglobin subunit zeta,40511,0.0116521584863356,0.0112192167312164,-0.0103375063068485,0.0336418232795198,0.299017971800957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.00518356376698026,0.00500306352609169,-0.00462244074415944,0.01498956827812,0.300188335446535
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.003974645625015,0.00383635766853649,-0.00354461540531651,0.0114939066553465,0.300203165292483
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00444633638746256,0.00431374424770691,-0.0129012751129681,0.00400860233804298,0.302686189375085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00581948868481468,0.00566420124956114,-0.00528234576432515,0.0169213231339545,0.304247523304983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPA33,Cell surface A33 antigen,42587,0.0149539739764564,0.0146377581076504,-0.0137360319145385,0.0436439798674513,0.306987406864857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00329940933775266,0.00324004653029675,-0.00305108186162897,0.00964990053713428,0.308543882498807
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD177,CD177 antigen,42595,-0.0141307451684352,0.0138868031500012,-0.0413488793424374,0.0130873890055671,0.308902401947839
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,40136,0.00796218764980115,0.00783419064478993,-0.00739282601398711,0.0233172013135894,0.30949080919528
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00496059499642468,0.00490259043688665,-0.0145696722527225,0.00464848225987315,0.311636780189213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.00366646867936615,0.00363003353457732,-0.0107813344071377,0.0034483970484054,0.312495712231703
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,40511,-0.00386794215060735,0.00385134669281897,-0.0114165816685325,0.00368069736731783,0.315251168948496
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBQLN3,Ubiquilin-3,40116,0.00571415217652933,0.0057323471006891,-0.00552124814082131,0.01694955249388,0.318871097684914
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALLD,Palladin,40199,-0.00409243642601804,0.00411372649103358,-0.0121553403484439,0.00397046749640778,0.319843438695881
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GJA8,Gap junction alpha-8 protein,40080,0.00684065942897095,0.00690080338091013,-0.00668491519761291,0.0203662340555548,0.321568712051299
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00358730351047979,0.00364239835668492,-0.00355179726862265,0.0107264042895822,0.324703476917067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,40182,-0.00742576458132118,0.00754150318212772,-0.0222071108182915,0.00735558165564915,0.324816171589165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.00392478739389224,0.00400085841180403,-0.00391689509324365,0.0117664698810281,0.326617163776586
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS53,Serine protease 53,40483,0.00385754293184393,0.00393930492741085,-0.00386349472588133,0.0115785805895692,0.327480139150618
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",40483,-0.00618276327800233,0.0063455431329453,-0.0186200278185751,0.00625450126257046,0.329904967783289
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4,Interleukin-4,42370,0.00959124717846817,0.00988692310349254,-0.00978712210437722,0.0289696164613136,0.332017325700313
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.0146699598967492,0.0151541321624606,-0.0150321391416735,0.044372058935172,0.33304083100161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN4,Nectin-4,42679,-0.00351243086207111,0.00363938011071363,-0.0106456158790698,0.0036207541549276,0.334503073153669
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABO,Histo-blood group ABO system transferase,40532,-0.0146469031984883,0.0153136716770683,-0.0446616996855422,0.0153678932885656,0.338860646589645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,40449,0.00306151194124025,0.00320397180190795,-0.00321827279049934,0.00934129667297983,0.339326988438568
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,42311,0.00326130983418527,0.00341478263559205,-0.00343166413157515,0.00995428379994569,0.339566802363751
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00328595329653357,0.00344163832529962,-0.00345965782105368,0.0100315644141208,0.339718051460428
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00774978423891077,0.00823610894118857,-0.00839298928581884,0.0238925577636404,0.346750164177906
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00450814350827476,0.00480759526215905,-0.00491474320555697,0.0139310302221065,0.348409300363555
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,40483,0.00279545224766401,0.00298726072420838,-0.00305957877178442,0.00865048326711244,0.349400729018439
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL2,Interferon lambda-2,40136,0.00611566700670476,0.00654361863084783,-0.00670982550975698,0.0189411595231665,0.350015021645356
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.00384096902258156,0.00412519765788174,-0.00424441838686665,0.0119263564320298,0.351822733978645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,40223,-0.00419126349857807,0.00451820789431097,-0.0130469509714276,0.00466442397427144,0.353615430352493
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,42311,0.00392960550461074,0.00425969415217289,-0.00441939503364814,0.0122786060428696,0.356280189914212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,40116,-0.00461385229300416,0.00504038929874383,-0.0144930153185421,0.00526531073253374,0.360014388700106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00543342384930724,0.0059394013519856,-0.00620780280058453,0.017074650499199,0.360311533978684
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPLX2,Complexin-2,40080,-0.00306493972460635,0.00335800687183702,-0.00964663319340691,0.00351675374419421,0.361406950007504
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKIV2L,Helicase SKI2W,40116,-0.00383054244107795,0.00420700953551395,-0.0120762811306853,0.00441519624852938,0.362571424823446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00538428137106352,0.00591686030039639,-0.0169813275598404,0.0062127648177134,0.362847951943794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,40451,-0.00399026941132424,0.00443259311049396,-0.0126781519078924,0.00469761308524393,0.368027190295831
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00379282227662834,0.00423544981714369,-0.00450865936497329,0.01209430391823,0.370542357682564
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,42311,-0.006246131144247,0.00706103898405694,-0.0200857675529986,0.00759350526450461,0.376393506513635
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NENF,Neudesin,40451,0.0102528639064785,0.0116226518283284,-0.0125275336770452,0.0330332614900022,0.377717249361957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.0026393486988528,0.0030049279794588,-0.00852900753859204,0.00325031014088645,0.379777800895601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00365690303068751,0.00416550977861238,-0.00450749613539276,0.0118213021967678,0.380017040115305
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNPO1,Transportin-1,40302,0.00328006362646957,0.00374462269806259,-0.00405939686173311,0.0106195241146722,0.381081764891693
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGN,Cingulin,40182,0.00381356149527709,0.00435815023967674,-0.00472841297448931,0.0123555359650435,0.381570555060334
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,42315,0.00267573869490304,0.00306651343278465,-0.00333462763335486,0.00868610502316095,0.382915053508429
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.0053597550400097,0.00620867905911864,-0.00680925591586284,0.0175287659958822,0.388009056293911
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00353885005122012,0.00413963220569523,-0.0116525291743828,0.00457482907194252,0.392641514657735
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,40083,-0.00792601437937675,0.00928612434624482,-0.0261268180980166,0.0102747893392631,0.393382522390752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13,Interleukin-13,42370,-0.00425642039377025,0.00501201249348008,-0.0140799648809912,0.00556712409345069,0.395761090760471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42660,0.00472620326511391,0.00557407823598481,-0.00619899007741632,0.0156513966076441,0.396514497238988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.00357272454146261,0.00422451166739165,-0.0118527674095502,0.00470731832662501,0.397731382196392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSND,Barttin,40080,0.00305068628246702,0.00361035731450994,-0.00402561405397246,0.0101269866189065,0.398139561681242
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF20,Fibroblast growth factor 20,40199,-0.00401566322036055,0.00476346486783042,-0.0133520543613082,0.00532072792058708,0.399239446469579
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00319452742784124,0.00383098822529118,-0.0107032643494119,0.00431420949372946,0.404375234619133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK12,Kallikrein-12,42346,0.012277536259851,0.0147315019798285,-0.016596207620613,0.0411512801403149,0.404622732373277
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN4,Alpha-actinin-4,42370,0.00287326958143677,0.00345586983646828,-0.00390023529804106,0.0096467744609146,0.405753059079963
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAX,Integrin alpha-X,40302,0.00477980953052569,0.00575163940114723,-0.00649340369572287,0.0160530227567743,0.405972124206827
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17F,Interleukin-17F,42370,0.00656824388163837,0.00797767107287968,-0.00906799142120579,0.0222044791844825,0.410336117452291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC5D,Netrin receptor UNC5D,40199,-0.00225762689139068,0.00276145839228675,-0.00767008534027271,0.00315483155749135,0.413632593895602
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00822947304494858,0.0101070930735476,-0.0115804293792047,0.0280393754691019,0.415532390340737
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.0147714496821551,0.0181498585168637,-0.0503451723752079,0.0208022730108978,0.415739620118533
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD2,Glutamate decarboxylase 2,40199,-0.0039609995672245,0.00486716375682131,-0.0135006405305943,0.00557864139614526,0.415765170488681
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA5,Annexin A5,42261,0.00261652236381083,0.00323453389497895,-0.00372316407034792,0.00895620879796958,0.418568208396439
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSTN,Osteocrin,40182,-0.00357608368566234,0.00442410097210642,-0.0122473215909909,0.00509515421966624,0.418924621733738
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,42311,0.00419707088706607,0.00519502162344989,-0.0059851714948957,0.0143793132690278,0.419161370542326
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00686460347239224,0.00851483470592414,-0.0235536794960036,0.00982447255121907,0.420148607199548
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.00353017990853908,0.004392203331292,-0.0121388984378714,0.00507853862079325,0.421562749626639
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPO,Lactoperoxidase,42134,0.00510203787088021,0.00641159236500071,-0.00746468316452119,0.0176687589062816,0.426190754502753
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL6B,Myosin light chain 6B,40182,0.00760870693969681,0.00961914737447587,-0.0112448219142759,0.0264622357936695,0.428963407713128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00580860891048395,0.00741678559081446,-0.0087282908475124,0.0203455086684803,0.433543848419721
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENG,Endoglin,42794,-0.00141976444498403,0.00183204825457902,-0.0050105790239589,0.00217105013399084,0.438376663114701
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_A,,40482,-0.00271504682628274,0.00350438684214088,-0.00958364503687887,0.00415355138431339,0.438499728351215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,42346,0.00376970736612646,0.00487797855057986,-0.00579113059301006,0.013330545325263,0.439653968579385
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHDC3L,KH domain-containing protein 3,40080,-0.00563807663786639,0.00729917177513073,-0.0199444533171226,0.00866830004138985,0.439878394939997
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,40449,-0.00379564609553508,0.00491615546539296,-0.0134313108077053,0.00584001861663512,0.440085572696369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.0039060975505504,0.0050749996738673,-0.0060409018102295,0.0138530969113303,0.441509678768937
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,40302,0.00604916120143983,0.00792913248753315,-0.00949193847412514,0.0215902608770048,0.445537279201483
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00220990116225905,0.00291831890226546,-0.00792980621069935,0.00351000388618125,0.448912464529697
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00423730783354938,0.00565554762523853,-0.0153221811790169,0.00684756551191815,0.453734280633724
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI2B,Protein EVI2B,40080,-0.00320966893350109,0.00432981485879791,-0.011696106056745,0.00527676818974281,0.458530747421715
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REST,RE1-silencing transcription factor,40080,-0.00267698404546693,0.0036277100981351,-0.00978729583781173,0.00443332774687787,0.460574915391403
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00512480983846085,0.00695400679080287,-0.00850504347151276,0.0187546631484345,0.461163551722157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.00501260395937135,0.00680226570280335,-0.0183450447368659,0.00831983681812321,0.461197679344274
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00391707067259434,0.00531670129895004,-0.00650366387334775,0.0143378052185364,0.461291220771058
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAG,Myelin-associated glycoprotein,40182,0.00381907752806894,0.00518815715490365,-0.00634971049554222,0.0139878655516801,0.461676754307019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00540243812633006,0.00734976438877624,-0.0198079763283315,0.00900310007567138,0.462325338554342
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL9,Interleukin-9,40302,0.0043639451042741,0.00594400654223227,-0.00728630771850115,0.0160141979270493,0.462857164136608
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00194822834250473,0.00266667717172091,-0.00717491559907772,0.00327845891406825,0.465049774043209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSCA,Prostate stem cell antigen,40449,0.0205098391322127,0.0280973311882319,-0.0345609299967218,0.0755806082611472,0.465431757822953
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAGE2A,G antigen 2A,40080,0.00513393741111968,0.00704976706418663,-0.00868360603468611,0.0189514808569255,0.466481041929781
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00194153739939602,0.00266696644914682,-0.00328571684093175,0.0071687916397238,0.466631880351217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF7,Fibroblast growth factor 7,40080,-0.00608478495818164,0.00838466587718187,-0.0225187300774581,0.0103491601610948,0.468035894173974
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00283482610866751,0.00392087024824811,-0.0105197317952338,0.00485007957789879,0.469689079333169
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAGLN3,Transgelin-3,40080,0.00467459280927911,0.00648235316343023,-0.00803081939104415,0.0173800050096024,0.470847538534226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00510746743193327,0.00714237637928889,-0.0191065251353395,0.00889159027147295,0.474566510962164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.00242203743347857,0.00339123980446579,-0.00422479258327437,0.00906886745023151,0.475115700827959
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN1,Transcobalamin-1,40337,0.00254499722897519,0.00360292988804307,-0.00451674535158923,0.00960673980953962,0.479973592621176
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.00507076947043906,0.00718390727810738,-0.0191512277355295,0.00900968879465141,0.480292968566846
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.002588554390074,0.00367466758733653,-0.0097909028612536,0.0046137940811056,0.481175791622586
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLHL41,Kelch-like protein 41,40482,-0.00355453730702352,0.0050618966011897,-0.0134758546453553,0.00636678003130829,0.482559868980882
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10,Interleukin-10,42370,0.00625115127262991,0.00896539799617719,-0.0113210287998774,0.0238233313451372,0.48565673438795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVPL,Envoplakin,40302,-0.00258795992428686,0.00371958778407134,-0.00987835198106669,0.00470243213249297,0.486590410862602
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00328984095790707,0.00474142025756279,-0.0125830246627301,0.00600334274691599,0.487789738292019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCLRE1C,Protein artemis,40080,0.00228978481729181,0.00330478005314355,-0.00418758408686955,0.00876715372145316,0.488405565022856
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.00474255585492277,0.0068588999491026,-0.0181859997551638,0.00870088804531832,0.48929750869018
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.00237034509346869,0.00343132924506993,-0.00909575041380575,0.00435506022686838,0.489708836025663
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,40286,0.00744830495727157,0.0108161901388198,-0.0137514277148153,0.0286480376293585,0.491073336229481
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASQ2,Calsequestrin-2,40116,-0.0035514082157464,0.00518903660090209,-0.0137219199535145,0.00661910352202169,0.493733297470447
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAND5,DAN domain family member 5,40199,0.00399226156606758,0.00585069041779043,-0.00747509165280165,0.0154596147849368,0.495027383815902
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00264618047587182,0.00389824319268621,-0.00499437618179316,0.0102867371335368,0.497270275249805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,42346,0.00225585159076306,0.00332694553740548,-0.00426496166255168,0.00877666484407781,0.49774883874111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31,Interleukin-31,40199,0.00400680260604478,0.00594851466024303,-0.00765228612803157,0.0156658913401211,0.500592293134871
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,40451,0.00259916107943142,0.00386649998030593,-0.00497917888196821,0.0101775010408311,0.501453749097118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGA,Fibrinogen alpha chain,40284,0.00218320700382469,0.00326113090488671,-0.00420860956975325,0.00857502357740264,0.503214009827983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,40283,0.00372769796476494,0.00560149938316355,-0.00725124082623561,0.0147066367557655,0.505755985255417
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD2,Leiomodin-2,40136,0.00438723648791635,0.00659350330266207,-0.0085360299853013,0.017310502961134,0.505816527354962
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFRC,Transferrin receptor protein 1,42673,0.00265253031872788,0.00398712483963421,-0.00516223436695517,0.0104672950044109,0.505886667617297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.00368685042232965,0.00556463792389219,-0.0145935407531583,0.00721983990849904,0.507632416335394
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",40451,0.00298070821822787,0.00451208902799338,-0.00586298627663915,0.0118244027130949,0.508879229760354
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00494702456195641,0.0075260698236805,-0.0196981214163702,0.00980407229245736,0.510990000585946
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00396062526577552,0.00606137477726467,-0.00791966929766323,0.0158409198292143,0.513496504814002
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC8,Histone deacetylase 8,40199,0.00407292107658329,0.00623876695877834,-0.00815506216262225,0.0163009043157888,0.513872609944996
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,42794,0.00222951314163652,0.0034165017987833,-0.00446683038397876,0.00892585666725179,0.514043322333836
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP15,Matrix metalloproteinase-15,40511,0.00336141518302417,0.00515292709665585,-0.00673832192642129,0.0134611522924696,0.514200777647059
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,42370,0.00276078178974543,0.00424217376553797,-0.00555387879070899,0.0110754423701998,0.51519073759009
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,40223,-0.00274753918878382,0.00422267574828026,-0.0110239836554131,0.00552890527784549,0.515277558161048
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.00203666953276163,0.0031353283468689,-0.0041085740271014,0.00818191309262467,0.515972083334426
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF3,Fibroblast growth factor 3,40199,0.00199114259955306,0.00307121643003215,-0.00402844160330995,0.00801072680241606,0.516789092863148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKZF2,Zinc finger protein Helios,42346,0.00596658988977687,0.00928223033889836,-0.0122265815744639,0.0241597613540177,0.520367030358602
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.00497813057465868,0.00775261313026547,-0.020173252309979,0.0102169911606617,0.520806827950903
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNB2,Ephrin-B2,40182,0.0037047759232705,0.00577010255802477,-0.00760462509045805,0.015014176936999,0.520844934253522
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRN1,Neuritin,40482,0.00246649499848598,0.00384289805741031,-0.00506558519403823,0.00999857519101019,0.520995293956252
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,40302,-0.00302028071020209,0.0047128945648006,-0.0122575540572113,0.00621699263680709,0.521630299771532
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSG1,Tryptase gamma,40199,0.0017928490192994,0.00280643853826528,-0.00370777051570055,0.00729346855429934,0.522944068804172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00474933920462437,0.0075375487713014,-0.0100242563871264,0.0195229347963751,0.528648361673003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",42311,-0.00360123058051344,0.00571865809145044,-0.0148098004397563,0.00760733927872941,0.528879928573521
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0179523804373159,0.0286056739253128,-0.0381147404562972,0.074019501330929,0.530291382855032
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,40483,-0.00180418945014106,0.00288224424733947,-0.00745338817492643,0.00384500927464431,0.531349318044648
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00181343873639374,0.00290013957965262,-0.00749771231251288,0.0038708348397254,0.531788867147283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,40080,0.00242019229553741,0.0038872273242899,-0.0051987732600708,0.0100391578511456,0.533559680703488
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00415336848066119,0.00669703978771916,-0.00897282950326837,0.0172795664645907,0.535152431769653
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.00390027485461859,0.00631138658284816,-0.00847004284776381,0.016270592557001,0.53660288947324
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REN,Renin,42636,-0.00555546225811716,0.00901062422865146,-0.023216285746274,0.0121053612300397,0.537544814433879
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,42370,0.00418531500266934,0.00680630830500948,-0.00915504927514923,0.0175256792804879,0.538620123496203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEB,Nebulin,40116,-0.00248331445863511,0.00405764648078069,-0.0104363015609653,0.00546967264369503,0.540544820871643
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,42594,0.0030896753292524,0.00506117896896988,-0.00683023544992857,0.0130095861084334,0.541563820166502
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDAN1,Codanin-1,40483,0.00145180673501607,0.00238866769121448,-0.0032299819397643,0.00613359540979645,0.543339433189713
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00189851115496151,0.00314092505899519,-0.00425770196066905,0.00805472427059208,0.545559352984954
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP4,Caspase-4,40302,0.0110243386761687,0.0182541828023469,-0.0247538596164312,0.0468025369687687,0.545899235448077
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2BP,LRP2-binding protein,40182,0.00549140323715713,0.00912609471828292,-0.0123957424106774,0.0233785488849916,0.547369336462386
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,40182,0.00321641671676525,0.00534736637791197,-0.00726442138394221,0.0136972548174727,0.547522429094726
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL5,Fc receptor-like protein 5,42611,-0.00371038178604112,0.00621224230485948,-0.0158863767035657,0.00846561313148346,0.550337658201911
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00509647019009564,0.00857316921871837,-0.0218998818587837,0.0117069414785924,0.552211602800712
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPN,Asporin,40511,-0.00175589125138537,0.00296441475245734,-0.00756614416620176,0.00405436166343102,0.553646103012995
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,40532,0.00164289794043599,0.00278563650231351,-0.00381694960409849,0.00710274548497048,0.555353457146406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,40182,0.00379857821999674,0.00648052289062546,-0.00890324664562916,0.0165004030856226,0.557784712867
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,40482,0.00220383699249617,0.00380439512983792,-0.00525277746198614,0.00966045144697849,0.562407033336494
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00460336468248158,0.00799232409239923,-0.0110615905386209,0.0202683199035841,0.564645125286398
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH2,Growth hormone variant,42346,0.0101357164131101,0.0176029441624938,-0.0243660541453777,0.0446374869715978,0.564762484733941
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,42638,-0.00144507588327303,0.00252613787530592,-0.00639630611887264,0.00350615435232658,0.567298011576933
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSP90B1,Endoplasmin,42247,-0.00400747887208306,0.00703476981339171,-0.0177956277063308,0.00978066996216468,0.568913123491098
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL4,Early placenta insulin-like peptide,40451,-0.00292346270962813,0.00514258447282351,-0.0130029282763622,0.00715600285710594,0.569719592090076
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,40059,0.00297975964549201,0.00525461373598906,-0.00731928327704655,0.0132788025680306,0.570674999080903
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB116,Beta-defensin 116,40136,-0.00461100470011975,0.0081392565690904,-0.0205639475755369,0.0113419381752974,0.571055878890186
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF6,Fibroblast growth factor 6,40199,-0.00247624225029597,0.0043777128085487,-0.0110565593550514,0.00610407485445948,0.571644971683812
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00242889275375853,0.00429430073246968,-0.00598793668188205,0.0108457221893991,0.571671584290484
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00178916976890715,0.003170904590269,-0.00442580322802009,0.00800414276583439,0.572597991373062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF75D,Zinc finger protein 75D,40302,0.00365265842228979,0.00648356767034701,-0.00905513421159036,0.0163604510561699,0.573193187849138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD1,Glutamate decarboxylase 1,40080,-0.00155720332625429,0.00276778399208106,-0.00698205995073318,0.00386765329822459,0.573707052907945
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00187317551238782,0.00334564389152954,-0.00843063753978572,0.00468428651501007,0.575569406666895
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00422542737234798,0.00758337321712787,-0.0106379841332227,0.0190888388779186,0.577404678130928
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPGN,Epigen,40451,0.00266594786181045,0.00480591130636603,-0.00675363829866697,0.0120855340222879,0.579095401316435
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.00346306118567236,0.00625896710104419,-0.015730636703719,0.00880451433237425,0.580072074119476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.00150988802963003,0.00273316934410808,-0.00686689994408187,0.0038471238848218,0.580664261619512
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00220520579380238,0.0039946716721333,-0.00562435068357888,0.0100347622711837,0.580934431162384
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RUVBL1,RuvB-like 1,42346,0.00612534894740597,0.0111516963633843,-0.0157319759248273,0.0279826738196392,0.582826009686511
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00276743249506236,0.00504408304470886,-0.0126538352626917,0.007118970272567,0.583257416302358
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN1,Neuroligin-1,40182,-0.00403059917176727,0.00738999030188766,-0.0185149801634671,0.0104537818199325,0.585480349872068
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCIN,Adseverin,40136,0.00419729571392169,0.00770779307504281,-0.0109099787131622,0.0193045701410056,0.586072631374003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGR,Progesterone receptor,40199,0.00558566762369429,0.0103243292116601,-0.0146500176311595,0.0258213528785481,0.58850481258727
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00213017418492941,0.00397432920528401,-0.00991985942728607,0.00565951105742724,0.591978959544099
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00354541989243142,0.00661697553341857,-0.0165146919379318,0.00942385215306898,0.592103034734558
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP4,Bone morphogenetic protein 4,42475,-0.00260311687875912,0.00490802810312557,-0.0122228519608852,0.007016618203367,0.595857790412686
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42587,-0.00366817738740982,0.00697544669217099,-0.017340052904065,0.0100036981292453,0.598987317222043
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,40136,0.00338891429410664,0.00644780429051336,-0.00924878211529954,0.0160266107035128,0.599182373238494
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPE,Coatomer subunit epsilon,42311,0.0026202508959456,0.00500158271311704,-0.0071828512217638,0.012423353013655,0.600367833471314
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK15,Kallikrein-15,40429,0.00294056339869385,0.00563694385919552,-0.00810784656532937,0.0139889733627171,0.601917947805777
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00238332891524731,0.00457069466614156,-0.0113418904608848,0.00657523263039014,0.602072996244195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,40116,0.00266367031043424,0.0051391891351856,-0.00740914039452955,0.012736481015398,0.604255592556164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.00348855536504155,0.0067419486332774,-0.0167027746862653,0.00972566395618215,0.604859351315135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00195787694721671,0.0037919771398579,-0.00547439824690477,0.00939015214133819,0.605638840169199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,42636,-0.00184007825117511,0.00357998642542195,-0.00885685164500213,0.00517669514265191,0.607267230439203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH4,Cadherin-4,40136,0.00269968734491921,0.00525815358513391,-0.00760629368194325,0.0130056683717817,0.607661789092985
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,40182,-0.00364583037930677,0.00712194463605376,-0.0176048418659721,0.0103131811073586,0.608720778623709
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3,Interleukin-3,40080,0.00331879585105087,0.00653489602601227,-0.00948960035993319,0.0161271920620349,0.611563582718485
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00369739747045849,0.00745086418613748,-0.010906296334371,0.0183010912752879,0.619736745819578
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PITHD1,PITH domain-containing protein 1,40065,-0.00423194139336794,0.00853809217919671,-0.0209666020645935,0.0125027192778576,0.620148413154612
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53BP1,TP53-binding protein 1,40199,0.0045289279337375,0.00916287894076551,-0.0134303147901629,0.0224881706576379,0.621126009803594
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPT1,Translationally-controlled tumor protein,42370,-0.00339053064384499,0.00689902664714662,-0.0169126228722524,0.0101315615845624,0.623115984107974
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAD,Chondroadherin,40283,0.0026670289745717,0.00547707375418005,-0.0080680355836212,0.0134020935327646,0.626307541231081
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORN4,MORN repeat-containing protein 4,40080,-0.00395791926344861,0.00813128069946998,-0.0198952294344098,0.0119793909075125,0.626443704674348
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,40182,0.00209571291261562,0.00444439791961981,-0.0066153070098392,0.0108067328350704,0.637264280703223
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,42592,-0.00243604020855657,0.00516883543047046,-0.0125669576522787,0.00769487723516554,0.637438600154474
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,40302,0.00182744803278116,0.00390011334574635,-0.00581677412488169,0.00947167019044401,0.639391366543111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,40302,0.00331404630277304,0.00708388371380453,-0.0105703657762839,0.0171984583818299,0.639916051509086
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17C,Interleukin-17C,42370,-0.00363840449424688,0.00788346834911046,-0.0190900024585034,0.0118131934700096,0.644430812554818
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA8,Carbonic anhydrase-related protein,40199,0.00138337893178333,0.00302294234400643,-0.00454158806246927,0.00730834592603592,0.64722973906166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.00248473859499225,0.0054803049797886,-0.0132261363553779,0.00825665916539341,0.650272295024127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,0.00253333294849701,0.0055944453984203,-0.00843178003240679,0.0134984459294008,0.650679855782787
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSB,Lupus La protein,42311,0.00276910750535776,0.0061404700698858,-0.00926621383161841,0.0148044288423339,0.652025701097638
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM2,Isthmin-2,40527,0.00205315069322737,0.00457254018619052,-0.00690902807170605,0.0110153294581608,0.653427597788425
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,40182,-0.00198880963829621,0.00444244021785373,-0.0106959924652895,0.00671837318869711,0.654390058339343
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STEAP4,Metalloreductase STEAP4,40136,0.0034227912264552,0.00769752180013876,-0.0116643515018168,0.0185099339547272,0.656573225013003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17A,Interleukin-17A,42347,-0.00201715063715219,0.00455553446360532,-0.0109459981858186,0.00691169691151424,0.657924040305844
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00136522170400062,0.00309379371695765,-0.00469861398123637,0.0074290573892376,0.659020747755109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00174768080577012,0.00396376513963347,-0.00951666047945173,0.00602129886791149,0.659282405239328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDS,Iduronate 2-sulfatase,42754,0.00040458196820535,0.000920484840242854,-0.00139956831867064,0.00220873225508134,0.660283556956737
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEFL,Neurofilament light polypeptide,42262,0.00210495271277557,0.00487641536983752,-0.00745282141210597,0.0116627268376571,0.66599577580988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,42679,0.00364692279713181,0.00844890272513316,-0.0129129265441292,0.0202067721383928,0.666006676429208
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00265518786367005,0.00618068189752539,-0.0147693243828198,0.00945894865547971,0.667498989943383
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMP,Olfactory marker protein,40136,-0.00227947242035473,0.00531932499121812,-0.0127053494031422,0.00814640456243278,0.668276183943577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.0017011680076845,0.00398739930023717,-0.00951647063614935,0.00611413462078036,0.669652895741844
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.00125247966246123,0.00299890405512299,-0.00462537228557982,0.00713033161050229,0.676214258293281
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR4,Complement factor H-related protein 4,40509,0.00326067167788012,0.0078588654286111,-0.0121427045621976,0.0186640479179579,0.678220329444688
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,0.00514219090662869,0.0125038474192198,-0.0193653500350421,0.0296497318482995,0.680896755363352
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.00240089245003541,0.00587220943701592,-0.0091086380465158,0.0139104229465866,0.68265283502431
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN1,Calsyntenin-1,42311,-0.00221056697316171,0.00560267636815111,-0.0131918126547379,0.00877067870841447,0.693177349006847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,42636,0.00130028831755222,0.00333603998290911,-0.00523835004894965,0.00783892668405408,0.69671280155005
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTN3,Myeloblastin,42276,0.00199599558434034,0.00514429069581089,-0.00808681417944901,0.0120788053481297,0.698020793968543
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,40199,-0.00358241823165757,0.00924998452317994,-0.0217123878970903,0.0145475514337751,0.698549679378662
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSPN,Claspin,42292,0.00142701318147916,0.00369651984067089,-0.00581816570623577,0.0086721920691941,0.699471579530601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN15,Lipocalin-15,40482,-0.00250724372498324,0.00661238403129331,-0.0154675164263181,0.0104530289763517,0.704565832019301
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00189396276330122,0.00501581588980405,-0.0117249619073172,0.00793703638071471,0.705735073336224
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN6,Prefoldin subunit 6,40182,0.00256587228154025,0.00685121868201234,-0.0108625163352039,0.0159942608982844,0.708029716251593
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR3,Folate receptor gamma,42629,-0.00730552000171269,0.019558673418793,-0.0456405199025469,0.0310294798991215,0.708768714334328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAEP,Glycodelin,42495,0.00352058549309954,0.00949200358188284,-0.0150837415273908,0.0221249125135899,0.710717814883411
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36A,Interleukin-36 alpha,40199,-0.00224601697971905,0.00607667686426976,-0.0141563036336878,0.00966426967424968,0.711678194264627
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00212810424046467,0.00578652140332412,-0.0134696861909799,0.00921347771005061,0.713052423188139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,40223,0.00191669709292355,0.00522186445179656,-0.00831815723259771,0.0121515514184448,0.713587086588175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMCN2,Hemicentin-2,40269,0.00225432826376474,0.00616769671557648,-0.00983435729876517,0.0143430138262946,0.714740938053711
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,42721,-0.00228258937396744,0.00625720949155106,-0.0145467199774075,0.00998154122947264,0.715271257442102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00112099272925132,0.00310160818437278,-0.00720014477062196,0.00495815931211933,0.717789947524839
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00121572572644137,0.00342397477050615,-0.00792671627663342,0.00549526482375067,0.722548199748258
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WNT9A,Protein Wnt-9a,42370,-0.00109609676057383,0.00313317287898399,-0.00723711560338244,0.00504492208223479,0.726467349098582
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.00121981884435632,0.00351600131133943,-0.00811118141458161,0.00567154372586897,0.728647906908255
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.0014952018481743,0.00431382578331129,-0.00695989668711582,0.00995030038346442,0.728892209755221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSMB,Beta-microseminoprotein,42559,0.00263970496705453,0.0076361715953183,-0.0123271913597693,0.0176066012938784,0.729585392337434
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,42721,-0.00217970909381715,0.00634918740575337,-0.0146241164090938,0.0102646982214595,0.731374199483076
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPE4,NXPE family member 4,40116,-0.00120526287619314,0.00356221155620669,-0.00818719752635824,0.00577667177397196,0.735108364308351
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00139662340682218,0.00414399746782425,-0.00672561163011336,0.00951885844375771,0.736104757346233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,40080,-0.00138522797617145,0.00412270407243759,-0.00946572795814913,0.00669527200580622,0.736877450460128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF12,Fibroblast growth factor 12,40199,-0.00165202620152207,0.00494255849889462,-0.0113394408593555,0.00803538845631138,0.738200946422595
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,-0.000878646391670524,0.00263438621410541,-0.00604204337131712,0.00428475058797608,0.738739595925089
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFAP,Glial fibrillary acidic protein,42326,0.00171347939217328,0.00516132787500041,-0.00840272324282752,0.0118296820271741,0.739906475255524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHC1,SHC-transforming protein 1,40080,-0.00402382808419312,0.0124934996404988,-0.0285110873795707,0.0204634312111845,0.747403020354956
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,-0.00151919063466464,0.00473012454016576,-0.0107902347333895,0.00775185346406026,0.748084862339783
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.0019304149762623,0.00602040767973001,-0.00986958407600851,0.0137304140285331,0.748485384194444
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00140830246162995,0.00440111544667915,-0.0100344887371211,0.00721788381386118,0.748983789221705
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00207032069749725,0.00647653372515883,-0.0147643267988086,0.0106236854038141,0.7492284620696
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTN,Neuroplastin,42346,-0.00263033413957452,0.00829900309710101,-0.0188963802098925,0.0136357119307435,0.751289762796212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,-0.000942339222979915,0.00299093465434811,-0.00680457114550222,0.00491989269954239,0.752717092136958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBB,Inhibin beta B chain,40283,0.00173361126955052,0.00575127317989239,-0.00953888416303855,0.0130061067021396,0.763091610691078
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELL,L-selectin,40539,0.000755286429994836,0.0025150943990603,-0.00417429859216335,0.00568487145215302,0.763952749293723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,42346,0.00149864264406598,0.00509638783541046,-0.00849027751333851,0.0114875628014705,0.768716870411657
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSD1,Tryptase delta,40482,-0.00117599631137908,0.0040568079854132,-0.00912733996278896,0.0067753473400308,0.771911705216056
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.000936583222194893,0.00323767529258451,-0.00540926035127074,0.00728242679566052,0.772374386536711
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,40080,-0.00130369332638036,0.00451020878199608,-0.0101437025390927,0.00753631588633197,0.772545654019019
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.00155966272284007,0.00542989864599293,-0.0122022640689862,0.00908293862330608,0.773937160794176
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOS,Proto-oncogene c-Fos,40065,0.00108446765413375,0.00377896399783152,-0.00632230178161603,0.00849123708988352,0.774137041181927
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCLN,Nicalin,42370,0.00156993344548976,0.00547270778516729,-0.00915657381343813,0.0122964407044176,0.774219484010167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42794,-0.000684635442381355,0.00239724187982054,-0.00538322952682961,0.0040139586420669,0.775194233278542
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,40080,0.00187408587901473,0.0066143546582796,-0.0110900492512133,0.0148382210092427,0.776924545209374
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.00164344997762771,0.00592844686389432,-0.0132632058308606,0.00997630587560515,0.781619963309055
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00167595275568171,0.00609889985591459,-0.0102778909619109,0.0136297964732743,0.783478252804435
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL24,Interleukin-24,42370,0.00144871427888046,0.00533508857067965,-0.00900805931965164,0.0119054878774126,0.785976486850683
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00147141139149149,0.00545261411654056,-0.012158535059911,0.009215712276928,0.787277431729648
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,40182,0.00121370626440123,0.00452971116553214,-0.00766452762004178,0.0100919401488442,0.788747906638214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00133941013907325,0.00516874981609201,-0.0087913395004671,0.0114701597786136,0.795535008772498
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAYN,Layilin,42476,-0.00103228538655545,0.00398783652982365,-0.00884844498500981,0.00678387421189891,0.795748429762399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN2,Contactin-2,42721,-0.00120143645353076,0.00469852187115997,-0.0104105393210043,0.00800766641394277,0.798182371068389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D2,DCN1-like protein 2,40080,0.00215766445406963,0.00847522478108789,-0.0144537761168626,0.0187691050250019,0.799048513569233
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,40302,0.00107122101519218,0.00422009810360334,-0.00720017126787037,0.00934261329825472,0.799625458289981
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.00100045581585296,0.00400213201528976,-0.0088446345658209,0.00684372293411497,0.802606095849155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL11,Interleukin-11,42370,0.00164700574200671,0.00661486173950656,-0.0113181232674261,0.0146121347514396,0.803375751652453
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00458963459390202,0.0184913793086445,-0.0316534688510412,0.0408327380388452,0.803981087921413
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB2,Integrin beta-2,42569,-0.000747652565636357,0.00301817133868508,-0.00666326838945912,0.0051679632581864,0.804357124814354
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,-0.00136027916252899,0.00549197015248189,-0.0121245406613935,0.00940398233633552,0.804382719109085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,40283,-0.000723922311477693,0.00294137248519223,-0.00648901238245447,0.00504116775949909,0.805596076921204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3A,Uroplakin-3a,40136,0.00132837589618438,0.00540291668764063,-0.00926134081159126,0.01191809260396,0.805793099856649
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,40116,0.000968683947505534,0.00400397505901547,-0.00687910716816478,0.00881647506317585,0.808838508314477
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,-0.00177687896828882,0.0073813719048887,-0.0162443679018707,0.012690609965293,0.80977289137776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB2,Beta-crystallin B2,40483,0.00204631023408595,0.00862309080803216,-0.0148549477496571,0.018947568217829,0.812423799643599
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRNN,Cornulin,42209,0.00172172949790809,0.00728502351812613,-0.0125569165976191,0.0160003755934353,0.813173949923273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.00155859527350917,0.00665043596849925,-0.0114762592247493,0.0145934497717677,0.814709933734773
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX33,Testis-expressed protein 33,40302,-0.000940701323389183,0.00403192871002673,-0.00884328159504157,0.0069618789482632,0.8155226751992
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLGAP5,Disks large-associated protein 5,40482,-0.00124217959575285,0.00536749715384804,-0.011762474017295,0.0092781148257893,0.816987889358861
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,42311,-0.00120064323069239,0.00519996033107155,-0.0113925654795926,0.00899127901820785,0.817400216855363
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGM2,Phosphoglucomutase-2,40182,0.0014297445226669,0.00632323290935676,-0.0109637919796723,0.0138232810250061,0.821120278181631
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCP11,T-complex protein 11 homolog,40302,0.00139364823829051,0.00625599816664731,-0.0108681081683382,0.0136554046449192,0.823718672661896
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.000919123489829025,0.00416727825702072,-0.00724874189393159,0.00908698887358964,0.825441187739174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.000682987962248635,0.00312052638614935,-0.00543324375460409,0.00679921967910135,0.826755674613769
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTH3,Cytohesin-3,40080,-0.00168436646899132,0.00789913981966483,-0.0171666805155344,0.0137979475775517,0.831148315650769
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D1,DCN1-like protein 1,40136,-0.00167871607672423,0.00792122645502419,-0.0172043199285716,0.0138468877751232,0.832168492894661
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR1B,Cornifin-B,40302,-0.00184093072406599,0.00877758494140318,-0.0190449972092162,0.0153631357610842,0.833881559288327
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,42698,0.00142711650254592,0.00689623603326606,-0.0120895061226556,0.0149437391277474,0.83605877070189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00110429424981297,0.00534624278514745,-0.00937434160907603,0.011582930108702,0.836361113550905
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.001918985331407,0.00956722799638323,-0.0206707522043181,0.0168327815415041,0.841031378352461
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00233593227551568,0.0116483183514943,-0.0204947716934132,0.0251666362444446,0.841063454211087
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC9,Histone deacetylase 9,40136,-0.00138908448187459,0.00693675113428288,-0.014985116705069,0.0122069477413198,0.841288778587217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXOSC10,Exosome component 10,40116,-0.00124987510109993,0.00638220982167934,-0.0137590063515914,0.0112592561493916,0.844741113007637
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLLT1,Protein ENL,40080,0.00131806455481313,0.00702057114715602,-0.0124422548936127,0.0150783840032389,0.851081455900061
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00102569921373837,0.00564050162951199,-0.0100296839801051,0.0120810824075819,0.855707437548144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2,Interleukin-2,42370,-0.000606809488680527,0.00338665064533222,-0.00724464475353169,0.00603102577617063,0.857801573820372
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM132A,Transmembrane protein 132A,40223,-0.0011813942160762,0.00661599861370384,-0.0141487514989357,0.0117859630667833,0.858281558652035
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,42594,0.000852779342705287,0.00484080462353703,-0.00863519771942728,0.0103407564048379,0.860167141681186
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRND,Prion-like protein doppel,40483,0.000968617490187594,0.00552765161572968,-0.00986557967664259,0.0118028146570178,0.860901046202794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00129997251819788,0.00757328461925964,-0.013543665335551,0.0161436103719468,0.86371398572608
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00058486283702157,0.00350654656538256,-0.00628796843112825,0.00745769410517139,0.867536517376922
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK3,Prostate-specific antigen,40527,0.00171750510951968,0.0103608174146769,-0.0185896970232471,0.0220247072422865,0.868341489670807
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00114930668907279,0.0069793675315499,-0.0148288670509106,0.012530253672765,0.869205182820335
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.000543509435787646,0.00333538658694176,-0.00599384827461821,0.0070808671461935,0.870558370374388
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN1,Prorelaxin H1,40482,0.000815052257802177,0.00511489255597337,-0.00921013715190562,0.01084024166751,0.87339688486222
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,40080,0.000919057527087891,0.00587544630606528,-0.0105968172328,0.0124349322869758,0.875702162195962
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,40302,0.00140461376492025,0.0091750847941486,-0.016578552431611,0.0193877799614515,0.87833007958439
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGN,Secretagogin,42370,-0.000703676999782137,0.00477297436988075,-0.0100587067647484,0.00865135276518414,0.882795315284303
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.000751252138999169,0.00509987176506624,-0.010747000798529,0.00924449652053066,0.882891146847573
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.00130858538971388,0.0089525073071103,-0.0188554997116501,0.0162383289322223,0.883790088648549
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.00136768414765125,0.00956019208592067,-0.0201056606360558,0.0173702923407533,0.886245161014605
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPT,Microtubule-associated protein tau,42311,-0.00080193281032754,0.00561243523079888,-0.0118023058626933,0.0101984402420383,0.886383199627165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A16,Protein S100-A16,42292,0.000869995893529671,0.00640294304832583,-0.011679772481189,0.0134197642682483,0.891922680362358
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,-0.00111197591738639,0.00833556802802508,-0.0174496892523155,0.0152257374175428,0.893878431236867
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF830,Zinc finger protein 830,40451,-0.00108254654703993,0.00818910066859779,-0.0171331838574916,0.0149680907634117,0.89483354036121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00108808000735926,0.00830970879131737,-0.0151989492236228,0.0173751092383413,0.895824527306172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.000676336513654661,0.00523539580939824,-0.0109377123000752,0.00958503927276589,0.897213355706418
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,40519,0.000342585738612275,0.00267035098140475,-0.00489130218494103,0.00557647366216558,0.897919856627067
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,0.000909530263890699,0.00738722537969246,-0.0135694314803065,0.0153884920080879,0.902012723540515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,40080,-0.000397528895898435,0.00323882989349992,-0.00674563548715828,0.00595057769536141,0.902316496989681
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.000696310071113065,0.00569215600269429,-0.0104603156941677,0.0118529358363939,0.902641502604157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANK2,Ankyrin-2,40116,-0.000943594210222598,0.00778027864933998,-0.016192940362929,0.0143057519424838,0.903471286625325
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BEX3,Protein BEX3,40080,0.000609679527488036,0.00505593361902654,-0.00929995036580397,0.01051930942078,0.904020444890495
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFR,Epidermal growth factor receptor,42794,-0.000185646389205549,0.00171634154976995,-0.00354967582675464,0.00317838304834354,0.913867186752101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.000581800970766547,0.00538740319143987,-0.00997750928445559,0.0111411112259887,0.914003343623178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.000483594130442607,0.00463844909069539,-0.00957495434820558,0.00860776608732037,0.916966711158062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.000523342552508296,0.00517756826316019,-0.0106713763483023,0.00962469124328569,0.919489743109546
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNLZ,DNL-type zinc finger protein,40136,-0.00095547340639152,0.00962278317678769,-0.0198161284328954,0.0179051816201123,0.920907587383198
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,40116,-0.00057975231197289,0.00605550151974043,-0.0124485352906641,0.0112890306667184,0.923729011936653
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,40116,-0.000778342331851358,0.00814176449972689,-0.0167362007513161,0.0151795160876133,0.923841029134524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,40136,0.000479442530401174,0.00508942798137129,-0.00949583631308656,0.0104547213738889,0.924949135520694
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.000262171107121462,0.00311215993750913,-0.00636200458463936,0.00583766237039644,0.932866406103373
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.000514556697614311,0.00612385306286221,-0.0114881953055956,0.0125173087008242,0.933038107227944
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.000355410571882645,0.00448170310265772,-0.00842872750932648,0.00913954865309177,0.936793404437204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.000138085475927729,0.00184335294624963,-0.00375105725057701,0.00347488629872155,0.940287475039957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171A2,Protein FAM171A2,40482,0.00112692322767803,0.0168944794588346,-0.0319862565116378,0.0342401029669938,0.946818820061255
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF174,Zinc finger protein 174,40199,-0.000259740520898817,0.00395169604461288,-0.00800506476834006,0.00748558372654243,0.947594880022805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHIT1,Chitotriosidase-1,42699,-0.00103903372725005,0.016270973857196,-0.0329301424873541,0.0308520750328541,0.949084148296323
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN15,Tetraspanin-15,40116,0.000348169159596198,0.00550679817729822,-0.0104451552679083,0.0111414935871007,0.949588227701209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESPL1,Separin,40080,0.000377272867488513,0.00608318366360774,-0.0115457671131827,0.0123003128481597,0.950548853004002
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESR1,Estrogen receptor,40199,-0.000357300209895621,0.00583817005442806,-0.0118001135165746,0.0110855130967834,0.951200467810315
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAP1,Antigen peptide transporter 1,40302,0.000385686009972286,0.00651112917277209,-0.012376127168661,0.0131474991886056,0.952766087041333
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,0.000396095328164452,0.00669761493032919,-0.0127312299352808,0.0135234205916097,0.952841855337583
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN4,Prefoldin subunit 4,40080,0.000309208084610963,0.0055533245559825,-0.0105753080451147,0.0111937242143367,0.955597901571882
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRX,Cone-rod homeobox protein,42357,-0.000623648063861438,0.0112070841056762,-0.0225895329109868,0.0213422367832639,0.955623336566502
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.000304367142900635,0.00547835643872968,-0.0110419457628108,0.0104332114770095,0.955694844497742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.000262029996113546,0.00478264867842277,-0.00911196141359507,0.00963602140582217,0.956308659182306
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEBP1,Heme-binding protein 1,42357,-0.000301701753844814,0.00556054654951619,-0.0112003729908965,0.0105969694832069,0.956730775917299
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN1,Cerebellin-1,40136,-0.000536367549924671,0.0100310232075792,-0.0201971730367799,0.0191244379369306,0.957357714998054
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.000482591814028246,0.0101816692132647,-0.0194734798439705,0.020438663472027,0.962196809757276
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,0.000153063481016352,0.00355641545250787,-0.00681751080589907,0.00712363776793177,0.965671474773512
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.000147468758281053,0.00365676008439553,-0.00731471852369629,0.00701978100713418,0.96783245723423
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYT1,Synaptotagmin-1,40483,0.000178012728388569,0.00447424694360381,-0.00859151128107489,0.00894753673785203,0.968264380831789
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.000318278945901412,0.00849265307164173,-0.0169638789663192,0.0163273210745164,0.97010526741603
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD8,Frizzled-8,40136,0.000180924925686129,0.00483648349044862,-0.00929858271559317,0.00966043256696543,0.970160087767877
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.000216733185057799,0.00607110227727191,-0.0121160936485107,0.0116826272783952,0.971522903632748
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.000263159143821621,0.00809241724617335,-0.0155979786586781,0.0161242969463214,0.974058560683946
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000118035781937203,0.00365804504250294,-0.00728780406524296,0.00705173250136855,0.974259359153984
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,-8.28464607719957e-05,0.00502790363612264,-0.00993753758757238,0.00977184466602838,0.986853883348005
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HK2,Hexokinase-2,42357,4.5559697937231e-05,0.00290963487884709,-0.00565732466460307,0.00574844406047753,0.987507297230272
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,40539,2.55315504062392e-05,0.00165478790156043,-0.0032178527366522,0.00326891583746468,0.987690281812522
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,40199,7.4646676080966e-05,0.00516741044368552,-0.0100534777935427,0.0102027711457046,0.988474690274634
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,5.16968902466324e-05,0.00471442592030167,-0.00918857791354464,0.0092919716940379,0.99125102777025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,40449,0.000140916300669837,0.0156873044691587,-0.0306062004588812,0.0308880330602209,0.992832998727845
